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ABSTRACT
Myelin is a multilamellar sheath that wraps the axons in the Central Nervous 
System (CNS) and in the Peripheral Nervous System (PNS). It is required for normal 
development, axonal health and to facilitate impulse conduction. MBP, one of the 
major myelin proteins, is synthesised by both oligodendrocytes (OL) in CNS and 
Schwann cells (SC) in PNS. Its synthesis is regulated primarily at the transcriptional 
level. MBP transcription is activated as a part of a program of coordinate myelin gene 
expression during development, overlapping but specific in OL as compared to SC. The 
nuclear proteins that bind to the MBP promoter are largely unidentified. In vitro and in 
vivo studies show that activation of the MBP proximal promoter requires different DNA 
binding sites and proteins in OL as compared to SC. Recently, transgenic mice studies 
identified a SC enhancer (SCE) located 9.0Kb upstream of the transcriptional start site 
of MBP. In this work, we compared MBP transcription mechanisms in OL and SC. 
Transient transfection analyses, in primary cultures of OL and SC, confirm the 
importance of SCE, and suggest that SCE is an activator in both cell types, but it is an 
enhancer only in SC. Biochemical analyses show that there are regions differentially 
protected by SC and OL nuclear extracts that can account for differential function. 
Analysis of internal deletions and transversion mutations of SCE suggests that multiple 
cis-acting elements cooperate to produce activation. Analyses of stably transfected SC 
show that chromatin upregulates SCE activation at least three fold. Co-culture of these 
stably transfected SC and dorsal root ganglia neurons reveal that axons markedly 
activate SCE, by at least two orders of magnitude. These results describe a model in 
which to analyse SCE biochemistry and function and identify trans-acting signals from 
axons that regulate MBP transcription in SC.
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Chapter 1
INTRODUCTION
1.1 THE NERVOUS SYSTEM
The nervous system comprises two distinct classes of neural cells: neurons and 
glia and other supporting cells likethose of blood vessels, meninges, immune cells and 
fibroblasts.
NERVE CELLS
A typical neuron contains four morphologically distinct regions: the cell body 
also named the perikaryon, the dendrites, the axon and the presynaptic terminal of the 
axon. The major characteristic of nerve cells is the ability to generate active electrical 
signals and each region has distinctive signalling functions. The perikaryon is the 
metabolic center of the neuron. It usually gives rise to a series of fine arborizing 
extensions named dendrites that constitute the receptive apparatus of the neurons. 
Some neurons develop a huge amount of dendrites, by constituting a sort of dendritic 
tree, while others can develop only a restricted number of them. The other 
characteristic neuronal structure is the axon, which is the conducting unit of the neuron. 
It is a tubular process that can extend for a long distance in the body. The high speed 
conduction of the action potential is facilitated by the myelin sheath which is present in 
the Central Nervous System (CNS) and in the Peripheral Nervous System (PNS), 
except at the level of the Node of Ranvier. The growth cone leads the axonal 
outgrowth. The growth cone moves by the elongation and contraction of microspikes, a 
series of pointed filopodia, which contain microfilaments, oriented parallel to the long 
axis of the axon. Micro spikes have both a sensory function and a structural role 
(Davenport et a l ,  1993). They contain microfilaments, that if  destroyed by
Introduction
cytochalasin B, blocks further axonal advance (Lamoureux et al., 1989). In general, the 
axon contains little protein synthesis machinery, and thus much of the protein required 
in the axon and synaptic terminal must be transported down the axon after it is 
synthesised in the cell body. Newly synthesised proteins are assembled into organelles 
and transported to the presynaptic terminals by a process called axoplasmic transport. 
The structures that support this transport are the microtubules, which serve as guides for 
the transport of organelles. Two families of motor proteins are involved in trafficking 
molecules and organelles along the microtubules: kinesins and dyneins. They are both 
microtubule -  activated ATPase proteins. Kinesins promote the anterograde transport, 
fi*om cell body towards the extremities, while dyneins are responsible for the movement 
in the other direction (Hirokawa, 1998). A recent paper shows that even the growth 
cone of the axon is a site of protein synthesis. This protein synthesis represents local 
translation since it occurs even when the growth cone is physically detached from the 
perikaryon (Campbell and Holt, 2001).
Near its end the axon divides into many fine branches, which have specialised 
extremities called presynaptic terminals, the transmitting elements of the neuron. 
Through them a neuron contacts and transmits information about its own activity to the 
receptive surfaces of any effector cells. The point of contact is called synapse. The 
synapse is formed by the presynaptic terminal of a cell, the receptive surface of the 
other and the space between them: the synaptic cleft. The terminals of the presynaptic 
neuron sometimes contact the post synaptic neuron directly on its cell body, more 
commonly they make contact with dendrites. In each neuronal cell information goes 
from the receiving sites of the neuron (cell body and dendrites), to the region from 
which the impulse initiates and finally to the presynaptic site in the axon that 
communicates with other cells. Between nerve cells there is no cytoplasmic continuity 
and each cell has specific and precise connections only with some nerve cells and not 
with others.
On the basis of the number of processes that arise from the cell body, neurons 
are classified into three groups, unipolar, bipolar and multipolar. Unipolar neurons 
have one primary process that gives rise to many branches. Some of them serve as 
dendritic structures and others as axons and terminal structures. They predominate in 
the nervous system of invertebrate animals. Bipolar neurons have an ovoid soma that
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gives rise to one process at each end: a dendrite or peripheral process and an axon or 
central process. The retinal bipolar cells belong to this class of neurons. Multipolar 
neurons predominate in the vertebrate nervous system. These cells have one or more 
dendritic processes and a single axon. In a typical multipolar cell, dendrites emerge 
from all parts of the neuronal body. Even within the category of the multipolar neurons 
the size and the shape of different cells vary greatly. Different types of multipolar cells 
account for all of the distinguishable neuronal types. The morphological differences 
among multipolar cells are due largely to variations in the number and length of 
dendrites and length of the axon. The number and extent of dendritic processes in a 
given cell correlate with the number of synaptic contacts that other neurons make on 
that cell, while the length of the axon reflects the signalling function of a neuron.
GLIAL CELLS
Glial cells are found between nerve cell bodies and also between axons. The 
various types of glial cells are thought to serve at least six distinct functions:
1. provide myelin;
2. provide firmness and structure to the brain. They also segregate and occasionally 
insulate groups of neurons from each other;
3. remove debris after neuronal death or injury;
4. buffer the concentration of the extracellular space and help to remove chemical 
transmitters released by neurons;
5. guide the migration of neurons and direct the outgrowth of axons during 
development;
6. be nutritive for nerve cells.
Glial cells are generally divided into major classes: macroglia and microglia. 
Macroglia include myelin forming cells (Fig. 1.1): Oligodendrocytes (OL) in the CNS 
and Schwann cells (SC) in the PNS, astrocytes and ependymal cells which line the 
central canal of brain and spinal cord. Microglia include an assortment of phagocytic 
cells that are mobilised after injury, infections or diseases. Some studies suggest that 
they can play active roles during cell degeneration. They also produce trophic factors 
that support the development of neurons and glia (Elkabes et a l,  1996). They originate
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from mesodermic precursors of hematopoietic lineages that enter the nervous 
parenchima from meninges, ventricular space or blood stream (Cuadros and Navascues,
1998). Once in the CNS they migrate to their final destination where they differentiate.
The two predominant classes of macroglial cells in the CNS are OL and 
astrocytes. Astrocytes are star-shaped cells with small irregular cell bodies, and many 
extensions that ramify between the processes of nerve cells. They are usually divided 
in two classes: fibrous and protoplasmic cells. Fibrous astrocytes contain many 
filaments and are found in the white matter areas of the CNS. The protoplasmic 
astrocytes have shorter processes that contain few filaments; they are located in the gray 
matter of the CNS and they are associated with nerve cell bodies, dendrites and 
particular synapses. They probably have nutritive functions; in fact their processes can 
contact blood capillaries on one side and neurons on the other. After injury, astrocytes 
and microglia remove neuronal debris and promote the sealing of the lesioned regions. 
They are also sensitive to small changes in K"*" concentrations in the extracellular space. 
By taking up the extracellular excess of K^, astrocytes can buffer concentration; in 
this way the membrane potential of neurons is protected from depolarisation that might 
result if accumulated after repeated neuronal firing.
The major function of OL and SC is to produce myelin respectively in the CNS 
and in the PNS. They form this sheath by wrapping their membranous processes 
around the axon in a tight spiral. One of the major differences between these two cell 
types is that a single OL can simultaneously envelop many axons in the CNS and make 
myelin around them, while SC can myelinate only a single axon whose diameter has to 
be larger than 1pm (Fig. 1.1). I will discuss their developmental origins and roles, in 
much more detail, in section 4 where I will present the nervous system development.
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Oligodendrocyte
Node 
of Ranvier
Myelin
Myelin
Axon
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Perikaryon
Figure 1.1
Schematic representation showing how an oligodendrocytes (A) and a Schwann cells 
(B) enwrap axons. (A) In the CNS, oligodendrocytes enwrap simultaneously many 
axons, whereas in the PNS SC wrap only a single axon (B). The region between two 
myelinated tracts is the Node of Ranvier and it is specifically indicated in (A). (B) 
shows also a schematic representation of a nerve cell, whose cell body is the 
perikaryon, myelinated by SC.
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1.2 HISTO ARCHITECTURE OF THE CNS
The anatomy of the CNS appears quite complex. The neurons of the brain are 
organised into layers {cortices) and clusters {nuclei), each having different functions 
and connections. The original neural tube is composed of a germinal neuroepithelium. 
As the cells continue to divide, the migrating cells form a second layer of cells around 
the original neural tube. This new layer is called the mantle or intermediate zone and 
the germinal epithelium is now called the ventricular zone. The mantle zone cells 
differentiate into neurons and glia. Neurons make connections among themselves and 
send axons away from the lumen forming another zone, with a reduced number of cells, 
named the marginal zone. The mantle zone, containing the neuronal cell bodies is often 
referred to as the gray matter, while the axonal, marginal layer is referred to as the 
white matter given the presence of myelin sheaths. This original organisation in three 
zones is maintained only in the spinal cord. In the brain, cell migration, selective cell 
death and differential neuronal proliferation produce modifications of the three zone 
patterns. The brain is composed of many regions; each of which can be further 
subdivided in several anatomically and functionally distinct areas. The major brain 
divisions are the brainstem, which comprises medulla, pons, and midbrain, the 
cerebellum, the diencephalon and the telencephalon (Fig. 1.2).
Information coming from neurons is always modified at every step, and the 
output of one stage of a functional system is rarely the same as its input. Information 
may be attenuated or amplified at any stage. At each stage a single neuron typically 
receives inputs fi*om thousands of presynaptic neurons, and all these influences govern 
the output of the neuron to the next stage. Although a variety of neurons are involved 
at each stage in information processing, neurons can generally be divided in three 
classes: sensory neurons, motor neurons and interneurons. Sensory neurons convey 
information fi*om the periphery of the cell body to the nervous system; instead motor 
neurons carry commands from the CNS to muscles and glands. The intemeurons 
convey information to the next stage in the system and they can be ulteriorly subdivided 
into projection and local intemeurons. Axons leaving one component of a functional 
system are bundled together in a pathway that projects to the next component.
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THE NEUROEPITHELIUM
The germinal neuroephitelium is one cell layer thick and it is composed of 
rapidly dividing neural stem cells. All the cells of the neuroepithelium extend from the 
luminal surface of the neural tube to the outside surface, but the nuclei of these cells are 
at different levels. Radiolabelling by incorporation of nucleotide analogs showed that 
these cells continue to divide while they remain in this layer of cells. Shortly thereafter 
certain cells stop dividing and they start to migrate and differentiate outside the neural 
tube (Jacobson, 1968). When an intraepithélial stem cell divides, the daughter cell 
adjacent to the lumen remains connected to the ventricular surface, while the other cell 
migrates away (Chenn and McConnell, 1995). The time of this vertical division is the 
last time at which a neural stem cell divides and is called the “neuron’s birthday”. 
Different types of neurons and glial cells undergo this last division at different times. 
Labelling at different times during development showed that cells with the earliest last 
division are those that migrate shorter distances. On the contrary the cells with later 
birthday are those that migrate through these layers to form the more superficial layers 
of the cortex. Subsequent differentiation depends on the positions that these neurons 
occupy once outside the germinal neuroephitelium (Jacobson, 1991).
THE SPINAL CORD
It is the most caudal part of the CNS (Fig. 1.2). The spinal cord receives 
sensory information from skin, joints and muscles of trunk and limbs and contains the 
motor neurons responsible for both voluntary and reflex movements. It is divided into 
gray matter and surrounding white matter. The gray matter contains nerve cell bodies, 
and it is typically divided into ventral and dorsal horns. The dorsal horn has sensory 
neurons that receive information from the periphery, while the ventral horn contains 
motor neurons. The white matter is made by longitudinal tracts of myelinated axons. 
The nerve fibers that link the spinal cord to muscles and sensory receptors in the skin 
are bundled in 31 pairs of spinal nerves in human, each of which have a sensory 
component that emerges from the dorsal root and a motor component that emerges from 
the ventral root.
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THE BRAINSTEM
It can be subdivided in medulla, pons and midbrain (Fig. 1.2). It is continuous 
with the spinal cord and contains distinct nerve cell clusters that contribute to a variety 
of sensory and motor systems. The sensory input and motor output are performed by 
12 cranial nerves that are functionally similar to spinal nerves. The brainstem is 
involved in sensation and motor control of the head, neck and face. Neurons in the 
brainstem control many parasympathetic reflexes such as blood pressure. It contains 
ascending and descending pathways that carry sensory and motor information to other 
divisions of the CNS.
THE CEREBELLUM
It receives sensory input from the spinal cord and motor information from the 
cerebral cortex (Fig. 1.2). It is important for maintaining posture and for co-ordinating 
head and eye movements and it is also involved in the movements of muscle and in 
learning motor ability. In it there are also some functions related with language and 
other cognitive aspects.
THE DIENCEPHALON
It is composed of the thalamus and the hypothalamus (Fig. 1.2). The thalamus is 
important for transfer of sensory information from the periphery to processing regions 
of the cerebral hemispheres. It is particularly important because it determines which 
sensory information reaches consciousness in the neocortex. The hypothalamus lies 
ventral to the thalamus and regulates several behaviours that are essential for 
homeostasis and reproduction. It is an essential component of the brain systems 
mediating emotions.
THE TELENCEPHALON
It constitutes the largest region of the human brain. It is formed by the cerebral 
cortex, the underlying white matter, the basal ganglia, the amygdala and the 
hippocampus (Fig. 1.2). The telencephalon, also identified as cerebral hemispheres, is 
involved in all cognitive functions, including memory and emotion. The two 
hemispheres are interconnected by the corpus callosum, a set of fibers that connect
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symmetrical regions in both hemispheres. The major characteristic of the human brain 
is given by the cerebral cortex. The number of neurons in it is one of the crucial 
determinants of cortex’s capacity for information processing. It is organised in six 
functional layers numbered from the outer surface of the cortex {pia mater) to the white 
matter. Each layer differs from the other in its functional properties, the type of 
neurons and the sets of connections they make. The neocortex receives inputs from the 
thalamus and from other cortical regions on both sides of the brain. The output of the 
neocortex is also directed to several brain regions, including other regions of the 
neocortex, the thalamus and the spinal cord. Two classical types of neurons principally 
form the neocortex: projection neurons and intemeurons. Projection neurons typically 
have pyramidal shaped cell bodies. They are mainly located in layer III, V and VI and 
use the excitatory acid glutamate as a primary neurotransmitter. Intemeurons use the 
inhibitory G ABA neurotransmitter, they constitute approximately 20-25% of the 
neurons in the neocortex and they are located in all layers.
Neurons in the neocortex are not only distributed horizontally in layers, but they 
are also positioned in columns that trasverse the layers. Neurons within a particular 
column tend to have very similar response properties, presumably because they form a 
local processing network. Neither the vertical nor the horizontal organisation of the 
brain is clonally specified. The developing cortex, in fact, originates from a mixing of 
cells that derive from different neural stem cells. After their final mitosis, most of the 
neuronal precursors generated in the ventricular zone migrate along glial processes to 
form the cortical plate. The fate of neuronal precursors from older brains are more 
restricted. While the neuronal precursor cells formed early in development can become 
any neuron, later precursor cells give rise to neurons only in outer layers (Frantz and 
McConnell, 1996). Young neurons reach their final destination, in the developing 
brain, through the interactions with radial glia. This mechanism, called glial guidance, 
is determined by a series of events, involving reciprocal recognition between glia and 
neuroblasts (Komuro and Rakic, 1992, Hatten, 1990). Radial migration is not the only 
mechanism that determines axonal movements; in fact axons can migrate also laterally 
from one functional region of the brain to another (O’Rourke et al., 1992). The 
specification of the cortical areas into functional domains occurs after neurogenesis. 
Once the cell arrives at its final destination it becomes organised in specific brain nuclei
10
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(Matsunami and Takeichi, 1995). Not all cells become glial cells or neurons and 
migrate; some cells remain as integral components of the neural tube giving rise to the 
ependymal cells, which are the precursors of neurons and glial cells.
Cerebral
hemisphere
Diencephalon
Brain stem
Midbrain 
Pons
Cervical
Thoracic
Lumbar
Sacral
Forebrain
Medulla
Cerebellum
Spinal cord
Midbrain
Hindbrain
Figure 1.2
Schematic representation of the Central Nervous System. The CNS can be divided into 
many regions. Each region can be ulteriorly sub-divided into other anatomical and 
functional parts. In particular the spinal cord is sub-divided into sacral, lumbar, 
thoracic and cervical districts, from which originate the spinal nerves. The brainstem is 
composed of medulla, pons and midbrain (Modified from Kandel E.R.;Schwartz 
J.H.and Jessell T.M. Principles of Neural Science;4^^  ^edition; published from McGraw- 
Hill, New York, 2000)
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CENTRAL NERVOUS SYSTEM STEM CELLS
Neural stem cells are defined as multipotent, self-renewing progenitor cells, and 
they have been identified both in the CNS and in the PNS. In the CNS, neural stem 
cells should differentiate into neurons, astrocytes and OL. Early studies led to the 
isolation of stem-like cells from many regions of the embryonic mammalian CNS 
(Kilpatrick and Bartlett, 1993). Other analyses showed that neural stem cells can be 
isolated also from adult CNS (Reynolds and Weiss, 1992). In particular adult neural 
stem cells have been found in the hippocampus and in the subventricular zone 
(Johansson et a l, 1999) including spinal cord (McKay, 1997). Neural stem cells can be 
isolated also from more primitive cells, including embryonic stem cells. It was in fact 
shown that mouse embryonic stem cells can be induced to differentiate into a 
population of cells enriched in oligodendrocyte precursors (Gage, 2000; Brustle et al,
1999).
These studies showed that stem cells associated with the lateral ventricles of the 
brain give rise to immature neurons that migrate to the olfactory bulb, where they 
differentiate and integrate as intemeurons. In adherent cultures, CNS stem cells 
produce large clones containing neurons, glia and also other stem cells. In vitro these 
cells can be expanded in defined media containing both EGF and FGF-2 (Gritti et a l, 
1996). Analysis of these clones suggested that stem cells are prevalent at early stages 
of embryonic development. Other studies suggest that stem cells isolated from different 
neural regions generate only particular sub-types of neurons. The pattern emerging is 
that vertebrate neural stem cells are regionally specified. Moreover it seems that neural 
stem cells acquire, during development, temporal information. In fact some early 
neural tube stem cells produce both CNS and PNS stem cells, suggesting that there is a 
common progenitor for two separate stem cell lineages (Mujtaba et a l,  1998). On the 
contrary stem cells purified in later stages of development confirm that not only there 
are different stem cell lineages between CNS and PNS, but also the neurogenic capacity 
in each lineage declines with age (Lois and Alvarez-Buylla, 1994).
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1.3 HISTO ARCHITECTURE OF THE PERIPHERAL NERVE
Individual nerve fibers are protected from the environment by a compact 
connective tissue matrix, consisting of three layers: the epineurium, the perineurium 
and the endoneurium (Fig. 1.3).
THE EPINEURIUM
k
The epineurium is mainly composed of connective tissue that surrounds the 
fascicles of the peripheral nerve. It is the only part of the PNS that contains a lymphatic 
capillary network connected to regional lymphnodes. The cellular components of the 
epineurium are fibroblasts lacking a basal lamina, while the non-cellular part consists 
mainly of collagen type I and III. In the epineurium there are also variable amounts of 
fat whose function is to protect the fascicles against damage by compression. Blood is 
supplied via the vasa nervorum, a network of arterioles and venules, which have 
branches through the perineurium and the endoneurium.
THE PERINEURIUM
The perineurium is a multilayered cellular sheath, usually in the number of six 
to eight, surrounding individual fascicles of the nerve. The epithelial cells that form 
these sheaths originate from the mesenchyme surrounding nerve fibers (Bunge et al., 
1989). The layers consists of concentric flattened epithelial cells with a basal lamina 
connected to each other by tight junctions and gap junctions. Both the inner and the 
outer cell layer of the sheath produce a basal lamina consisting of a fine network of 
collagen type IV fibers, fibronectin, and heparin sulfate proteoglycan. In the 
perineurium there is a selective transport mechanism that restricts transfer of molecules 
into the endoneurium. The presence of pinocytic vesicles and caveolae in perineurial 
cells together with high ATPase and creatine kinase activity confirm this active 
transport mechanism. The other function of the perineurium is to protect the nerve 
from damage through a cushioning function obtained by collagen layers. SC can 
directly influence the formation of the perineurium through the action of the signalling 
molecule Desert hedgehog {Dhh) (Parmantier et a l, 1999). This molecule is expressed 
by SC precursors during development. Dhh  null mice mice revealed that all
13
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components of the connective tissue sheath were defective, whereas myelination 
occurred normally. Both the perineurium and the epineurium were disorganised and 
uncompacted; the perineurial cells were ectopically located in the endoneurial space 
and failed to express the gap junction protein Connexin 43. Ultrastructural analysis 
showed that tight junctions were abnormal despite the fact that proteins were normally 
located. In addition the endoneurium was accessible to bacteria showing the complete 
lack of the barrier function of the perineurium. This and other studies strongly suggest 
that SC are important regulators of PNS development. In fact, beside myelination, they 
can control the formation of the connective tissue surrounding the nerve, and the 
distribution of ion channels along nerve fibers (Riethmacher et al., 1997) and axon 
survival (Vabnick et a l, 1996; Salzer, 1997; lessen and Mirsky, 1999).
THE ENDONEURIUM
It mainly consists of a thick layer of collagen fibrils running parallel along the 
nerves and it constitutes the intrafascicular compartment of the nerve. Its function is 
presumably mainly supportive and protective. This collagen layer takes up almost 50% 
of the intrafascicular space, and increases as the animals age. Embedded in the 
endoneurium are axons ensheathed by SC. SC, together with endoneurial fibroblasts, 
are the major cellular component of the intrafascicular space. Endoneurial fibroblasts 
are the main producers of the collagen that is present in this structure.
NON MYELINATED PERIPHERAL AXONS
Most non-autonomic peripheral nerves in vertebrates consist of a mix of 
myelinated and non myelinated fibers. In contrast, sympathetic and parasympathetic 
nerves contain predominantly non myelinated fibers. The decision to become a 
myelinating versus non-myelinating SC is determined by the axonal diameter; in fact, 
under normal conditions, only axons with a diameter bigger than Ip-m will become 
myelinated, whereas smaller axons will not (see chapter 5; SC-axon reciprocal 
influences). Non myelinating SC segregate a variable number of small caliber axons, 
from a single axon up to twenty, by sending out cytoplasmic processes in between. The 
way in which a SC can enwrap the axons in a bundle of unmyelinated fibers can vary 
depending on nerves and between species. Usually many axons are packed in a
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common compartment limited by SC tongues. Some axonal isolation is achieved when 
SC tongues divide the bundles and separate individual axons. Although several axons 
continue to stay in the same bundle, they can not contact other axonal surfaces. More 
frequently SC processes cover the whole surface of unmyelinated axons. When a SC 
process fails to cover part of the surface of a peripheral axon, there is still a layer of 
basal lamina separating the axon from the endoneurium.
A
PERIPHERAL NERVOUS SYSTEM STEM CELLS
Self renewing progenitors of neurons and glia were first identified by in vitro 
subcloning experiments in the PNS (Stemple and Anderson, 1992). They originate 
from the lateral edges of the neural plate. Multipotent progenitors are derived from post 
migratory neural crest populations, but they are more restricted in the types of 
derivative they can generate. Various multipotent neural crest-derived populations have 
been isolated also from rat sciatic nerve during development (Morrison et al., 1999). 
As for the CNS neural stem cells, also the PNS neural stem cells are temporally 
specified.
By FACS sorting, different populations of multipotent self-renewing stem cells 
were isolated based on the presence or absence of the peripheral Myelin Protein Zero 
(PO) and the Nerve Growth Factor Receptor p75. Progenitors expressing p75 in the 
presence or absence of PO behave in an identical manner as the originally identified 
neural crest stem cells, when grown in the presence of Glial Growth Factor-2 (GGF-2), 
Bone Morphogenetic Proteins-2/4 (BMP-2/4) or Transforming Growth Factor P2 
(TGFp2). However these clones, when grown in standard culture conditions are fate 
restricted.
Two different studies purified and studied in cell culture clones of neural crest 
cells expressing PO. In the first case Lee and co-workers, found that PO expressing cells 
represent a subpopulation of cells predetermined to form glia (Lee et al., 1997). In the 
other study, performed by Hagedom and collaborators, they purified a multipotent 
precursor population expressing p75, PO and Peripheral Myelin Protein 22 (PMP22) 
from Dorsal Root Ganglia (DRG). When these cells are treated with TGFP2 they 
generate muscle like cells, while communities of P0/PMP22 progenitors generate 
neurons that undergo apoptosis (Hagedom et ah, 1999). The fact that PO expressing
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cells can give rise also to neurons and myoblasts, either in the presence or absence of 
instructive signals, suggesting that early PO expression is not restrictive for neural crest 
to generate glial cells, at least in vitro (Morrison et a l, 1999). Whether this is actually 
the case in vivo still has to be determined.
Before entering into the mechanisms that control the development of both CNS 
and PNS, I will introduce a general section on transcriptional mechanisms. In fact 
formation and specification of both CNS and PNS are strictly regulated by many 
transcription factors.
Epineurium
Perineurium
Epineurium Endoneurium
Figure 1.3
Transverse section through a sciatic nerve. In the figure the main anatomical structures 
of a peripheral nerve are indicated: the epineurium, the perineurium and the 
endoneurium (From Balboni et al. Anatomia Umana, 3°vol.; Edizioni Ermes Milano, 
1991J
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1.4 TRANSCRIPTION FACTORS
Biochemical and genetic analysis of many model organisms has identified a 
huge number of proteins responsible for transcriptional control; nevertheless the 
complexity of the general machinery has not been completely dissected. Despite these 
advances, little is known on the detailed mechanisms by which individual genes are 
turned on or off. This limitation is principally due to the fact that many of these studies 
were aimed at the identification of transcription factors in a context different from the in 
vivo situation. In fact a general approach taken to study transcriptional regulation has 
been to first identify a protein binding site by placing single or multiple copies of the 
site upstream of heterologous promoter. This approach has the advantage of a simple 
and sensitive analysis. However this kind of study provides information concerning 
what a transcription factor has the potential to do but does not necessarily reveal the 
specific contribution of a factor in the natural context. In fact a transcription factor can 
be influenced either by its position relative to other factors or by the abundance of 
transcriptional co-factors in the cell. Recent evidence suggests that there is an ordered 
progression of events leading to RNA synthesis in vivo and that an highly structured 
eukaryotic nucleus may be important in orchestrating transcription.
The first indication of the complexity of eukaryotic transcription was suggested 
by the finding of three distinct and separate enzymes for RNA synthesis (Roeder and 
Rutter, 1969):
- the RNA polymerase I which transcribes the ribosomal RNA (rRNA)
- the RNA polymerase II which transcribes the messenger RNA (mRNA)
- the RNA polymerase III which transcribes the transfer RNA (tRNA) and the
small 5S rRNA.
Usually the analysis of transcriptional regulation focuses on the identification of 
components fundamental for correct gene regulation. This can be addressed first at the 
transcriptional start site, where the RNA polymerase II holoenzyme is bound. 
Nevertheless it is important to study also c/5-acting elements (i.e. DNA sequences) and 
trans-?icXmg factors (i.e. transcription factors) that determine the regulation of gene 
expression during development or even during adult life.
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The characterisation of the DNA sequences involved in gene regulation has led 
to the mapping of promoter and enhancer sequences. Core promoter elements that 
direct transcription by RNA polymerase II include the TATA box, the initiator and the 
downstream promoter element (Matsui et al, 1980; Smale and Baltimore, 1989). Many 
genes have enhancer elements in the proximal promoter, but many gene-specific signals 
are located far upstream of the transcription start site, in distal enhancer sequences 
(Carlsson et a l 1993). Eukaryotic genes, in fact, contain complex arrays of specific 
DNA sequences that combine common core promoter elements, with many gene- 
specific enhancer elements and cooperate to define specific expression patterns (Dynan, 
1989). After these discoveries it was hypothesised that enhancer-bound activators 
would directly recruit RNA polymerase II to promoters in nucleosome-ffee regions of 
the template to initiate RNA synthesis (Ptashne and Gann, 1997).
The purification of transcription factors from mammalian cells with biochemical 
techniques revealed the existence of large families of sequence specific DNA binding 
proteins. They include the Specificity Protein-1 (Sp-i), the Activator Protein-1 (AP-1), 
the CCAAT Enhancer-Binding Protein (C/EBP), steroid receptors and tissue specific 
transcription factors (Dynan and Tjian, 1983; Mitchell and Tjian, 1989). In the mean 
time a series of proteins necessary to program a functional basal machinery were 
characterised. They comprise the TATA -  binding protein (TBP), and general 
transcription factors such as TFIIA, TFIIB, TFIID, TFIIE, TFIIF and TFIIH (Conaway 
and Conaway, 1993). The availability of in vitro transcription reactions as well as 
biochemical techniques, helped in establishing a general order of assembly of these 
factors for the formation of an active pre-initiation complex in vitro (Buratowski et a l, 
19%%.
Using the same techniques it was possible to characterise TFIID, which at the 
beginning was thought to be equivalent to TBP (Hahn et a l, 1989). However, purified 
TFIID contains not only TBP but also some ancillary factors, named TBP-associated 
factors (TAFs), which are critical to mediate the responsiveness (Pugh and Tjian, 1990; 
Dynlach et a l,  1991; Tanese et a l,  1991). Based on these experiments it was 
postulated that a new class of molecules, called co-activators or adaptors are necessary 
to convey the information instructed by the trans-acting factors to the polymerase II 
machinery. Many biochemical and genetic analyses characterised most of the
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components of the basal machinery as well as co-activators and co-repressors which 
modulate different transcription factor functions (Tyler and Kadonaga, 1999; Glass and 
Rosenfeld, 2000). In addition many studies showed that not only sequence-specific 
DNA binding regulators have cell type specific expression, but also co-regulators may 
have tissue-restricted expression. For example the human TAF105 is highly expressed 
in B cells (Dikstein et a i, 1996). Co-activators can also play a role in regulating the 
cross-talk between tissue-specific transcription factors which can lie also far upstream 
of the start site of transcription and the RNA polymerase II machinery. Together with 
differential expression patterns, additional controls came from the modification of 
regulators, or co-regulators, via cellular signal transduction pathways, allowing 
transcription factors to target different subsets of basal co-regulators at different genes 
or in different cell types. Consistent with the fact that many genes are regulated by 
mixing different types of activators and repressors, many transcriptional co-factors are 
constituents of multi-subunit complexes, such as TFIID.
Transcriptional co-activators can be subdivided in three different classes:
- Co-factors that are intrinsic or intimately associated with components of the 
core machinery. They are also involved in promoter recognition and enzymatic 
functions. In this category belong the TAFs and TFIIA.
- Activator and repressor adaptors preferentially associated with activator or 
repressor molecules. They modulate DNA binding and target other co­
regulators or other core machinery. Examples of this category are Groucho, 
Notch and also viral co-regulators El A and VP 16.
- A family of large multi-subunit co-activators structurally related but divergent 
in function. Some of them can interact with RNA polymerase II; others appear 
to have inherent enzymatic functions or chromatin selective properties. In this 
category belong: the yeast Mediator, and the human Srb mediator.
Co-regulators also include components of the chromatin remodelling machinery
and the histone acetylases and deacetylases. One of the major problems that a 
transcription factor has to overcome is DNA accessibility. Eukaryotic cells contain a 
huge amount of genetic information and to control such a large genetic load, eukaryotes 
have organised colinear DNA into chromosomes each packaged into chromatin, the 
minimal unit of which has been defined as the nucleosome. The nucleosome consists of
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146bp of DNA wrapped in superhelical turns around a histone octamer containing two 
molecules of histones H2A, H2B, H3 and H4. Adjacent to the core nucleosome, there 
is another histone, histone H I, which is located at the linker DNA between two 
nucleosomes and whose function is probably to seal DNA in the nucleosome by binding 
at the point where the nucleic acid enters and leaves. This unit is repeated once every 
200bp ± 40bp as a nuclesomal array in chromosomal DNA. The functional 
consequence of this packaging is to restrict the access of DNA to a variety of DNA 
binding proteins that regulate gene activity. Variable degrees of DNA sequence 
accessibility exist within chromatin throughout the cell cycle to permit and regulate 
biological processes such as DNA replication, gene expression and cell division. 
Previous biochemical and genetic evidence suggested that nucleosomes are repressive 
for DNA transcription (Pennisi, 1997). Instead it is becoming clear that chromatin is a 
dynamic and active structure in regulating transcription of the eukaryotic genome. In 
fact several distinct mechanisms are involved in modulating the chromatin; some of 
them function as motors to disrupt nucleosomes or as enzymatic machinery to 
chemically modify histones.
CHROMATIN REMODELLING
The mechanisms by which specific genes are activated in chromatin have been 
extensively investigated in a variety of biochemical and genetic systems. From these 
studies it has emerged that chromatin remodelling and transcriptional activation are 
separate processes that can be regulated by distinct proteins or subunits (Pazin, 1994). 
There are five chromatin remodelling complexes, identified to date: Switching/Sucrose 
non-fermenting (SWI/SNF), Remodel the Structure of Chromatin (RSC), Nucleosome 
Remodelling Factor (NURF), Chromatin-Accessibility Complex (CHRAC) and ATP- 
utilising Chromatin assembly and remodelling factor (ACF). They are multi-subunit 
complexes whose molecular weight ranges from 2MDa to O.SMDa. They can disrupt 
nucleosomes through ATP hydrolysis. Their action results in a facilitation of factors 
binding, in the case of SWI/SNF, NURF, and ACF or in transcription of chromatin- 
assembled genes for NURF and ACF. These complexes are distributed in all 
eukaryotes from yeast to mammals and they are both functionally and mechanistically 
distinct.
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SWI/SNF is a multi-subunit complex formed by 9-12 subunits, present in yeast 
and mammals. It facilitates the formation of a ternary complex composed of DNA, 
histones and activators, which results in a destabilisation but not the loss of 
nucleosomes. SWI/SNF is required only transiently to generate a stable chromatin 
structural change in the presence of transcription factors (Owen-Hughes et a i, 1996).
RSC is an abundant complex in yeast and it is encoded by essential genes. It is 
composed of at least of 15 subunits. RSC shows similarities with SWI/SNF in terms of 
subunit composition, but it is 10-fold more abundant and essential for mitotic growth 
(Cairns et aL, 1996).
NURF is a chromatin-remodelling complex present in Drosophila and is 
composed of 4 subunits (Tsukiyama and Wu, 1995). It is required for chromatin 
remodelling for GAGA factors and it facilitates transcription from pre-formed 
chromatin templates. After chromatin remodelling NURF is no longer required to 
maintain an active promoter configuration. It functions with a variety of proteins 
containing distinct DNA binding domains to remodel nucleosomes (Mizuguchi et al., 
1998). Recently it was shown that NURF can alter nucleosomal structure by interacting 
with the histone H4 tail (Georgel et al., 1997).
CHRAC is a chromatin remodelling complex purified in Drosophila, it is 
composed of 5 subunits and in addition to ATPases it also contains topoisomerase II 
(Varga-Weisz et al., 1997). It reconfigures chromatin by increasing its general 
accessibility and converting irregular nucleosomal arrays to physiologically spaced 
structures. This is the first complex shown to contain activities that modulate both 
nucleosome structure and DNA topology. The role of topoisomerase II in CHRAC is 
not completely clear; it is possible that it functions to direct CHRAC to a particular 
chromosomal site.
ACF is composed of 4 subunits with a molecular weight of 220KDa, it was 
purified in Drosophila and it is required for nucleosome assembly and periodicity. ACF 
assembles nucleosomes, in combination with an histone chaperone. Chromatin 
Assembly Factor 1 (CAF-1), and remodels pre-formed chromatin to facilitate protein 
binding and DNA transcription. Both the assembly and remodelling functions are ATP 
dependent (Ito et al., 1997). This is the first remodelling complex that was shown to 
directly activate transcription of chromatin template.
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The other remodelling complex identified to date is Facilitate Chromatin 
Transcription (FACT). This a 230KDa complex composed of 2 subunits and purified 
from humans. This complex is quite distinct from the others because it does not 
facilitate transcriptional initiation or require ATP hydrolysis (Orphanides et al., 1998).
All these studies suggest that chromatin remodelling of the promoter region is 
one of the critical steps in transcription but it is not sufficient for gene activation unless 
coupled with activities that favour efficient elongation through nucleosomes.
ACETYLATION AND DEACETYLATION
The other mechanism involved in transcriptional regulation is acétylation and 
deacetylation. These modifications occur at specific lysine residues at the amino 
terminus of histone tails. Usually hyperacetylation of these residues favours active 
transcription of DNA, while deacetylation is considered to be an inhibitory mechanism 
(Kwok et al., 1994). There are many histone acetylases such as CREB-binding protein 
(CBP)/p300, the yeast transcription factor GCN5, P/CAF, and the Steroid Receptor Co­
activator-1 (SRC-1) (Ogryzko et al., 1996; Yang X.Y. et al., 1996; Spencer et al., 
1997), as well as histone deacetylases HDAC-1, HD AC-2 and sir2 (Kadosh and Struhl, 
1997; Zhang Y. et al., 1997; Imai et a l, 2000). In yeast there is now evidence that 
many acetyltransferases act in concert with large complexes to provide a physical 
connection between acétylation and transcription (Grant et al., 1997).
The fact that histone deacetylation is connected with repression of transcription 
became relevant with the discovery that the human HDAC-1 is an homologue of the 
yeast transcriptional regulator Rpd3 (Taunton et ah, 1996). Ablation of this gene, in 
fact, results in an increased level of histone acétylation and hyper activation of the 
CUPl gene. In yeast, even histone deacetylases can be part of complexes. Several 
papers have linked specific transcriptional repressors, such as Y Y l, with histone 
deacetylation (Yang W-M. et a l,  1996). However with the exception of YYl, 
transcriptional repressors do not directly interact with deacetylases. Instead co­
repressors such as sin3 and SMRT usually mediate the association.
All these studies suggest that the precise gene regulation is facilitated by the 
specific recruitment of appropriate complexes, containing either acetyltransferases or 
deacetylases. It is possible to formulate many regulatory mechanisms:
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- histone acetylation/deacetylation could modulate the structure of individual 
nucleosomes making DNA sequences accessible to the basal machinery of RNA 
polll transcription;
- acétylation of histones or other proteins could act as a specific signal, similar to 
phosphorylation, and promote recognition by other factors;
acétylation and deacetylation of histones could affect higher order chromatin 
compaction.
HOW IS THE TRANSCRIPTIONAL MACHINERY ORGANISED?
In order to explain how the assembly of the transcription machinery is achieved, 
in particular regarding the core machinery, two models were proposed: a stepwise 
model and holoenzyme recruitment.
The stepwise model proposes an ordered assembly of transcription factors on the 
basis of the formation of active transcription complexes in vitro. It was in fact observed 
that to get efficient promoter binding, as well as the transcription initiation from naked 
DNA, the stepwise addition of purified basal factors is required (Buratowski et al., 
1989). The steps that lead to the formation of this complex are:
- the formation of a complex containing TFIID, TFIIA and TFIIB able to 
recognise and to bind to the TATA box;
a more stable complex containing in addition also hypophosphorylated RNA 
polymerase II and TFIIF;
an activated open complex formed by the addition of TFIIE and TFIIH;
- the clearance of the promoter and nascent RNA synthesis upon 
hyperphosphorylation of the RNA polymerase II carboxy terminal domain.
The holoenzyme recruitment model was proposed when certain preparations of 
RNA polymerase II were co-purified with subsets of the basal machinery including 
some co-regulators, chromatin remodelling factors and proteins involved in DNA 
replication and repair (Koleske and Young, 1994; Maldonado et al., 1996). One 
possible advantage of the holocomplex is to bypass the limited cellular concentration of 
individual transcription factors. On the other hand the recruitment of a pre-formed 
complex does not fit well with the observation that animal cells need a vast diversity.
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Both the stepwise model and the holoenzyme complex are not sufficient to 
explain how transcription proceeds in eukaryotes. Recent cytological studies suggest 
that some co-regulators and components of the general machinery may be segregated 
from each other in the nucleus (Reyes et al., 1997). It is possible that gene regulator 
systems have evolved as organised compartments in the nucleus containing increased 
local concentrations of some co-regulators and a subsets of the transcription machinery. 
Recently these nuclear compartments were described and they led to the identification 
of many nuclear structures such as speckles, interchromatin granule clusters, Cajal 
bodies and PML bodies. These structures have been associated with various 
transcription factors, co-regulators, RNA polymerases and RNA processing factors 
(Matera, 1999). Moreover RNA polymerase II is localised in a few discrete foci in 
isolated nuclei as visualised by immunofluorescence and three-dimensional microscopy 
(Zeng Qt al., 1997). Transcriptionally active genes are located preferentially in the 
center of the nucleus while silenced genes are arranged at the periphery of it (Andrulis 
et al., 1998; Verschure et al., 1999). In addition to that, other studies established that 
individual chromosomes are organised into territories that condense and décondense in 
a cell cycle co-ordinated fashion (Ferreira et al., 1997; Croft et al., 1999). These and 
other similar regulatory regions may serve to protect and promote an open or accessible 
chromatin domain, which can be important in regulating cell type specific transcription 
(Jenuwein e/a/., 1997).
The model emerging from all these studies is that genes might first undergo an 
early chromatin rearrangement through initial interactions with primary transcriptional 
activators and some chromatin remodelling machinery. After those events the DNA is 
susceptible to the action of enhancer binding factors. In order to completely open the 
chromatin they could recruit other appropriate remodelling factors, for example histone 
acetyltransferases. The next step is the co-operative interactions between sequence 
specific regulators and co-regulators that can initiate promoter binding and subsequent 
events leading to formation of an active initiation complex. At the end, the disassembly 
of the initiation complex and the release or the transfer of DNA template from the 
transcription site to other functional compartments may facilitate RNA elongation and 
processing.
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1.5 NERVOUS SYSTEM DEVELOPMENT
The nervous system of vertebrates derives from the ectoderm, one of the three 
embryonic layers that are established at the gastrula stage, together with mesoderm and 
endoderm. As gastrulation proceeds the neural fold will form, bend and fuse to form 
the neural tube overlying the epidermis, and cause delamination of neural crest cells. 
The neural tube will eventually generate the CNS and its components, neurons, and 
glial cells, while delamination of the neural crest cells will generate SC and peripheral 
neurons (Fig. 1.4).
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Figure 1.4
Schematic diagram of all ectoderm derivatives. The ectoderm is divided into three 
main regions: the outer ectoderm from which originate the epidermis, the neural tube 
from which derive CNS components and the neural crest from which derive SC and 
peripheral neurons. (Modified from Gilbert S.F. Developmental Biology 6^  ^ Edition 
Sinauer Associated Inc. Publisher, Sunderland, Massachusetts, 2000)
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In the generation of the nervous system, the first step consists of the 
specification of a homogeneous layer of ectodermal cells into the neural plate and the 
epidermis. Many studies suggest that BMP proteins are involved in this process. In 
particular BMP-4 and BMP-7 are expressed throughout the gastrula ectoderm except in 
the future neural plate (Fainsod et al., 1994) and this expression pattern coincides with 
the presumptive epidermis. Other factors such as Noggin and Chordin are produced 
and secreted by the notochord in a graded pattern and are only present in the 
presumptive neuroectoderm, where BMP-4/7 are absent. Treatment of Xenopus laevis 
animal cap explants with BMP-4/7 promoted the formation of the epidermis, while 
treatment with Noggin and Chordin induced the formation of the neural tissues (Wilson 
et al., 1995; Smith et al., 1992; Sasai et al., 1994). Moreover Chordin and Noggin can 
directly inhibit BMP-4/7 by binding to their extracellular domain. Evidence for this 
model comes from Drosophila melanogaster, in which the ablation of the BMP-4 
orthologue, decapentaplegic (dpp) induces the expansion of the neuroectodermal region 
(Wharton et al., 1993). On the contrary, ablation of the Drosophila Chordin orthologue, 
short-gastrulation (sog), results in expanded epidermis with less neuroectoderm 
(Holley et al., 1995). Analysis of these genes in mice revealed that BMP-4 is relevant 
during gastrulation and formation of posterior body as well as ventral mesoderm 
(Winnier et al., 1995). Targeted deletion o f Noggin and Chordin separately do not 
affect ectoderm specification (McMahon et al., 1998). However the double knock out 
for both genes is embryonically lethal and produces clear defects in forebrain 
development (Bachiller et al., 2000). Based on all these experiments it seems that 
factors such as Chordin and Noggin play an important role in patterning the neural 
ectoderm into neuroectoderm and neural plate.
The second step requires further patterning of the neural fold along the dorso- 
ventral (D/V) axis. This patterning is mediated by BMP-4 whose expression is 
restricted to neural folds. In chicken not only BMP-4/7 are required for this 
specification, but also a ventralising signal from the notochord is necessary. A good 
candidate is Sonic hedgehog (Shh), that can change the D/V pattern of pre-existing 
neural tissue by inducing the expression of Noggin in ventral neural plate (Liem et al., 
1995; Roelink et al., 1994; Ekker et al., 1995; Hirsinger et al., 1997). Nevertheless the 
key “player” in directing the D/V axis formation, is the BMP-4/7 gradient present in the
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neural tube (Fig. 1.5). Although strong evidence favours this model, other data suggest 
that BMP-4/7 is not the only factor involved in the process of neural crest specification 
(Marchant et a l, 1998). For instance, expression of basic Fibroblast Growth Factor 
(bFGF) seems to be required for a correct neural crest induction. It is also possible that 
bFGF makes the neural crest competent to react to signals such as BMPs (Mayor et a i, 
1997). Members of the Wingless family of growth factors (Wnt) Wntl/3A have also 
been implicated in neural fold induction through cooperation with BMP-4/7 or bFGF 
(Saint-Jeannet et al., 1997). All these data indicate that induction of the neural crest 
fate might be determined by the position of a cell in a network of morphogen gradients, 
such as BMP-4/7, bFGF, Wnt-1/3A, along each axis in the developing embryo 
(Panchision, 1998).
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Figure 1.5
Specification of the nervous system components. The BMP proteins are first expressed 
in the outer ectoderm and then in the roof plate. These proteins are responsible for the 
formation of the epidermis and for the specification of the dorso-ventral axis. The other 
component essential for the formation of the dorso-ventral axis is Shh, which is 
expressed in the floor plate. Shh is responsible of the formation of the ventral neural 
tube and it is involved in the generation of motor neurons and oligodendrocytes. See 
text for details. (Modified from Gilbert S.F. Developmental Biology 6^ Edition Sinauer 
Associated Inc. Publisher, Sunderland, Massachusetts, 2000)
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CNS DEVELOPMENT
The differentiation of the neural tube into various regions of the CNS occurs 
simultaneously in three different ways:
1. at the anatomical level with the constriction of its lumen to form the chambers of 
the brain and the spinal cord;
2. at the tissue level with the rearrangement of the cell populations within the wall of 
the neural tube to form the brain and the spinal cord;
3. at the cellular level, with the differentiation of the neuroepithelial cells into neurons 
and glial cells.
At the tissue level the most anterior part of the tube develops into the three 
primary vesicles: forebrain (prosencephalon), midbrain (mesencephalon), and hindbrain 
(rhom boencephalon) (Fig. 1.6). The forebrain is subdivided into the anterior 
telencephalon and the more caudal diencephalon. The telencephalon then gives rise to 
the cerebral hemispheres, while the diencephalon will form the thalamic and the 
hypothalamic brain regions. The midbrain is not subdivided into segments; instead the 
pattern of cells is controlled by a long-range action of many signals, the principal of 
which are FGF8 and Wnt molecules. The hindbrain is subdivided into a posterior 
myelencephalon and a more anterior metencephalon, from which originates the 
cerebellum. It is also divided in smaller compartments called rhomhomeres that form 
clusters of neuronal cell bodies, the ganglia. Cells of a rhombomere can mix within, 
but not between adjacent rhombomeres (Guthrie and Lumsden, 1991).
It is possible to follow CNS organisation at the cellular level because the neural 
tube is polarised along its D N  axis. As discussed above, this polarity is induced by 
signals coming from its immediate environment (Fig. 1.5). The epidermis imposes the 
dorsal pattern, while the notochord induces the ventral pattern. The BMP-4/7 gradient 
causes the expression of different types of transcription factors in cells at various 
distances from the roof plate, giving them a specific identity. The ventral tube is 
specified by external cues, and in particular by Shh and retinoic acid. Shh is initially 
produced by the notochord, where it is cleaved and secreted. The secreted form is the 
active part of the protein, which induces the formation of the floor plate of the neural 
tube. The floor plate cells also secrete Shh which forms a gradient highest at the most 
ventral portion of the neural tube (Roelink et al., 1995). This gradient specifies the type
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of neurons that are created (Briscoe et a l, 1999). The variety of Shh concentrations 
induces the expression of a different set of cell-fate transcription factors and they 
determine the destiny not only of neurons but also of OL. Shh is also a repressor of 
genes that otherwise will be expressed throughout the neural tube causing a 
dorsalization of the phenotype (Echelard et a i, 1993; Roelink et a l, 1994).
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Figure 1.6
Schematic diagram of the CNS vesicles (A). The more anterior part of the CNS, the 
forebrain is sub-divided into the telencephalon and the diencephalon, whereas the 
hindbrain is sub-divided into the metencephalon and the myelencephalon (B). 
(Modified from Gilbert S.F. Developmental Biology 6^ Edition Sinauer Associated Inc. 
Publisher, Sunderland, Massachusetts, 2000).
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OLIGODENDROCYTE DEVELOPMENT
The developmental pattern of OL, is best understood in spinal cord and in optic 
nerve, while the origin in the forebrain is less well known. The initial specification of 
Oligodendroglial Precursors Cell (OPC) depends on signals coming from the notochord 
and the ventral roof plate. OPC originate in a region adjacent to the floor plate in the 
same zone of the neural tube that gives rise to motor neurons (Noll and Miller, 1993).
A critical signal in OPC specification is Shh and the basic Helix-Loop-Helix 
(bHLH) genes Oligl and Oligl. After their appearance, OPC migrate throughout the 
neuraxis. A precocious marker that identifies these cells is recognized by the A2B5 
antibody, directed against cell surface gangliosides, which stains bipolar and mobile 
cells (Fig. 1.7). When cultured in vitro, these cells are responsive to both basic 
fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF) (Noble et 
a i, 1988). These cells mature into pro-oligodendroblasts that are characterised by a 
reduced motility and the expression of a fine arbor of processes. They also express 
specific sulfatides that can be labelled with the 0 4  antibody. In vitro, these cells 
proliferate primarily in response to bFGF (Pfeiffer et al., 1993). Only after this stage of 
development, the cells exit the cell cycle and start to express galactocerebroside (GalC), 
a major glycolipid of myelin (Raff et a l, 1978). These cells are identified as 01 cells. 
The last steps in OL development require a transition from pre-myelinating to 
myelinating OL. These last changes are not well understood, but axonally derived 
signals, like neuregulins (NRG), seem to be required (Fernandez et a l, 2000).
Recent studies have shown that PDGFRa^ OL develop also from region of the 
neuroepithelium that generates somatic motor neurons, suggesting the possibility of a 
common progenitor for these two cell types (Richardson, 2001). The existence of this 
common progenitor between neuron and OL is supported by clonal analysis performed 
in embryonic chick spinal cord (Leber and Sanes, 1995).
Sonic Hedgehog
A  recent study showed that regions of the telencephalon, where Shh is 
expressed, are the first to express early OL markers (Nery et a l, 2001). Grafting and 
neural plate explant studies showed that one of the main agents involved in the initial 
generation of OL is Shh. It induces oligodendrogenesis and is required for OPC
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specification in chick embryo spinal cord (Orentas et ah, 1999). In the spinal cord, 
OPC differentiate from bipolar migratory precursor cells that arise from specific regions 
of the ventral neuroephitelium. Then they disperse through the developing gray matter 
to populate white matter tracts. These precursor cells give rise to progenitors that 
migrate to their correct location where they first proliferate and then terminally 
differentiate to OL.
PlateledDerived Growth FactorReceptor a  (PDGFRa)
A marker for OPC differentiation is PDGFRa. Both mRNA and protein were 
detected in embryonic spinal cord at E12.5 in mouse (E14 in rat) (Fig. 1.7). By E17 in 
mouse, PDGFRa expressing cells are distributed throughout the spinal cord (Pringle et 
al., 1996). When these cells are purified from embryonic rat spinal cord at E l6 and put 
in culture, they differentiate into OL (Hall et al., 1996). Recently the analysis of the 
PDGF-A deficient mice showed a massive decrease in the amount of OL in the brain. 
Nevertheless there are other regions in the brain of these animals in which OL mature 
normally (Fruttiger er a/., 1999).
PLP/DM-20
Another marker of the early steps in OL development is the myelin gene plp/dm- 
20. In mice early plp/dm-20 expressing cells are detected in the ventricular zone before 
E10.5 (Fig. 1.7). Between the time of emergence and birth the number of plp/dm-20^- 
cells increase and they progressively invade the future white matter tracts (Timsit et al., 
1995). The period during embryonic development in which these precursors are first 
detected matches the emergence of the first axonal tracts. Although plp/dm-20 and 
PDGFRa cells were both localised in the same region of the embryonic spinal cord, 
they are never co-localised in the same cell at early stages. It is likely that plp/dm-20 
and PDGFRa represent two distinct populations of OL. Moreover plp/dm-20’^ -cells are 
not only differently located from those expressing PDGFRa, but when put in culture 
they are not responsive to PDGF (Spassky et al., 1998).
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TRANSCRIPTIONAL CONTROL IN  OLIGODENDROCYTE DEVELOPMENT
Recently some transcription factors involved in specifying OL development 
have been identified in vivo.
Nkx2.2
Nkx2.2 is an homeodomain transcription factor that is knoAvn to be involved in 
the regionalization of the ventral zone. In particular it is known to be involved in the
A
generation of the motor neurons.
Recent studies suggest that, both in chicken and in rodent spinal cord, OL 
originate from the ventral zone pattern of the neural tube that is Nkx2.2 positive (Xu et 
a l ,  2000; Qi et ah, 2001). Double labelling experiments showed a co-localisation 
between Nkx2.2 and some OL markers. The importance of Nkx2.2 in directing 
oligodendrogliogenesis is shown also by the analyses of Nkx2.2 null mice. In these 
mice there is a strong reduction in the number of OL that can differentiate, while the 
number of OPC that express both PDGFRa and OliglIOUg2 genes is increased.
Sox-10 (Sry-box containing)
Sox-IO is a member of superfamily of High-Mobility-Group (HMG) protein. 
Members of this family bind to the consensus sequence (A/T)(A/T)CAA(A/T) in the 
minor groove of DNA, strongly bending it (Wegner, 1999). Sox-10 transcripts can be 
detected in mouse embryo from E8.5 in the dorsal neural tube and in the presumptive 
neural crest region (Fig. 1.7). The expression of Sox-10 disappears in CNS until day 
E l3.5 where it reappears. The next day, Sox-10 positive cells are detected in the spinal 
cord correlates with the first appearance of OPC. From this day of development, cells 
positive for Sox-10 are detected in all regions of the brain. Later in development and in 
the adult, Sox-10 is preferentially found in OL. Moreover in the CNS high expression 
of Sox-10 is recovered in areas with myelinated fibers (Kuhlbrodt et a l, 1998). A 
recent paper also shows that Sox-10 expression is restricted to myelin forming 
oligodendroglia (Stolt et a l, 2002). In the same study the authors showed that in Sox- 
10 deficient mice OPC precursors are generated, however the terminal differentiation of 
OL is impaired. The relevance of Sox-10 in OL development is underlined also by the 
fact that its expression is detected at about the same time of 0Hg2 and precedes that of
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Oligl in the same cells. Ectopic expression of Olig genes in brain causes ectopic 
expression of Sox-10 in vivo (Zhou et a l,  2000). Moreover classical in vitro 
transcriptional studies, showed that Sox-10 directly controls the expression of both 
Myelin Basic Protein (MB?) and Proteolipid Protein (PEP) suggesting that it is a 
general regulator of myelin genes expression (Stolt et a l, 2002).
Oligl and Oligl
Recently two closely related bHLH genes, named O lig l  and O ligl, 
preferentially expressed in OL cell lineage, were identified (Lu et a l, 2000; Zhou et a l, 
2000). They represent the first known transcription factors suggested to be fate 
determining genes for OL. Their sequence is almost identical in the bHLH domain, 
while it is completely divergent in the loop region. At the structural level, the bHLH 
domain resembles that of other bHLH genes, such as NeuroD and Neurogenin, which 
are know to be fate specific genes in neuronal development. In the ventral spinal cord 
they are both expressed at E9.5 (Fig. 1.7). At this Stage Oligl is more evident than 
Oligl. At E l0.5 both genes are expressed in the ventricular zone. No expression was 
found in the DRG of the PNS. In adult rat CNS, the expression of both genes is 
restricted to regions enriched in OL.
In situ hybridisation studies showed that Olig gene expression precedes that of 
both plp/dm-20 and PDGFRa. PDGFRa and Oligl are co-expressed in the same cell 
types. Lu and co-workers (Lu et a l, 2000) showed that Shh is both necessary and 
sufficient for normal Olig expression in the developing CNS. In fact, ectopic induction 
of Shh causes is an ectopic expression of Olig genes. Moreover mRNA for both Olig 
genes is not detected in embryos homozygous null for Shh, either in brain and in spinal 
cord. On the other hand Zhou et al (Zhou et a l, 2000) showed that ectopic expression 
of O ligl, induces the expression of Sox-10 in vivo, but they do not detect the 
expression of myelin genes indicating that other factors are necessary for full 
development of oligodendrocytes.
M2
In vitro analysis of OL differentiation led the identification of other basic bHLH 
genes involved in their differentiation. They are mainly involved in timing the
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differentiation of OL. Those transcription factors include at least one member of the Id 
family, Id2, whose overexpression blocks OL differentiation and enhances proliferation 
(Wang et a l, 2001).
Neuroepithelial 02A progenitor Pro-oligodendrocyte 
precursor
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►
Oligl/Olig2/Scx10
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04
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Figure 1.7
Schematic representation of oligodendrocyte development and markers expressed at 
each step. See text for details.
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PNS DEVELOPMENT
The different components that make up the PNS originate from different germ 
layers. During embryonic development neurons and their associated glial cells derive 
jfrom the neuroectoderm, while the nerve sheath and nerve vasculature derive from the 
mesoderm. The cells that give rise to neurons and glial cells are the neural crest cells. 
Neural crest cells are formed at the border between the neural plate and the presumptive 
epidermis, overlaying the lateral plate mesoderm in a gastrulating embryo.
Two principal steps are involved in determining their development: neural crest 
delamination and neural crest fate determination.
Neural crest delamination is important in determining subsequent differentiation 
and migration of these cells towards target organs. At the beginning they have to 
switch from an epithelial to a mesenchymal morphology. In Xenopus, chicken and 
mouse, neural crest induction is marked by the expression of the zinc-finger protein 
Slug. In chick and mouse embryos, cells of the dorsal midline express Slug before 
delamination. Although Slug has proven to be a useful marker for presumptive neural 
crest cells, its involvement in neural crest induction and delamination remain unclear, in 
fact its deletion does not cause any failure in this process (Jiang et al., 1998). 
Delamination of neural crest cells starts at the rostral end of the embryo in Slug positive 
migrating cells. It was also demonstrated that ectopic expression of Noggin can prevent 
migration and since Noggin is a BMP-4 inhibitor it is possible that somehow it 
positively regulates the epithelial-mesenchymal transition (Sela-Donenfeld et al., 1999).
A series of homotypic graft experiments demonstrate that neural crest, 
originating from rostral to caudal levels, can generate distinct but also overlapping sets 
of derivatives (Baker et al, 1997). For example only a small population of trunk neural 
crest generate chromaffin cells of the adrenal, while SC derive from neural crest cells of 
the entire antero-posterior axis (Le Douarin et al., 1993). Many tracing experiments 
were performed to understand if the environment is instructive on a homogeneous 
population of neural crest cells or selective on a collection of committed cells. These 
studies show that while most pre-migratory cells, such as sensory neurons and glia, are 
multipotent (Frank and Sanes, 1991), there are also precursors generating a single 
unique neural crest derivative. To understand the entire repertoire of these cells, rat and 
mouse neural crest cells were grown at clonal density. These studies showed that many
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cells, before leaving the neural crest, are multipotent self renewing stem-like cells (Ito, 
1993). These clonal cell cultures allowed also the identification of factors that are 
potentially involved in the lineage determination of the neural crest. These factors act 
in an instructive manner since they promote development of one lineage. One of these 
factors is GGF-2. This is the product of the neuregulin gene and it can induce 
differentiation of neural crest cells in SC (Shah et a l, 1994). On the contrary, BMP-4 
or BMP-2 promote neuronal differentiation, while smooth muscle cells are induced by 
TGFp (Shah et ah, 1996). The importance of GGF-2 is shown also in vivo and given 
its importance in determining SC development I will discuss it in the next session.
SCHWANN CELL DEVELOPMENT
During vertebrate development, SC originate from a multipotent migratory cell 
population that derives from the neural crest. In this process, cells migrate from the 
dorsal ridges of the neural folds to form the migratory population known as neural crest 
cells.
The process of SC development involves three transitions (Fig. 1.8):
1. from neural crest cells to precursor SC;
2. from precursor to immature SC;
3. from immature to the two different types of adult SC, the myelinating and the non 
myelinating SC.
SC precursors are identified in rat nerves at El 4-El 5 (El 2-El 3 in mouse), while 
the immature SC are present from E17 to birth in rat (E l5 in mouse) (Bhattacharyya et
al., 1991; Lee et al., 1997; Zhang S.M. et al., 1995). The first contact between early
post migratory neural crest and axons probably occurs when both start to migrate away 
from the neural tube through the rostral part of the somites. This migration along the 
rostral somite is mediated by interaction with attractive cues such as tenascin, laminin 
and thrombospondin and repulsive cues, such as ephrins and their receptors, F-spondin, 
cytotactin binding proteoglycan, cadherin and versican (Krull et al., 1998). These 
signals are responsible for PNS segmentation; in fact they direct axons and the 
associated neural crest cells towards target organs. All these transitions can be 
distinguished in SC based on their morphology. The intimate relationship between 
neural crest, its derivatives and axons are a prerequisite for these transitions. To
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investigate how neural crest cells become SC, a good model is represented by 
developing rat sciatic nerve. In fact approximately two days after neural crest 
migration, between E13 and E l4, the axons project out into the rat hind limb. At this 
stage glial cells are strictly associated with the axons (lessen et al., 1994).
Neural crest — SC precursor transition
One of the major problems in defining the development of SC from neural crest 
cells is the absence of early differentiation markers. Precursor SC have sheath like 
processes, which contact each other and encircle groups of axons into large bundle, a 
phenomenon that in rat sciatic nerve is present at E14 (Fig. 1.8). SC precursors are 
characterised by some differentiation markers, such as p75. Growth associated Protein- 
43 (GAP-43), Neural Cell Adhesion Molecule (N-CAM) and LI adhesion molecule. 
Another precocious marker identified in a population of neural crest cells is the PO 
mRNA. During development it is expressed at very low level, in precursor and 
immature SC regardless of whether they are destined to attain myelinated or non­
myelinated phenotypes (Bhattacharyya et al., 1991; Lee et al., 1997). SC precursors 
need an axonally derived signal to survive. In fact if they are dissociated from the 
neurons and they are put in culture, they die (see chapter 5: SC-axon reciprocal 
influences). The signal involved in survival of SC precursors is ^-Neuregulin (NRG) 
(Mirsky and lessen, 1999).
Neuregulins and ErbB receptors
Neuregulins play fundamental roles in cell survival, migration and 
differentiation of many cell types. There are four genes that encode neuregulins: NRG- 
1, NRG-2, NRG-3 and NRG-4. Little is known of the role of NRG-2, NRG-3 and NRG- 
4, whereas NRG-1 has been most intensely studied and it is fundamental for SC and OL 
survival and differentiation. Neuregulins are a family of growth factors, characterised 
by the combination of different domains: an Epidermal Growth Factor (EGF)-like 
motif, a signal peptide, an immunoglobulin (Ig)-like domain, a cysteine-containing N- 
terminal domain, a glycosylation domain and a transmembrane domain. All NRG-1 
isoforms can be proteolytically cleaved and released from the cell surface.
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Alternative splicing of the NRG-1 gene produces many variants, which are 
grouped in three different isotypes. Members of isotype 1 include NDF and 
Acetylcholine Receptor Inducing Activity (ARIA), members of isotype 2 include GGF- 
2 and members of group 3 include Sensory and Motor Derived Factor (SMDF).
Targeted deletion of NRG-1 in mice results in an early embryonic lethal 
phenotype, caused by cardiac defects. However, just before the embryo dies it is 
possible to show the almost complete absence of SC precursors (Meyer and Birchmeier, 
1995). In vitro studies showed that NRG-1 is important to drive the differentiation of 
neural crest progenitors toward a glial cell fate. In the early post-natal peripheral nerve, 
NRG-1 is an important survival factor and it regulates the number of pre-myelinating 
SC (Grinspan et a l,  1996). The level of NRG-1 protein in adult mice is strongly 
reduced as compared to the early postnatal period. Moreover a recent paper showed 
that addition of GGF-2 to SC-DRG cocultures blocks the myelination process and it 
causes demyelination if added to co-cultures that have already myelinated (Zanazzi et 
al.,200l).
The role of NRGs in the CNS is not well understood. In OL, NRG-1 promotes 
proliferation of OPC and in long term cultures it constitutes a potent survival factor 
(Fernandez et al;, 2000). In vivo NRG inhibitors reduce the OPC number in optic 
nerve. It seems to be required for oligodendrogliogenesis; in fact spinal cord explants 
of NRG-1 null mice, do not develop OPC until they are rescued by external addition of 
recombinant NRG-1 (Vartanian et a l, \999).
Receptors for these ligands are the four members of the EGF family of receptor 
tyrosine kinases: ErbBl (EGF-receptor), ErbB2, ErbBB and ErbB4. The ErbB 
receptors contain a large extracellular ligand-binding domain, a single transmembrane 
domain and an intracellular part with a COOH-tail and a tyrosine kinase domains. They 
usually form heterodimers on the cell surface, and nearly all combinations are possible. 
This mechanism leads to receptor phosphorylation and activation of downstream 
signalling pathways. However, ErbB2 has no affinity for NRGs, while ErbBS receptor 
lacks the tyrosine kinase activity. The lack of the catalytic activity of the ErbBS 
receptor is overcome by the process of ligand induced dimerization, in which one of the 
other ErbB members is recruited as co-receptor.
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Many of these receptors are expressed in neurons and in glial cells, both OL and 
SC, during development (Burden and Yarden, 1997). The ErbB2/ErbB3 heterodimer is 
the primary NRG-1 receptor in SC, while in OL all receptors are expressed (Canoll et 
al, 1996).
Knockout mice for ErbBS cause death soon after birth, and their nerves are 
devoid of SC, presumably because they lose SC precursors even if axons can reach their 
normal target with normal innervation (Riethmacher et a l, 1997). The influence of SC 
on axons and the role of these null mice in understanding the importance of SC 
signalling to axons I will present later (see chapter 5: SC-axon reciprocal influences). 
Like (3-NRG null mice, mice lacking ErbB2 receptor die for cardiac defects at an 
embryonic stage in which it is not possible to evaluate the effect on SC development 
except in ventral roots (Lee et a l, 1995; Garratt et a l, 2000). Recently transgenic mice 
that can rescue this cardiac defect were generated (Morris et a l, 1999; Woldeyesus et 
a l, 1999). In both studies, rescued animals survived until birth, but all peripheral 
nerves were devoid of SC, showing a phenotype similar to the one described for ErbB3 
knock out. The ablation of the ErhB4 gene results in precocious embryonic death, but 
the fact that it is not expressed in SC makes it not relevant in regulating the 
development of SC precursors (Gassman et a l, 1995; Grinspan et a l, 1996).
In the CNS targeted disruption of ErbB2 shows that it is not required for the 
formation of early OL lineage, while it seems to be involved in later stages of OL 
development (Park et a l, 2001).
Precursor -  immature SC transition
This transition occurs between E14 and E l7 in rat and in vivo it is characterised 
by a series of morphological changes (Fig. 1.8). Immature SC invade bundles of axons 
and sort them into smaller groups. Depending on the size of axons, they associate with 
only one large axon or with multiple small caliber axons, in order to adopt a pro- 
myelinating or a non pro-myelinating phenotype, respectively. When put in culture 
immature SC are not very mobile and they have a hi- or tri-polar morphology, whereas 
precursor SC have high mobility and they are flattened. Immature SC are characterised 
by the expression of specific markers such as S I00 and the sulphatide antigen 04  
(lessen and Mirsky, 1991). These cells can survive when cultured at high density in a
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defined medium without external addition of NRG or DRG conditioned medium 
(lessen et al., 1994). In vivo analysis of SC development revealed that the switch from 
axon-dependent to axon-independent survival occurs gradually as SC mature in 
peripheral nerves (Fig. 1.8).
Immature to non-myelinating SC transition
Non-myelinating SC express several characteristic surface markers such as p75, 
Glial Fibrillary Acidic Protein (GFAP), N-CAM, LI. These markers are also present in 
pro-non-myelinating SC. The analysis o f L I  knockout mice revealed that only non­
myelinating SC of the sensory fibers are affected and there is a reduced association 
between sensory axons and non-myelinating SC (Dahme et a l, 1997). Transplantation 
experiments between wild type SC and LI deficient mice showed that these SC in 
contact with affected axons reproduced the LI deficient phenotype, strongly suggesting 
that LI expression on axons is essential for the formation of unmyelinated fibers 
(Haney et al., 1999). Probably heterophilic interactions between LI on the axonal 
membrane and other components on the non myelinating SC membrane are required for 
the formation of these fibers.
SC-axon reciprocal influences
During PNS development, both SC and axons play a central role influencing 
each other in their different functions. In fact while it was well known from many 
studies that axons directly regulate SC development, it is now becoming evident that 
even SC can directly influence neuronal survival and development.
Signals coming from axons are determinants for the survival of SC precursors. 
When these cells are dissociated from neurons and put in culture, they undergo 
programmed cell death, strongly suggesting that SC precursors need an axonally 
derived signal to survive. In fact both close proximity in culture to DRG neurons and a 
conditioned medium prepared from PI DRG can rescue the programmed cell death of 
SC precursors (Dong et al., 1995). These studies showed that a soluble hybrid protein 
containing the extracellular domain of ErbB4 receptor blocks this activity. In addition 
to that, when NRG is added to the medium it mimics the effect of the neuron 
conditioned medium, supporting the survival of SC precursors in vitro (Mirsky and
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lessen, 1999). In SC development, the important role of NRG is suggested by the fact 
that its mRNA is present at the right time and place to act as a neuron-instructive signal. 
It is in fact highly expressed in DRG and ventral horn in motor neurons at E14 
(Bermingham-McDonogh et al., 1997; Marchionni et al., 1993). Studies on the 
processes that govern SC development showed that the switch from axon-dependent to 
axon-independent survival is likely to occur gradually as SC develop from precursors
and mature in peripheral nerves (Fig. 1.8). This is demonstrated by the fact that when
;
SC-axonal contact is lost after nerve transection at perinatal stages, there is a significant 
SC death that can be prevented by the addition of NRG. On the contrary if the same 
transection is performed in an animal 15 days after birth there is very low apoptotic 
death showing that SC are already able to survive (Trachtenberg and Thompson, 1996; 
Syroid et al., 1996). This mechanism of number control during SC maturation is 
relevant in vivo to exactly regulate peripheral nerve development. In fact the 
dependence of precursors on axonal contact is probably involved in matching precursor 
numbers to axon numbers (Zorick et al., 1999).
Axons directly influence the decision of a SC to become myelin-forming or not. 
In fact axon diameter determins if an immature SC will acquire a myelinated or a non­
myelinated phenotype. The decision to become a myelinating versus non-myelinating 
SC is determined by cell-extrinsic signals coming from the axons. The identity of the 
axonal signals responsible for this choice is not known, although it is determined by the 
axonal diameter; in fact only axons with a diameter bigger than 1pm will become 
myelinated, whereas smaller axons will not. However SC directly control the number 
of neurofilaments of the axons and their phosphorylation state. This is particularly 
important because a change in neurofilaments number is important in determining axon 
diameter (Martini, 2001).
Nevertheless, it is becoming evident that not only are axons influencing SC 
development, but also SC exert fundamental effects on neuronal final development. SC 
play a role in controlling axonal survival, regeneration and normal development. They 
also somehow affect changes in the axons in some inherited human neuropathies.
SC directly support axonal survival as evidenced by the analysis of the ErbB3 
knock out mice. These mice die soon after birth, but their nerves are devoid of SC, 
presumably because they lose SC precursors even if axons can reach their normal target
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with normal innervation (Riethmacher et a l, 1997). This suggests that cells of the SC 
lineage are not necessary for normal axonal development; however analysis of DRG 
survival in these mice revealed that 80% of them die before reaching the final target 
between E13 and E l8, indicating that sensory neuron death is due to lack of SC and 
their precursors. These studies underline that during PNS development a cross talk 
between SC precursors and neurons is necessary to reach a normal development at least 
in DRGs.
Signalling from SC to neurons is also relevant after axonal damage. This 
process known as Wallerian degeneration, causes a retraction of proximal and distal 
stumps of the nerve near the lesioned point. In correspondence to all these defects SC 
de-differentiate to an immature phenotype. At this stage SC proliferate and they form 
endoneurial tubes, called band of Bungner. The basal lamina produced by these SC 
form a trace in which axons can regenerate. After re-establishment of contact between 
SC and axons these SC stop proliferating.
SC also influence the formation of the protective connective tissue layers that 
surround boundles of nerve fibers as shown by the analysis of Dhh null mice 
(Parmantier et a l, 1999), and as we discussed in the description of the perineurium in 
Chapter 3.
SC mediates also the spacing of Na^ channel clusters during development of the 
Node of Ranvier (Salzer, 2002). Na"*" channels are positioned in the middle of the Node 
of Ranvier and their distribution is particularly important for the saltatory conduction of 
impulses. Recent papers showed that the targeting of these channels at the Node of 
Ranvier is regulated by myelinating glia not only in the PNS but also in the CNS 
(Boiko et al, 2001). Other papers suggests that soluble factors could be involved in the 
clustering of these channels at the Node of Ranvier (Kaplan et a l, 1997; Martini, 2001).
More importantly it has been shown that some of the mutations that cause 
human inherited neuropathies such as Charcot Marie Tooth (CMT) disease, Dejerine 
Sottas Syndrome (DSS) and Congenital Hypomyelination (CH) disease are due to a 
primary defect in SC. However, as a consequence of these mutations, some patients 
show also changes in the axons, such as reduced axonal caliber and alteration in the 
phosphorylation state of neurofilaments (Bjartmar et a l, 1999). These secondary
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defects affecting the axons could led to axonal degeneration with subsequent severe 
clinical consequences (Sahenk Z., 1999).
All these observations strongly suggest the existence of a strict relationship 
between SC and axons. Both axons and SC cooperate for development and 
maintenance of the PNS.
0 #
Non-myelinating SCSC precursor Immature 8 0
E12
Figure 1.8
Schematic representation of the main transitions occurring during SC development in 
mice: from neural crest cell to precursor cell; from precursor to immature Schwann cell 
and from immature to myelinating or non-myelinating Schwann cell (Modified from 
lessen and Mirsky, TINS 22(9), 1999).
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TRANCRIPTIONAL CONTROL IN SCHWANN CELL DEVELOPMENT
The differentiation of SC during development is controlled by many 
transcription factors (Fig. 1.9).
Pax-3
Pax-3 is a member of the murine Paired Box gene family composed of at least 
nine members in vertebrates (Mansouri et a i, 1996). The Pax genes contain a DNA 
binding domain homologous to the pair rule gene paired  in Drosophila. Several 
members of this family contain also an homeobox domain. The Pax-3 recognition site 
contains two DNA sequence blocks, encompassing 18bp: an ATT A motif and a 
GTTCC region. In the mouse Pax-3 expression starts at E8.5 in the dorsal 
neuroepithelium and by E 9.5 is present in somitic mesoderm and neural crest. In SC 
lineage Pax-3 mRNA is expressed in the embryonic sciatic nerve from E l2 and peaks at 
E l7 (Blanchard Qt a l, 1996). Pax-3 level of expression fails gradually after birth and 
reaches the lowest level 3 days after birth. It is also expressed by E14.5 in immature or 
precursor SC and strictly in non-myelinating SC in sciatic nerves 5 days after birth and 
in adult animals. All these data indicate that Pax-3 is associated with neural crest and 
non-myelinating SC (Kioussi et al., 1995). Nerve crush and transection experiments 
showed that Pax-3 expression is dependent on axonal contact. These results suggest 
that Pax-3 is involved in determining the fate of immature SC into a non-myelinating 
phenotype. The role of Pax-3 in SC development has been studied also in two natural 
mutant mice: splotched (sp) and splotched delayed (sp^). In the homozygous state both 
mice are embryonically lethal. The sp mouse dies at E l3.5 and its nerves lack SC. The 
sp^ mouse die at El 8.5 and it has a small number of SC at E l3.5 but at E l5.5 SC could 
no be longer detected. These studies suggest that neural crest delamination or SC 
precursors are affected in these mice or that SC precursors can form, but they can no 
longer survive.
Sox-10
Another transcription factor involved in specifying SC development is Sox-10. 
In the PNS, Sox-10 can be detected in migrating mouse neural crest cells after E8.5 
(Fig. 1.9). In later stages of embryonic development. Sox-10 is detectable in enteric
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ganglia, glial cells of the sensory and sympathetic ganglia and from E 10.5 also in SC 
precursors. Its expression remains high in enteric glia and in SC during all subsequent 
stages of embryonic and postnatal development. The natural Sox-10 mutant. Dominant 
megacolon {Dom), has many defects in all neural crest derived tissues. Depending on 
genetic background, mice homozygous for this mutation die between E l3 or 
immediately after birth, however in these mice no SC alterations have been reported. 
The targeted Sox-10 ablation in mice shows that in the heterozygous state the animal 
resemble the same phenotype observed in the spontaneous Sox-10 Dom mutant. More 
interestingly homozygous Sox-10 null mice do not develop SC or satellite cells, even if 
sensory neurons are normally formed in their DRGs (Britsch et al, 2001). However at 
later developmental stages these animals have severe degeneration of both sensory and 
motor neurons, resembling the same phenotype observed in ErbB3 null mice. The 
analysis of expression of these genes in Sox-10 null mouse, revealed that Sox-10 
controls ErbB3 expression in neural crest cells (Britsch et al, 2001).
Co-transfection experiments showed that Sox-10 synergistically interacts with 
Pax-3 and the POU domain transcription factor Oct-6 to activate transcription of a 
reporter gene in which DNA binding sites for each of these factors were cloned. On the 
contrary it represses the transcriptional activity of the zinc finger protein Krox-20 
(Kuhlbrodt et al., 1998). These in vitro results suggest that Sox-10 may be relevant in 
SC development.
Another transcription factor involved in the regulation of SC development is 
Oct-6/SCIP/Tstl. It belongs to the class III family of POU domain transcription 
factors. This family consists of two conserved regions, an amino terminal specific 
domain and a carboxy terminal homeodomain. The consensus-binding site for these 
transcription factors is ATTTGCAT; the homeodomain binds to the ATTT sequence, 
while the specific domain recognises the GCAT region (Verrijzer et al., 1992). During 
early stages of development Oct-6 is expressed in many ectodermally derived tissues. 
In later stages it is expressed in proliferating OL precursors and in some neurons of the 
CNS (Collarini et a l, 1992). In the SC lineage both Oct-6 mRNA and protein can be 
detected in SC precursors, rising to a peak shortly after birth (Fig. 1.9). In adult it is
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expressed at low levels in non-myelinating SC (Arroyo et a l, 1998; Blanchard et a l,
1996). In Oct-6 null mice SC achieve a 1:1 relationship with axons but animals die at 
birth from respiratory defects (Bermingham et al., 1996). However a small number of 
knock out mice can survive, and these animals show a delayed myelination (Jaegle et 
al., 1996). An explanation for this rescue is that Oct-6 might be involved in 
determining the transition from pro-myelinating to myelinating SC. It is also possible 
that other POU genes compensate for its absence. Other in vitro and in vivo studies, 
using a dominant negative form of Oct-6, postulated that it can act as a negative 
transcriptional regulator and a general repressor for myelin genes (Monuki et al., 1993; 
Weinstein et al., 1995). However a recent paper showed that Oct-6 is a direct Krox-20 
activator in the “so-called” dominant negative transgenic mice. In particular the authors 
showed that it acts as a positive regulator at the beginning of the myelination process 
(Ghislain et al., 2002). Thus, Oct-6 probably serves to regulate the timing of 
myelination by regulating how SC transit from pre-myelinating to pro-myelinating to 
myelin-forming.
Krox-20 and Krox-24
Egr-1 (Krox-24) and Egr-2 (Krox-20), two zinc finger transcription factors 
belonging to the Early Growth Response (Egr) family, are expressed in the SC lineage. 
This family includes also Egr-3 and Egr-4 genes. In addition to a DNA binding 
domain, both Krox-20 and Krox-24 contain an activation domain and a domain that is 
able to interact with two co-factors NABl and NAB2 (NGF-1 A-binding protein) 
(Russo et a l, 1995; Svaren et a l, 1996). Both genes are activated around E l0.5 in the 
peripheral nerve in a non-overlapping pattern! Only Krox-24 is expressed in SC 
precursors while both genes are present in the dorsal and ventral roots close to the 
neural tube. Krox-20 is activated in the peripheral nerve around E l5, exactly in the 
same period in which Krox-24 is downregulated (Fig. 1.9). The transition between 
Krox-20 and Krox-24 expression is thought to be associated with the acquisition of a 
one-to-one relationship between SC and axons. Krox-24 expression is strongly re­
activated around birth. As myelination proceeds, Krox-24 expression decreases in 
myelinating SC, while it is maintained in non-myelinating SC. In contrast, Krox-20 
expression marks myelinating SC until adulthood (Topilko et a l,  1997). This
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differential regulation is evident also after nerve damage. During Wallerian 
degeneration SC lose their myelin sheath and they de-differentiate to an immature SC 
phenotype, concomitantly Krox-24 is upregulated, while Krox-20 is turned off. Nerve 
crush experiments demonstrated that both genes are axonally regulated (Topilko et a l,
1997). This was shown also by in vitro study in which Krox-20 expression is lost when 
SC are grown without axons, but its expression is restored in a co-colture system with 
sensory DRG neurites. The signal that allows Krox-20 induction is a diffusible factor, 
in fact it can be restored by growing pure SC in the presence of a conditioned medium 
with Neuregulin, or in a combination with CNTF or bFGF (Murphy et a l, 1996).
The ablation of the Krox-24 gene does not reveal any phenotype in SC (Lee et 
al, 1996). On the contrary mice with a targeted deletion of Krox-20 die soon after 
birth, and in addition to defects in hindbrain segmentation and in bone formation, they 
are defective in SC differentiation (Topilko et a l,  1994; Schneider-Maunoury et a l, 
1993). All SC in these mice acquire a one-to-one relationship with the axon, but they 
seem to be arrested at the pro-myelinating stage. This impairment is also showed by a 
strong reduction in the expression of PO, MB? and PMP22 myelin genes. In the 
peripheral nerves of the few animals that survive after birth, both SC survival and 
apoptosis are increased as compared to control littermates. It is possible that Krox-20 is 
involved in regulating cell-cycle exit into the pro-myelinating phenotype (Topilko et 
a l, 1994). The block at this stage causes an increase in SC, and subsequently in a 
competition for survival.
In humans, mutations in Krox-20 are associated with peripheral neuropathies 
such as CMT, CH and DSS neuropathies (Warner et a l,  1998; Warner et a l, 1999). 
Co-transfection experiments show that Krox-20 can partially trans-activate the PO 
promoter (Zorick et a l, 1999). A recent paper describes an induction of mRNAs for 
PO, MBP, MAG, PMP22 Cx32 and MAG by Krox-20 (Nagarajan et a l, 2001). They 
showed that some of the mutations described in human have a dominant negative effect 
on the wild type Krox-20, affecting, at the end, the expression of myelin genes. 
Because until now there is no evidence of a functional binding of Krox-20 to any of 
myelin gene promoters, the modulation of the wild type activity by these mutants is 
probably associated with their ability to sequester Krox-20 co-activators or co­
repressors that are crucial for its function. Moreover, at the level of protein, these
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Krox-20 mutants are more stable, strongly suggesting that this enhanced stability causes 
an increased expression that is sufficient to interfere with wild type Krox-20. Another 
mutation that causes human neuropathy is recessive and is located in the Krox-20 
domain interacting with the NAB transcriptional co-factors (Warner et ah, 1999). The 
location of this mutation strongly suggests that NAB proteins are required for a correct 
modulation of Krox-20 on myelin genes. The recent finding that NAB can also be 
activators and not only repressors, depending on the specific promoter context, suggest 
that they may be responsible for the different effects of mutant Krox-20 proteins on 
individual promoters. Moreover both NABl and NAB2 contain multiple Egr binding 
sites, suggesting also a feed back regulation mechanism. (Sevetson et al., 2000; 
Mechta-Grigoriou et al., 2000).
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Figure 1.9
Schematic representation of the expression profile of transcription factors involved in 
Schwann cell development (Modified from Topilko P. and Meijer D., Glial cell 
development 2"  ^Edition Oxford University Press, 2001)
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1.6 MYELIN
Myelin, one of the fundamental adaptations of vertebrates, is a multilamellar 
structure deriving from the spiral wrapping around an axon which in PNS has to be 
larger than 1pm in diameter (Scherer, 1997; Martenson, 1992). Biochemical analysis 
revealed that myelin membrane is enriched in lipids composition; in fact it contains 
70% lipid and 30% protein, with a high concentration of cholesterol and phospholipid; 
whereas usually plasma membranes contain 50% of lipids and 50% of proteins. CNS 
and PNS myelin include specific and overlapping sets of proteins (Martenson, 1992). 
They both contain high amounts of sphingolipids, including galactocerebroside and 
sulfatide. In compact myelin the membranes adhere to one another at both the 
cytoplasmic surfaces and the extracellular surface, giving rise respectively to the major 
dense line and the intraperiod line (Fig. 1.10). The alternating intraperiod and major 
dense lines give myelin its characteristic periodicity which is approximately 14nm in 
conventional preparation for electron microscopy while in fresh nerves prepared for X- 
ray diffraction it is approximately 18nm. The adhesion is stabilised by a combination 
of non-specific forces such as van der Waals attraction and electrostatic repulsion and 
specific short-range interactions mediated by protein. The major dense line can be 
interrupted by Schmidt Lanterman incisures, which appear in longitudinal section in a 
V-shaped configuration. These structures are much more visible in PNS than in CNS. 
They constitute a continuous channel of cytoplasm, which extends through the sheath 
from the periaxonal process to the soma. The incisure membrane is characterised by 
the presence of tight junctions, adherens junctions and gap junctions. Tight junctions 
separate paranodes and incisures from extracellular space. Adherens junctions link 
together consecutive layers of the myelin sheath. Gap junctions mediate a pathway of 
diffusion across incisures by forming a radial pathway for ions and small molecules 
(Balice-Gordon et ah, 1998). In contrast, CNS myelin has a radial component which is 
a network of interlamellar junctions running parallel to the nerve fiber axis and radially 
through the stacked membrane. It is essentially composed of tight junction proteins, in 
particular by claudin-11/oligodendrocyte-specific protein. Myelinated axons are 
completely covered by myelin sheaths except at nodes of Ranvier. Those are small 
gaps (less than 1pm in length), directly exposed to the extracellular components.
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The molecular components of CNS myelin partially overlap that of the PNS. 
The organisation of the axon itself is quite similar in the CNS and in the PNS (Fig. 
1.10). However while SCs make a one to one relationship with the axons before 
myelinating, each OL can take contact with many axons whose number varies from 
tract to tract and appears to be related to axonal caliber. OL make fewer sheaths in 
tracts containing large myelinated fibers. They do not have a basal lamina or 
microvilli, like SC. OL express two proteins that are not present in SC, the Myelin 
Oligodendrocyte Protein (MOG) on their outer cell membrane (Brunner et al, 1989), 
and Myelin Oligodendrocyte Basic Protein (MOBP) in the major dense line (Holz et a l, 
1996). The principal myelin proteins expressed in the PNS are Protein Zero (PO), 
Peripheral Myelin Protein 22KD (PMP22) and MBP (Fig. 1.10).
Given the importance of myelin proteins in regulating the final structure of 
myelin I will discuss them in much more detail in a separate section.
Schwann cell Oligodendrocyte
Major 
dense line
Intraperiod 
line ^
Figure 1.10
Schematic diagram of the myelin structure in the CNS and in the PNS. The major 
myelin proteins involved in its formation and maintenance are indicated. See text for 
details.
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1.7 MYELIN PROTEINS
In this section I will introduce not all the proteins that are constituents of myelin, 
but only those in which some of components of the transcriptional regulator 
mechanisms were identified.
MYELIN PROTEIN ZERO (PO)
PO is the major PNS myelin protein, comprising approximately 50% of all PNS 
protein (Greenfield et al., 1973; Lemke et a l, 1988). It is the main adhesive molecule 
in compact myelin and it has a single extracellular IgG-like domain that it is thought to 
hold together the extra-cellular surfaces of compact myelin. PO mRNA can be detected 
in a population of migrating neural crest cells, as well as in SC starting fi*om E l4, and 
in embryonic SCs prior to myelination (Lee et a l, 1997). Post-natally it is strongly 
upregulated in myelinating SC, both at the level of message and protein. The presence 
of PO in early stages of development, suggests that it can play a role not only in the 
myelination process, but that it can be involved also in other mechanisms, such as cell­
cell interactions in early glial cell development although PO -/- mice show no pre-natal 
phenotype. The X-ray resolution of the PO protein structure suggests that in myelin, it 
forms tetramers in the plane of the membrane and that these tetramers can interact with 
their counterparts on the opposing cell membrane (Shapiro et a l, 1996).
In humans, mutations in the PO gene cause different demyelinating 
neuropathies: CMT-IB, CH and DSS. The mechanism through which these mutations 
act is different. Many observations, particularly in transgenic mice, suggest that the 
majority of these mutations operate at least in part through a gain of function 
mechanism. In some cases the mutant PO is translocated to the membrane where it can 
interfere with the normal PO protein and completely alter its function. In other cases, 
the mutation may act through a loss of function mechanism (Previtali et a l, 2000; 
Warner et a l, 1995).
SC in PO null mice can still form a multilamellar spiral around axons, but 
myelin is uncompacted, producing reduced nerve conduction velocity. The 
heterozygous PO null mice develop a late onset demyelinating neuropathy (Martini et 
al, 1995). On the contrary PO overexpression causes a much more severe phenotype in
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mice, indicating that the amount of this protein in SC must be strictly regulated 
(Wrabetz et al., 2000).
PERIPHERAL MYELIN PROTEIN 22KDa (PMP22)
PMP22 represents approximately 2-5% of total peripheral myelin. It is 
expressed in low quantities in several other organs, including neurons in CNS, 
especially during development (Parmantier et al., 1997). Its expression is regulated by 
two different promoters (Suter et ah, 1994). PMP22 was recently shown to interact 
with PO protein (D'Urso et ah, 1999) and recruited to intercellular plasma membranes. 
Both overexpression and deletions of the PMP22 gene cause myelin defects, strongly 
supporting the idea that even the amount of PMP22 is strictly regulated. In humans, 
duplication of the genomic region, in which the PMP22 gene is located, causes CMT- 
lA  disease, while transgenic mice carrying 15-30 copies of the gene, completely lack 
peripheral myelin and their SC show impaired differentiation and marked proliferation 
(Magyar et ah, 1996). Heterozygous deletion of the PMP22 gene in mice and human or 
a frame shift mutation in human cause a mild peripheral neuropathy, the Hereditary 
Neuropathy with liability to Pressure Palsy (HNPP). On the contrary mice completely 
lacking PMP22  have a similar but more pronounced phenotype with both 
hypomyelination and hypermyelination in young animals and severe demyelination in 
older animals (Adlkofer et ah, 1995).
MYELIN ASSOCIATED GLYCOPROTEIN (MAG)
MAG is a minor myelin constituent, comprising approximately 1% and 0.1% of 
total myelin proteins in CNS and in PNS respectively. It is a glycoprotein of the Ig- 
superfamily with significant homology to N-CAM. An alternative splicing of the 
primary transcript gives rise to two MAG isoforms, S-MAG and L-MAG which differ 
in their cytoplasmic domains (Fujita et ah, 1998). In rodents, MAG expression peaks 
early during development and declines thereafter both in CNS and in PNS. MAG 
interacts with a component of the extracellular matrix, tenascin R and with different 
types of collagen influencing the formation of collagen fibrils (Bachmann et ah, 1995; 
Probstmeier et ah, 1992). MAG immunoreactivity is detectable on OL processes before 
formation of compact myelin (Trapp et ah, 1989). On myelinating SC, MAG is
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detected only after SC processes have turned at least once around the axon (Martini and 
Schachner, 1986). After myelin formation MAG is restricted to the periaxonal, 
paranodal and Schmidt-Lanterman regions (Arroyo and Scherer, 2000). Based on cell 
culture experiments, it has been suggested that MAG can mediate the interactions 
between myelinating SC and neurons and it can play a role in the initiation of 
myelination (Poltorak et al., 1987; Sadoul et al., 1990). Experimentally reduced levels 
of MAG in SC-DRG co-culture experiments renders SC unable to segregate large 
caliber neurites and impaired myelination (Owens and Bunge, 1991). Conversely 
experimentally increased levels of MAG in SC accelerated initial ensheatment of DRG 
neurites (Owens et al., 1990). However MAG  null mice showed a delay in the 
formation of compact myelin only in optic nerves of young animals while in PNS the 
initiation of myelination was not affected (Montag et al., 1994). The analysis of adult 
and aged MAG -/- mice revealed degenerative alterations of myelin in the PNS and to a 
minor extent in the CNS, with the formation of classical onion bulbs in the peripheral 
myelin. Those alterations support an in vivo role for MAG in the long-term 
maintenance of myelin integrity, at least in PNS.
PROTEOLIPID PROTEIN (PLP/DM20)
The PLP/DM20 protein constitutes approximately 50% of the total CNS myelin 
protein, and it is a minor component also of the PNS myelin (Garbem et a l, 1997). The 
gene gives rise to two alternatively spliced transcripts that encode the classical PLP 
gene and the smaller isoform DM20. The only difference between them is the presence 
of an additional 35 aminoacids in the intracellular region of PLP. The plp/dm-20 gene 
is expressed primarily by mature OL, although small amounts of the protein products 
have been detected in embryonic CNS, PNS, heart, spleen, thymus and lymphnodes 
(Martenson, 1992; Bongarzone et a l, 1999; Bronstein, 2000a). PLP duplication is a 
relatively common cause of Pelizeaus-Merzbacher disease in man and results in a fairly 
mild phenotype, although larger duplication of the genomic region can result in more 
severe clinical manifestations (Inoue et a l, 1999). In mice, 2-fold overexpression 
causes severe hypomyelination, astrocytosis, seizures, and premature death (Readhead 
et a l, 1994). OL in these animals contain vacuoles with a variety of myelin proteins, 
suggesting that dysmyelination is a result of protein missorting and subsequent inability
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to assemble myelin (Anderson et a l, 1999). Surprisingly disruption of the gene as well 
as spontaneous deletion or mutations, with a complete lack of the protein, result in 
relatively mild disease. PLP/DM20 null mice have normal compact myelin but the 
ultrastructural analysis revealed condensed intraperiod lines and reduced stability 
(Klugmann et a i, 1997; Boison and Stoffel, 1994). There are two spontaneous mutant 
mice, jim p y  and msd, in which point mutations cause premature OL death and 
subsequent inability to form normal myelin. OL of these mutants have perinuclear 
inclusions, which probably represent an accumulation of mutant protein (Gow et a i,
1998). Recently transgenic mice expressing only the DM20 isoform were created. 
These mice have altered CNS myelin periodicity and older animals develop 
abnormalities in coordination, although the DM20 isoform was normally targeted in 
myelin, suggesting that the aminoacids not present in DM20, are not essential for 
myelin structure and function (Stecca et a l, 2000).
OLIGODENDROCYTE-SPECIFIC PROTEIN (OSP/CLAUDIN-11)
In CNS myelin there are two OSP/claudin-11 transcripts of approximately 2Kb 
and 4Kb and they probably derive from a single gene. In adult, these proteins 
contribute 7% of total CNS protein and they are also present in Sertoli cells. 
Embryonically OSP is widely expressed in the mesenchymal cells adjacent to 
chondrocytes, in developing meningeal cells and in OL precursor cells before 
myelination starts (Bronstein et a i, 2000b; Morita et al., 1999). Low level expression 
was also found in the human PNS. The osp/claudin-11 gene contains three exons 
(Bronstein et al., 1996). The ablation of osp/claudin-11 gene in mice abolishes tight 
junctions in CNS and in Sertoli cells, leading to neurological deficits and abnormal 
formation of the testes. However myelin was grossly intact even if animals show 
reduced nerve conduction velocity and difficulties in coordination (Gow et al., 1999).
MYELIN-OLIGODENDROCYTE GLYCOPROTEIN (MOG)
MOG is a myelin glycoprotein preferentially expressed at the outer surface of 
the myelin sheath and OL processes, with only low expression in the compact myelin 
(Johns and Bernard, 1999). It is a quantitatively minor component of myelin 
representing 0.05-0.1% of all myelin proteins. Immunocytochemical studies on
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cultured OL showed that MOG is expressed 24-48 hours after other myelin proteins. 
MOG shows a caudo-rostral gradient of expression that is typical of all myelin genes 
both at the mRNA and at the protein level. Based on its secondary structure MOG can 
be considered an adhesion molecule even if there is no direct evidence supporting this 
function. It was speculated that MOG might have an immune function in the CNS. 
Many studies were performed to correlate this hypothesis with the generation of 
diseases like multiple sclerosis, suggesting that MOG does not have a direct role in the
4
myelination processes, rather it mediates interactions with the immune system.
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1.8 TRANSCRIPTIONAL CONTROL OF MYELIN GENES
In the case of the genes encoding for the myelin proteins, very little is known of 
their transcriptional regulation. Many studies have tried to identify transcription factors 
that are relevant in controlling the expression of myelin genes, because they are 
predominantly regulated at the transcriptional level. Classical transcription studies, 
aimed at identifying cis-acting sequences present in the promoter and transcription 
factors able to bind them, were performed on the principal myelin proteins expressed 
both in CNS and in PNS and they led to the identification of some transcription factors.
PLP
One of the first transcription factors known to be involved in the regulation of a 
myelin gene, was identified in the proximal promoter of the pip  gene. This factor is a 
zinc finger transcription factor named MyTl and it recognises the region from -242nt 
to -232nt of the proximal PLP promoter (Kim and Hiidson, 1992). MyTl is expressed 
in OPC both in vivo and in vitro. The other factor that was recently shown to be 
involved in the regulation of the PLP promoter is Gtx. It is an homeodomain 
transcription factor that binds also in 75 Ont of the proximal MBP promoter. In the PLP 
promoter Gtx can bind four cis DNA elements, located in 1.3Kb of the promoter 
(Awatramani et al., 1997). The precise role of these transcription factors in regulating 
the PLP gene is still controversial. In fact the expression of MyTl declines 
immediately after the cells differentiate and begin to myelinate, and Gtx is expressed 
only in completely differentiated OL. Nevertheless a recent paper suggest that Gtx can 
be a repressor in glial cells (Awatramani et al., 2000).
PO
The analysis of the proximal 1.1Kb of the PO promoter led to the identification 
of strong conservation between human, mouse and rat, of 350 nucleotides proximal to 
the transcription start site. Dnasel footprinting and EMSA analysis on the promoter 
revealed the presence of binding sites for the transcription factors NF-Y and Sp-1 
(Brown and Lemke, 1997). Another transcription factor that has an effect on the in 
vitro activation of the same region of the PO promoter is Oct-6/SCIP/Tstl. In vitro
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studies showed that it could be considered as a repressor not only for PO but also for 
MBP (Monuki et ah, 1993). Subsequent in vivo studies are not consistent with a 
repressive role of Oct-6 on myelin genes, but as we previously discussed, it is possible 
that Oct-6 has two separate functions. Recently, another transcription factor known to 
be involved in SC development, Sox-10, was shown to transactivate the 1.1Kb frgament 
of the PO promoter. Unfortunately all the analyses were performed in the N2A cell line, 
which do not express myelin genes, and not in SC. Nevertheless the authors showed 
that Sox-10 dependent induction is specific for PO (Peirano et ah, 2000).
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1.9 THE MBP GENE
MBP comprises approximately 35% of total protein in CNS myelin and 15% in 
PNS myelin. It has been found in all vertebrates that have myelin, both in the CNS and 
in the PNS. It is localised in the major dense line of myelin and in CNS it is required 
for normal myelin compaction. The analysis of a natural mouse mutant, the shiverer 
{sh) mouse, shows that an intragenic deletion of the 3 ’ region of the gene causes severe 
hypomyelination, a delamination in the CNS major dense line, tremors and tonic 
seizures (Molineaux et a i, 1986). Although MBP is also expressed in the PNS, the 
peripheral myelin in these animals is relatively normal, suggesting the presence of 
another myelin gene in PNS that can rescue its absence. The mbp gene is composed of 
seven exons that span a region of 32Kb in the mouse genome. When the mRNA retains 
all the exons the primary transcript gives rise to a protein of 21.5KDa. Alternative 
splicing of the exons produces various MBP isoforms (Fig. 1.11). In mouse, for 
example, there are other isoforms of 18.5KDa (exon 2 excised), 17KDa (exon 6 
excised) 17.2KDa (exons 2 and 5 excised) and 14KDa (exons 2 and 6 excised). The 
18.5KDa and the 14KDa isoforms are the most abundant proteins present in the adult 
mouse CNS (Barbarese et a i, 1978). The human mbp gene is composed of seven exons 
spanning a region of 40-45Kb. Its analysis revealed the existence of four isoforms, the 
21.5KDa, with all seven exons, the 20.2KDa (exon 5 excised), the 18.5KDa isoform 
(exon 2 excised) and the 17.2KDa isoform (exons 2 and 5 excised) (Kamholz et a i, 
1988) (Fig. 1.11). The molecular basis for this pattern of alternative splicing is not 
known. Comparison of the splice junction sequences surrounding the exons showed 
that there are no significant differences between them. Human and mouse primary 
transcripts were shown to be structurally similar, since they are both transcribed from a 
unique site in the genome within a single promoter and are polyadenylated at similar 
positions. The accumulation rates of these protein isoforms change during development 
and it is due to a modulation of their mRNA levels (Carson et a i, 1983). Between day 
10 and day 30, the most active period of myelination, the molar ratio among the 
21.5KDa:18.5Kda:17KDa: 14KDa isoforms is 1:5:2:10. In later phases of mice life the 
ratio between these isoforms changes to 1:10:3.5:3.5 (Barbarese et al., 1978).
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Figure 1.11
Schematic diagram of the MBP isoforms present in the mouse and human gene. The 
formation of each isoform is due to alternative splicing of MBP exons. The exons 
maintained in each isoform are indicated. These isoforms are differentially expressed 
during development. See text for details.
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The classical mbp gene is a part of a much larger gene, named golli-mbp, which 
is composed of 11 exons. Golli-mbp is expressed in brain regions rich in 
oligodendrocytes and their precursors, in neurons and also in organs of the immune 
system. Interestingly not only MBP exons but also the classic MBP promoter overlap 
the coding region of some Golli-mbp transcripts (Campagnoni et a l, 1993).
Nuclear transcription run on assays showed that the developmental expression 
of MBP is primarily regulated at the level of transcription (Wiktorowicz and Roach, 
1991). The total amount of MBP mRNA increase during the myelination process. The 
levels of these mRNAs increases 10- to 100-fold between day 2 and day 30 after birth, 
and fall to approximately 40% of this peak in adult (Wiktorowicz and Roach, 1991). 
Moreover the steady state level of MBP mRNA increases in parallel with protein, and 
both precede the appearance of compact myelin (Lemke and Chao, 1988; Zeller et a i,
1984). Unlike SC, OL are able to initiate MBP transcription in vitro in the absence of 
axons, although in vivo, in transgenic mice, the proximal MBP promoter is significantly 
axonally regulated (Wrabetz et a i, 1998). Although the myelin proteins appear at 
different times during OL development, the mRNAs encoding these proteins 
accumulate with similar temporal profiles both in the developing brain and in OL in 
culture (Zeller et al., 1984; Scherer et al., 1994a). In brain they are detected at birth in 
brainstem of rodent animals, and subsequently, appear in the forebrain, following a 
caudo-rostral gradient.
Analysis of MBP transcriptional regulation has been studied both in vitro and in 
vivo, in transgenic mice. Transgenic mice were generated in order to define the 
minimal region at the 5’ of the gene that confers the precise tissue specificity and 
developmentally regulated expression of a heterologous gene. In transgenic mice this 
strict regulation can be achieved with as small a portion as 256bp of the MBP promoter, 
but only in OL and not in SC. All transgenic mice generated up to now, with different 
parts of the promoter from 9.0Kb to 256bp, activate regulated MBP or heterologous 
cDNA expression in the CNS (Forghani et al., 2001; Foran and Peterson, 1992; Goujet- 
Zalc et al., 1993; Goverman et al., 1993; Gow et al., 1992; Hayes et al., 1992; Jensen et 
al., 1993; Katsuki et al., 1988; Kimura et al., 1989; Miskimins et al., 1992; Readhead et 
a l, 1987; Zingemakel et ah, 1990; Wrabetz et a l, 1998). However the analyses of 
more distal regions of the MBP promoter revealed the existence of a specific PNS
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enhancer located between -9.0Kb and -8.4Kb and named Schwann Cell Enhancer 1 
(SCEl), that activates transcription only in SC (Forghani et al., 2001). This is the first 
region that was shown to be both necessary and sufficient to obtain a correct pattern of 
expression of MBP in SC. The same researchers found a more distal region located 
between -12.0kb and -9.0Kb of the MBP promoter region, named SCE2, that can direct 
the expression of the reporter gene in SC, even if the analysis of the transgenic mice 
was restricted only to one line. These in vivo studies confirm that the transcriptional 
machinery that regulates the expression in OL and in SC is different.
The possibility of obtaining MBP expression in OL in cultures, in the absence of 
axons (Zeller et a l, 1985), allowed the in vitro analysis of the MBP promoter in this 
glial cell type. This analysis was restricted to the identification of cis-acting elements 
lying in the proximal region of the MBP promoter and the trans acting factors binding 
them. One approach used to identify important DNA elements was to compare these 
sequences between different species or, with that of other myelin genes. These studies 
allowed the identification of a strong conservation in the first 150bp upstream of MBP. 
The start site of transcription is located, both in mouse and in human, 48bp upstream 
from the translational start site. No TATA or CAT boxes are present in either 
promoter, although both contain a TATA-like sequence, TTC A A A, 30bp upstream of 
the cap site, and a CAT-like sequence, CCACTT 80bp from this site. Two other 
elements were found also in promoters of other myelin genes, a sequence located at 
-96bp, which is present also in the PLP and in the PO promoters, and 12bp located at 
-53bp which are present also in the PLP promoter. Unfortunately the functional 
significance of these elements is not known.
The analysis of the first 149bp of the human MBP promoter in primary culture 
of OL allowed the identification of two functional regions. A positive region is located 
proximal to nucleotide -102 and it is active both in cell types that do not transcribe 
MBP and in primary developing OL cultures (Wrabetz et a l, 1993). Another region 
firom -149bp to -102nt is a repressive element in Cos? cells, while in primary OL there 
is a negative element between - 1 16nt to -124nt and a positive element from -124nt to 
-149nt (Taveggia et al, 1998). Interestingly Aoyama et al. showed that from -124nt to 
-1 lOnt, there is a consensus binding site for a family of transcription Nuclear Factor 1 
(NF-1) encoded, at least, by four genes differentially expressed in brain (Aoyama et a l.
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1990; Chaudhry et al., 1997). We also described a sequence upstream and partially 
overlapping the NF-1 binding site, which activates the MBP promoter in primary OL 
but not in Cos? cells. A complex of protein enriched in brain, OL and SC, named 
MEBA, binds this sequence (Taveggia et al, 1998). The analysis of the more proximal 
region of the MBP promoter allowed the identification of another region, named MBl, 
from -14nt to -5 Ont, which is bound by Pura, a 39KDa protein. This is a sequence 
specific single stranded DNA binding protein that has a high affinity for the purine rich 
motif (Haas et al., 1993; Haas et ah, 1995). Recently another transcription factor Gtx, 
belonging to the homeodomain family of transcription factors, was shovm to bind inside 
?50nt of the proximal MBP promoter and in 1.3Kb of the PLP promoter region. Gtx is 
a sequence specific DNA binding protein that binds to DNA sequences containing a 
core AT rich homeodomain binding site. It is exclusively expressed in differentiated 
OL and not in SC or precursor OL and astrocytes and its mRNA increases in parallel 
with that of MBP and PLP (Awatramani et ah, 199?). Apart from the attempts 
performed to clarify the transcription mechanism of the MBP gene, the integrated 
functions of all of them are still obscure.
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Chapter 2
RESULTS
2.1 IN VITRO ANALYSIS OF A SC MBP ENHANCER IN VITRO
FUNCTIONAL ANALYSIS
Previous analysis performed in transgenic mice and in cultured cells showed that 
transcription of MBP is regulated by different cis-acting elements and trans-acting factors 
in SC as compared to OL. In particular, A. Peterson and colleagues identified a 588nt 
region 9Kb upstream of the start of MBP transcription required to activate transcription in 
SC but not in OL. Whether this region contributes to MBP transcription in OL was not 
determined (Forghani et a l, 2001). Therefore we analysed the extended MBP regulatory 
region in cultured cells to address two questions; does the 588nt region activate 
transcription in both SC and OL; and can cultured SC provide the means to dissect cis- 
acting elements within the 588nt region.
We generated a series of reporter constructs containing the same MBP regulatory 
region analysed in transgenic mice: 9.0Kb, 8.4Kb, 6.0Kb, 3.2Kb, 1.9Kb and 256bp. Even 
if MBP is transcribed robustly both in CNS and in PNS, only transgenic mice containing 
the region from 9.0Kb express the lacZ reporter gene both in CNS and PNS. All other 
constructs activate the reporter gene only in CNS (Forghani et a l, 2001). We cloned all of 
these fragments upstream of the luciferase gene, used as a reporter gene, in the pXPl 
promoterless plasmid, and we measured their activity after transient transfection of primary 
OLand SC. (Fig. 2.1)
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Figure 2.1
Schematic representation of the constructs previously used to generate transgenic mice, 
with their relative expression in Central and Peripheral Nervous System. The same 
constructs were used in our analyses. Numbers indicate MBP promoter regions inserted in 
the constructs. The dark grey box indicates the enhancer element located between 9.0 and 
8.4Kb upstream of the transcription start site. Black boxes represent the reporter gene, 
which is lacZ gene in the case of transgenic mice and luciferase in our study.
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To measure-cell specific activation of the 9.0Kb MBP construct, we transiently 
transfected primary cultures of OL and SC, as well as cells that normally do not express 
MBP, including undifferentiated murine fibroblast L cells, a human carcinoma cell line, 
HeLa, and monkey SV40 transformed renal cells, Cos7. As shown in Fig. 2.2, 9.0MBP lue 
was specifically activated in OL and in SC. In OL it activated approximately 200-fold 
above the promoterless control plasmid, whereas in SC the expression was increased 27- 
fold above pXPl. On the contrary, L cells and HeLa cells did not show any significant 
activation mediated by 9.0Kb of the MBP promoter. In Cos7 cells we found that this 
construct was transactivated approximately 13-fold above the promoterless construct, even 
though MBP is not expressed in this cell line. It is possible that this activation is an artifact 
due to cell transformation. These data show that strong cell-specific activation of the 
9.0Kb promoter is maintained both in primary cell culture of OL and SC, allowing us to set 
up a system in which to dissect the MBP promoter.
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Figure 2.2
Transient transfection analysis of plasmids containing 9.0Kb of the MBP promoter in 
oligodendrocytes (OL), Schwann cells (SC), Cos7, HeLa and L cells. Fold-activation is 
expressed as a ratio between luciferase and (3-gal activity as a measure of transfection 
efficiency. The final activity is relative to the promoterless construct pXPl = 1.0. Bars 
represent the mean luciferase activity ± S.E.M. of at least three independent experiments.
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In order to identify putative regions important in regulating MBP expression within 
the 9.0Kb mouse promoter, we performed a DNase I hypersensitivity assay on nuclei 
prepared from brain. This is one of the principal methods used in mapping the accessibility 
of a genomic locus. The major advantage of this technique is that it allows the detection of 
regions that are bound by transcription factors in vivo and for this reason they can be 
relevant to direct transcription of a specific gene in a particular time of the development. 
Using this approach, a Schwann cell enhancer in the genomic locus of the Oct-6 gene was 
recently identified (Mandemakers et ah, 2000). We prepared nuclei from 30 day old mouse 
brains, and we treated them with increasing amounts of DNase I. We then extracted the 
DNA and performed Southern blot analysis. We digested DNA using BamHI, as previous 
genomic mapping showed that this restriction enzyme releases a 10Kb fragment of the 
MBP promoter with the start site of transcription at its 3’ extremity (Takahashi et a l,
1985). The design of a probe inside intron 1 of the gene and at the 3’ of the lOkb region 
allowed us to detect possible hypersensitive sites (HSS). Unfortunately, we were unable to 
distinguish any HSS despite multiple attempts. The proximal promoter should have served 
as a positive control, as we know that it is highly active in OL from brain at P28. This 
negative result can be due to the fact that in brain there are many cell types and OL 
represent only a small part of the total. We did not try the same experiments on nuclei 
prepared from sciatic nerve because of the difficulty of obtaining sufficient number of 
nuclei. Schwann cells in culture were also not examined because the level of MBP 
transcription required to detect HSS would likely require axonal contact.
To map regions important for activation within the 9.0Kb construct, we transiently 
transfected primary cultures of OL (Fig. 2.3a) and SC (Fig. 2.3b) with the same constructs 
previously used to generate transgenic mice. In OL, we found that deletion from 9.0Kb to 
8.4Kb reduced the activity of the reporter gene approximately 50%. On the contrary the 
region from 8.4Kb to 1.9Kb had no significant effect. Deletion from 1.9Kb up to 256nt 
reduced the activity approximately 15%, and deletion of the proximal MBP promoter 
reduced the activity to background level. Thus, in agreement with previous results, we 
identified two regions important for the positive regulation of the 9.0Kb region: from 9.0Kb
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to 8.4Kb and the proximal part of the MBP promoter (Forghani et al., 2001; Wrabetz et al., 
1993).
In SC, we found that deletion from 9.0Kb to 8.4Kb had a stronger effect than the 
one observed in OL; in fact there was a reduction of approximately 70%. Deletion from 
8.4Kb to 6.0Kb had no significant effect. When we deleted to 3.1Kb we found an 
activation, which was 4-fold above the 9.0Kb region, and the same activation was 
maintained in deletion to 256nt. Finally, as in OL, removal of the proximal 256nt region 
reduced activity to background levels. The paradoxical activation of 3.1Kb, 1.9Kb and 
256nt fragments was not observed in transgenic mice, as these constructs are not able to 
transactivate the reporter gene. This analysis strongly suggests that, among all these 
elements, two regions are important activators in 9.0Kb of the MBP promoter, both in OL 
and in SC. The first one is the proximal promoter and the other one is the region from 
9.0Kb to 8.4Kb, which is an important activator in primary culture of both SC and OL.
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Figure 2.3a
Transient transfection analysis of plasmids containing progressive deletions of the 9.0Kb 
MBP promoter in primary OL. The final activity is relative to 9.0Kb = 100. Deletion of the 
588nt between 9.0Kb and 8.4Kb reduces the activity by approximately 50%, while deletion 
of the proximal MBP promoter region reduces the activity to background level. Bars 
represent the mean luciferase activity ± S.E.M. of at least three independent experiments.
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Figure 2.3b
Transient transfection analysis of plasmids containing progressive deletions of the 9.0Kb 
MBP promoter in primary SC. The final activity is relative to 9.0Kb = 100. Deletion of the 
588nt between 9.0Kb and 8.4Kb reduces the activity by approximately 70%, while deletion 
of the proximal MBP promoter region reduces the activity to background level both in OL 
and SC. Of note, the 4-fold activation in the 3.1Kb construct was not present in transgenic 
mice. Bars represent the mean luciferase activity ± S.E.M. of at least three independent 
experiments.
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We determined if the 9.0-8.4 region was an enhancer in SC and OL. A classical 
enhancer activates a heterologous promoter in an orientation- and distance-independent 
fashion. For example, in the in vivo characterisation of 9.0Kb of MBP promoter, the 588bp 
lying between 9.0Kb and 8.4Kb, behaves as an enhancer only in SC. By cloning it, in both 
orientations, upstream of 300bp of the minimal hsp68 heterologous promoter, A. Peterson 
showed that even in transgenic this element is a SC enhancer, in fact the lacZ reporter gene 
is specifically activated only in SC and not in OL in spinal cord or brain. To validate our in 
vitro model, we cloned this region in both orientations, upstream of homologous and 
heterologous promoters, and performed transient transfection analyses of primary SC and 
OL (Fig. 2.4). As homologous promoter we chose the minimal MBP promoter (256nt). 
Because of the excessive activation found in SC, we were able to analyse these constructs 
only in OL (Fig. 2.4a). These transient transfection assays revealed that, in OL, constructs 
containing these 588nt are not able to significantly enhance the activation of the reporter 
gene (Fig. 2.4a). To test the enhancer activity in primary SC, we cloned the same region, 
upstream of another myelin specific promoter. We used the 1.1Kb region of the proximal 
PO promoter that was previously shown to be specifically expressed in SC (Lemke and 
Chao, 1988; Brown et a l,  1997). These 588nt can upregulate the heterologous PO 
promoter 3-4 fold in both orientations (Fig. 2.4b), strongly suggesting that it behaves as an 
enhancer in SC. Finally we also cloned this element upstream of the Thymidine Kinase 
promoter (TK109). This is a heterologous, non-myelin promoter that can be activated in 
both OL and SC. Constructs containing the 588nt, in either orientation, were transiently 
transfected in both cell types. In SC, the region activated the TK promoter approximately 
3-fold above the construct containing only TK109, whereas in OL we never detected a 
transactivation above TK109 (Fig. 2.4c). These results strongly suggest that the region 
from 9.0Kb to 8.4Kb is an enhancer in SC, as evidenced in transgenic mice, but they also 
suggest that it mediates a different function in SC as compared to OL. We also conclude 
that our system represents a model to study the regulation of this SC enhancer (SCE) 
because it partially parallels the description revealed in vivo in transgenic mice.
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Figure 2.4a
The 588nt were cloned in both orientations upstream of the minimal homologous MBP 
promoter and transiently transfected in primary OL. The activity is relative to 256EMBP = 
100. Bars represent the mean luciferase activity ± S.E.M. of at least three independent 
experiments.
73
Results
125
100 -
LLIO
CL
I
§
I
i2
Schwann cells
PO POE POEr pX P I
Figure 2.4b
The 588nt were cloned in both orientations upstream of the 1.1Kb region of the 
heterologous myelin PO promoter and tested in primary SC. The activity is relative to POEr 
= 100. Bars represent the mean luciferase activity ± S.E.M. of at least three independent 
experiments.
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Figure 2.4c
The 588nt were cloned in both orientations upstream of the 109nt of the heterologous 
Thymidine Kinase promoter (from -109nt to + 52nt) and tested both in primary OL and SC. 
The activity is relative to TK109EMBP =100 transfected in primary SC. Bars represent 
the mean luciferase activity ± S.E.M. of at least three independent experiments.
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BIOCHEMICAL ANALYSIS
Based on the analysis performed in transient transfection assays, we focused our 
attention on the SCE in order to identify regions inside it that are responsible for its 
differential behaviour, in SC as compared to OL. The presence of endogenous factors 
binding to SCE was tested by DNase I footprinting experiments. The 588nt were 
subdivided into five overlapping fragments: Fragment 1 from nucleotide 72 to nucleotide 
290; Fragment 2 from nucleotide 290 to nucleotide 570; Fragment 3 from nucleotide 1 to 
nucleotide 195; Fragment 4 from nucleotide 195 to nucleotide 390; Fragment 5 from 
nucleotide 390 to nucleotide 588 (Fig. 2.5a). Increasing amounts of nuclear extracts 
prepared from either rat SC, mouse brain or liver, the last one used as a negative control, 
were incubated with end-labelled probes corresponding to SCE fragments, subsequently 
digested with DNase I and then resolved on a sequencing gel. We analysed both upper and 
lower strands of each fragment. We found regions specifically protected by each extract: 
regions protected by SC and brain but not by liver; and regions protected only by SC or 
only by brain. In particular we found four regions that were exclusively protected in SC 
nuclear extracts: Region I from nucleotide 33 to nucleotide 42; Region 2 from nucleotide 
112 to nucleotide 127; Region 3 from nucleotide 372 to nucleotide 380; Region 4 from 
nucleotide 549 to nucleotide 554 (Fig. 2.5c). An example of one of these footprinting 
experiments is shown in Fig. 2.5b.
76
Results
SCE
Fg 3________
Fg4
Fg 5
F g l
Fg2
Figure 2.5a
Schematic representation of SCE overlapping fragments generated by restriction enzyme 
cuts and tested in DNase I footprinting analyses. Both upper and lower strands of each 
fragment were tested by DNase I digestion.
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Figure 2.5b
DNase I footprinting analysis of the lower strand of fragment 3. The filled rectangle 
represents a protection present only in SC and not in brain or liver. The arrowheads 
indicate hypersensitive sites that delimit this protection in SC nuclear extracts. The same 
protection was confirmed also on the upper strand. Note that in liver, hypersensitive sites 
are present also at 38/39, but the protected region extends up to nucleotide 45. G+A: 
Maxam and Gilbert sequence reaction; 0: no nuclear extract.
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We focused our attention on these SC-specific regions because we wanted to better 
define the binding responsible for SCE activity. Therefore we searched for known 
transcription factors that can bind to these protected sequences using a TransFac database 
fwww.cbil.upenn.edu/cgi-bin/tess/tess331 and we found the possible binding sites for some 
of them, including Nonamer Binding Protein (NBF), Activating Transcription Factor lA 
(ATF), cAMP Responsive Element Binding site (CREB), Retinoid X Receptor (RXRa/(3), 
Thyroid Hormone Receptor (T3R-al), Growth Hormone Factor (GHF). In particular we 
found the putative binding site for Peroxisome Proliferator-Activated Receptor (PPAR), a 
family of transcription factors known to be involved in the regulation of genes mediating 
lipid metabolism and recently identified also in OL (Granneman et a l, 1998) (Fig. 2.5c). 
Just upstream of the last region differentially protected at the 3 ’ end of the enhancer, there 
is a consensus-binding site for Krox-20 transcription factor. Krox-20 is particularly 
interesting, as it is required to activate myelination in the peripheral nerve, as shown in 
Krox-20 null mice (Topilko et a l, 1994). However, the region containing the Krox-20 
binding site was not sufficient to replicate SCE activity either in vivo or in vitro. In fact, 
this element is maintained in the 8.4Kb construct and this plasmid is not sufficient to drive 
the expression of a reporter gene in either transgenic mice, or in transfected SC. To 
determine whether this element is necessary, Forghani and colleagues mutated this site in 
one transgenic line. They showed that despite this mutation, the lacZ gene is expressed 
throughout the PNS, demonstrating that it is not necessary to confer the specific expression 
in SC (Forghani et a l, 2001). Thus, the Krox-20 binding site is neither necessary nor 
sufficient for SCE activation.
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Figure 2.5c
Schematic representation of protected regions identified by DNase I footprinting analyses 
only in SC nuclear extracts (striped boxes). Under each box the consensus binding sites 
identified by TransFac analyses are indicated.
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To confirm the differential binding and explore the cellular origin of binding 
proteins previously identified, we designed oligonucleotides encompassing the regions 
protected only in SC nuclear extract and we tested for their ability to bind SC, brain and 
liver nuclear extracts in Electro Mobility Shift Assay (EMSA). This analysis confirmed 
that in all regions the binding was different in SC as compared to brain and liver (Fig.2.6a, 
2.6b, 2.6c, 2.6d). Because in brain only a proportion of the cells are OL, we decided to 
repeat the same assays using nuclear extracts prepared from CG4 cells, a rat 
oligodendroglial population (Louis et al., 1992). In these analyses we found that in region 
1, 2 and 4 the binding was different (Fig.2.7a, 2.7b, 2.7c). Taken together these results 
indicate that, at least in three regions, there is a differential set of trans-activating factors in 
SC as compared to OL, in large part confirming the results obtained in the DNase I 
footprinting assays. Moreover the presence of this set of binding proteins specifically 
present in SC and different from OL, may explain the differential function of SCE in SC 
and in OL.
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Figure 2.6a
EMSA analysis with probe encompassing region 1 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from brain, liver and SC. Bindings 
were specifically competed out using the same regions lOOx in excess as cold competitor 
(S). They were not competed out by unrelated cold oligonucleotide lOOx in excess (NS). 
Black arrows denote bindings specific for SC.
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Figure 2.6b
EMSA analysis with probe encompassing region 2 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from brain, liver and SC. Bindings 
were specifically competed out using the same regions 1 OOx in excess as cold competitor 
(S). They were not competed out by unrelated cold oligonucleotide lOOx in excess (NS). 
Black arrows denote bindings specific for SC, while arrowheads indicate bindings present 
both in SC and brain.
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Figure 2.6c
EMSA analysis with probe encompassing region 3 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from brain, liver and SC. Bindings 
were specifically competed out using the same regions lOOx in excess as cold competitor 
(S). They were not competed out by unrelated cold oligonucleotide lOOx in excess (NS). 
Black arrows denote bindings specific for SC, while arrowheads indicate bindings present 
both in SC and brain.
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Figure 2.6d
EMSA analysis with probe encompassing region 4 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from brain, liver and SC. Bindings 
were specifically competed out using the same regions 1 OOx in excess as cold competitor 
(S). They were not competed out by unrelated cold oligonucleotide lOOx in excess (NS). 
Black arrows denote bindings specific for SC, while arrowheads indicate bindings present 
both in SC and brain.
85
Results
Comp 
NE 0 rzL
S NS
( z £
S NS
Region 1
sc CG4
Figure 2.7a
EMSA analysis with probe encompassing region 1 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from SC and pure differentiated 
oligodendrocytes (CG4). The bindings were specifically competed out using the same 
region as a cold competitor lOOx in excess (S), while unrelated oligonucleotide (NS) used 
lOOx in excess is not able to compete out the binding. Black arrows denote bindings 
specifically present only in SC, while the arrowhead denote a binding present both in SC 
and CG4.
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Figure 2.7b
EMSA analysis with probe encompassing region 2 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from SC and pure differentiated 
oligodendrocytes (CG4). The bindings were specifically competed out using the same 
region as a cold competitor lOOx in excess (S), while unrelated oligonucleotide (NS) used 
lOOx in excess is not able to compete out the binding. Black arrows denote bindings 
specifically present only in SC, while arrowheads denote a binding present both in SC and 
CG4.
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Figure 2.7c
EMSA analysis with probe encompassing region 4 differentially protected in SC. Probe 
was tested with 0-4 pg of nuclear extracts prepared from SC and pure differentiated 
oligodendrocytes (CG4). The bindings were specifically competed out using the same 
region as a cold competitor lOOx in excess (S), while unrelated oligonucleotide (NS) used 
lOOx in excess is not able to compete out the binding. Black arrows denote bindings 
specifically present only in SC, while arrowheads denote a binding present both in SC and 
CG4.
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The use of specific antibody can help in the identification of proteins that form a 
binding complex in an EMSA assay. In fact if an antibody recognises a protein present in 
the complex, when added to the binding reaction, it changes the mobility of one or more of 
the retarded bands visualised in the acrylamide gel. To verify one prediction of the 
TransFac analysis for a protein relevant in myelination, we performed EMSA supershift 
analysis. We used an antibody able to recognise all PPAR isoforms (a, P, y). Using 
nuclear extracts prepared from SC we changed the mobility of a band in the complexes 
bound to region 3, in which we previously found the putative binding site for PPAR (Fig. 
2.8). As positive control, we used the Acyl-CoA oxidase promoter region that was 
previously shown to contain a PPAR responsive element binding site that can be 
supershifted by an antiserum directed against the same family of transcription factor 
(Forman e / <3/ . ,  1997).
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Figure 2.8
EMSA supershift analysis with probe encompassing region 3 differentially protected in SC. 
0-8|ig of nuclear extracts prepared from SC were used to bind a probe containing the 
putative binding site for PPAR family of transcription factor. The binding was specifically 
competed out using the same region as a cold competitor lOOx in excess (S), while 
unrelated oligonucleotide, used lOOx in excess (NS), is not able to compete it out. The use 
of an antibody able to recognize all PPAR isoforms (a,p/5,y) can specifically supershift a 
band in SC nuclear extracts (arrowhead). The black arrow indicates PPAR binding that is 
present also in liver. The same result is shown in liver nuclear extract using a probe 
designed to the single Peroxisome Proliferator Response Element (PPRE) of the Acyl-CoA 
oxidase.
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To test whether the differentially protected regions identified in SC have a 
functional role in regulating SCE activity, we specifically mutated them by transversion in 
the context of the 9.0Kb promoter. In particular we transverted region 1 (lOnt), 2 (16nt) 
and 3 (9nt). We did not transvert region 4 (Krox-20) because it was already shown that it is 
neither sufficient nor necessary to direct the expression of the reporter gene in SC. We 
mutagenised each region by PCR using appropriately designed oligonucleotides. Each 
mutation was confirmed by sequence analysis and re-cloned in the native context of the 
9.0Kb construct. We transiently transfected these mutated constructs together with 9.0Kb 
and 8.4Kb constructs in primary cultures of OL and SC. We compared the luciferase 
activity of these mutations relative to the 9.0Kb as 100%. Transient transfection analyses 
in primary OL revealed that transversion of region 1 reduced the activity by approximately 
60% and mutation in region 2 by approximately 50%. On the contrary, mutation in region 
3, which contains the PPAR binding site, had no effect (Fig. 2.9a). Transient tranfections 
of these plasmids in primary SC revealed that mutation of region 1 reduced luciferase 
activity by approximately 40% whereas mutation of region 2, as in OL, reduced the activity 
by approximately 50%. Surprisingly mutation in the consensus-binding site for PPAR did 
not have any effect (Fig. 2.9b).
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Figure 2.9a
Transient transfection analysis in primary OL of plasmids containing mutations in three 
regions differentially protected in SCE. The final activity is relative to 9.0Kb = 100. 
Mutations in regions 1 and 2 reduce the activity by approximately 50%, while mutation in 
region 3, containing the PPAR binding site, had no significant effect. Bars represent the 
mean luciferase activity ± S.E.M. of at least three independent experiments.
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Figure 2.9b
Transient transfection analysis in primary SC of plasmids containing mutations in three 
regions differentially protected in SCE. The final activity is relative to 9.0Kb = 100. 
Mutations in regions 1 and 2 reduce the activity by approximately 50%, while mutation in 
region 3, containing the PPAR binding site, had no significant effect. Bars represent the 
mean luciferase activity + S.E.M. of at least three independent experiments.
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To further dissect the SCE region responsible for the enhancer activity, we created a 
series of internal lOObp deletions and we transiently transfected them into primary cultures 
of OL and SC. This strategy had two advantages over the previous analysis: first it was 
random and made no assumptions about the specificity of nuclear extract binding, and 
second it increased the probability that cooperative cis-acting elements would be removed 
together. We generated these deletions using unique single restriction enzymes sites 
present in the MBP enhancer or, when this strategy was not possible, we created them 
through standard PCR technique using appropriately designed oligonucleotides. We named 
these deletions Aa, Ab, Ac, Ad, Ae, Af (Fig. 2.10a). In particular:
Aa comprises deletion of the first 103nt, starting from SacII site to BstEII site;
Ab comprises deletion from 103 to 204, starting from BstEII site to StuI site;
Ac comprises deletion from 204 to 290, starting from StuI site to Bglll site;
Ad comprises deletion from 290 to 400, and it was generated by PCR;
Ae comprises deletion from 400 to 519, and it was generated by PCR;
Af comprises deletion from 519 to 588, starting from Nael site to Sad site.
Both Ad and Ae were confirmed by sequence analysis. Once generated all constructs were 
transiently transfected into primary cultures of OL and SC and they were analysed relative 
to 9.0Kb and 8.4Kb constructs. Both in OL (Fig. 2.10b) and in SC (Fig. 2.10c) we found 
that most deletions showed a trend toward reducing activity of luciferase but the results 
were not statistically significant. The only region that seems to be clearly relevant from 
this analysis is Ae whose deletion reduces the activity of the reporter gene approximately 
65% in SC and 80% in OL. Consistent with the observation that this region is relevant both 
for SC and OL, previous biochemical analysis showed that it is not differentially protected 
in EMSA analysis of these two cell types.
All together, the data of site-direct mutants and random mutants in SCE suggest that 
activation depends on multiple sites and that activation in these cell culture models is too 
low to clearly identify specific cis-acting elements.
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Figure 2.10a
Schematic representation of SCE internal deletions. Deletions were generated using unique 
restriction enzyme sites or standard PCR technique using speeific oligonuclotides.
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Figure 2.10b
Transient transfection analysis in primary OL of plasmids containing SCE internal 
deletions. The final activity is relative to 9.0Kb = 100. Ae deletion that removes from 
400nt to 519nt, reduces the activity by approximately 60%. Bars represent the mean 
luciferase activity ± S.E.M. of at least three independent experiments.
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Figure 2.10c
Transient transfection analysis in primary SC of plasmids containing SCE internal 
deletions. The final activity is relative to 9.0Kb = 100. Ae deletion that removes from 
400nt to 519nt, reduces the activity by approximately 60%. Bars represent the mean 
luciferase activity ± S.E.M. of at least three independent experiments.
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2.2 ANALYSIS OF SCE IN STABLY TRANSFECTED SC
Transient transfection experiments in primary SC showed that SCE behaves as an 
enhancer not only in transgenic mice but also in vitro. Thus SCE could specifically direct 
the activity of a reporter gene in an orientation and distance independent way and 
transactivate a heterologous promoter as well as myelin promoters. However the amplitude 
of activation is not as high as would be expected based on transgenic mice. Forghani and 
colleagues showed, in multiple independent lines, that SCE activated robust lacZ  
expression above an undetectable background in the absence of SCE. In our experience 
(Taveggia and colleagues, 1998), with other lacZ transgenes in the nervous system, such a 
change in staining represents at least 100-fold induction. Instead the largest activation we 
revealed in SC cultured was 3-fold. Given that the cis-acting sequences utilized in 
transgenic mice and transfected SC are identical, we are probably lacking some element 
acting in trans on SCE. The first possibility is that this reduced activation is due to the 
episomic state of the plasmid. Chromatin can actively regulate the expression of a 
promoter-reporter construct and therefore the episomic state may not exactly recapitulate 
the regulation pattern. This was previously confirmed also for another myelin gene, the 
PLP gene (Nave and Lemke, 1991).
To investigate the role of chromatin in regulating SCE we produced stably 
transfected SC. In particular we created stable transfectants for 9.0Kb, 8.4Kb, 3.1Kb and 
the promoterless construct pXPl. To select stably transfected SC each plasmid was co­
transfected with pMAMneo plasmid containing the neo gene for positive selection. To 
average insertions near unrelated transcriptional regulatory sequences that could alter SCE 
activity, each plasmid was transfected into six different plates. After selection, we obtained 
a range of 10 to 20 clones per plate. The clones obtained in each plate were together 
pooled by passage, resulting in 4-6 independent pools of cells for each construct, each 
likely representing a different insertion site (see Table 1 and Fig. 2.11).
To confirm the polyclonal nature of the pools, and to normalise the luciferase 
activity determined by the biochemical assay, we performed Southern blot analysis on 
genomic DNA prepared from each single pool. We digested DNA with Xbal restriction
98
Results
enzyme that produces a fragment of approximately 1.6Kb overlapping the luciferase gene. 
As probe we used a DNA fragment contained in the luciferase gene. This strategy allowed 
us to detect luciferase copy number as well as 3’ junction fragments representing 
independent insertions. Fig. 2.11 shows that clones contained multiple insertions.
s c  pool #2 #8 #13
[iîi
Figure 2.11
Southern blot analysis on SC pools #2 (pXPl), #8 (8.4Kb) and #13 (pXPl) obtained after 
G418 selection. Genomic DNA was digested with Xbal restriction enzyme. The probe 
used was the Xbal/BsrGI DNA fragment contained in the luciferase gene that allows also 
the recognition of 3’ junction fragments. The arrow denotes the 1.6Kb fragment of the 
luciferase gene; whereas arrowheads indicate multiple integration sites.
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In order to normalise the luciferase activity of the pools as measured by biochemical 
assay, we quantitated copy number by performing densitometry of total luciferase signal. 
We expressed this quantity relative to the signal obtained re-probing the Southern for a 
single copy autosomal gene, the PO gene, using the BamHI/Hindlll fragment overlapping 
PO exon 1. The copy number obtained by this analysis for various pools of each construct 
is represented in Table 1.
TABLE 1
COPY NUMBER Hue signal/PO signal x 21
Pool number 
Plasmid
#1 #2 #3 #13 #14 #15
pXPl 11.6 11.4 2.4 11.6 2.6
#4 #6 #17 #18
3.1Kb 9.8 20 14 12.6
#8 #9 #19 #20
8.4Kb 53 12.2 13.6 4.4
#10 #11 #22 #23 #24
9.0Kb 2 K6 2.8 2 6
Table 1
Quantitation of copy number of the integrated luciferase gene after stable transfection in 
SC. The total luciferase signal, determined by densitometric analysis, is expressed relative 
to the signal obtained re-probing the same Southern blot, with a BamHl/Hindlll fragment 
recognising the single autosomal PO gene.
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By doing this analysis we observed that the 9.0Kb construct increased the activity 
by approximately 30-fold, while the 8.4Kb was increased 5-fold compared to the 
promoterless construct (statistical analysis: p=0.005). Thus the 9.0Kb activation was 
increased at least 6-fold above 8.4Kb. This represents a doubling of the increase seen by 
9.0Kb over 8.4Kb in transient transfection analyses. This represents an activation of the 
9.0Kb construct, and not repression of the other constructs, as the 8.4Kb was activated 5- 
fold above pXPl in both transient and stably transfected SC. On the contrary, the 3.1Kb 
construct activity was paradoxically increased in both transient and stably transfected SC, 
even if the overall activation of 3.1Kb in the stably transfected was reduced (compare Fig. 
2.3b with Fig. 2.12). This result suggests that a chromatin context activates SCE, but it is 
still not sufficient to explain the absence of two orders of magnitude activation seen in 
transgenic mice.
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Figure 2.12
Luciferase activity of primary SC stably transfected with 9.0KB, the 8.4Kb, the 3.1Kb 
constructs and the promoterless pXPl. Fold activation is relative to the promoterless 
construct pXPl = 1. Note that the 9.0Kb construct increases the activity approximately 30- 
fold above pXPl, whereas the 8.4Kb construct has the same activity observed in transient 
transfection analysis (p=0.005).
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2.3 AXONAL INFLUENCE ON SCE MEDIATED-ACTIVITY
Another element that is well known to induce myelin gene expression is the axon. 
Axons upregulate MBP (or myelin gene) expression as suggested by analyses of transected 
nerves both in CNS and in PNS; 3-4 fold in optic nerve (Wrabetz et a l, 1998; Kidd et a l, 
1990; McPhilemy et a l, 1990; Scherer et a l, 1992) and at least two orders of magnitude 
(PO) in sciatic nerve (Scherer et a l, 1994a).
To specifically test the effect of axons on the regulation of SCE, we set up a co­
culture system in which previously characterised pools of stably transfected SC were put in 
contaet with purified DRG neurons. We chose pools of SC that were in the middle range of 
copy number and luciferase activity near the mean value for that plasmid (see Table 1 and 
Fig. 2.12). In particular we chose pool # 24 for the 9.0Kb, pool #19 for the 8.4Kb, and pool 
#14 for the promoterless construct pXPl. The co-culture model is a well-developed and 
useful system through which it is possible to obtain myelination in vitro in a synchronised 
way. We prepared DRG neurons fi*om rat at embryonic day 15.5 (E l5.5), and we allowed 
them grow in the presence of nerve growth factor (NGF). Through addition of antimitotic 
agents, we reduced the number of fibroblasts and satellite cells present after purification. 
When the neurites reached an extensive expansion in the culture, either wild type or stably 
transfected SC were added back in order to repopulate the neurites. Addition of ascorbic 
acid stimulated SC to organise a basal lamina and initiate myelinogenesis.
To control for the capacity of our stably transfected SC to properly respond to 
axonal signals, we measured their ability to form compact myelin; myelinogenesis is in fact 
strictly axonally-dependent. Ultrastructural analyses performed on these SC-neuronal co­
cultures showed that stably transfected SC for each construct myelinate as well as wild type 
SC. We checked myelin compaction after 17 days of ascorbic acid treatment, when many 
neurites are myelinated and we found that cells from each pool can form compact myelin 
(Fig. 2.13).
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Figure 2.13
Ultrastructural analysis of SC-neuron co-cultures. In (A) and (B), neurites were re­
populated with wild type SC. In (C) and (D) neurites were re-populated with SC stably 
transfected with 9.0Kb construct. In (E) and (F) neurites were re-populated with SC stably 
transfected with 8.4Kb construct. At high magnification (B), (D) and (F), myelin 
periodicity of compact fibers is normal both in wt, SC9.0MBP and 8.4MBP. Bars: (A) = 
1pm; (B) and (D) = 0.140pm; (C) and (E) = 0.583pm and (F) = 0.116pm.
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Normally, in co-culture experiments, SC are added back and allowed to re-populate 
the culture one week before the addition of ascorbic acid. During this period SC proliferate 
and sort axons in order to achieve a one to one relationship with them (Salzer and Bunge, 
1980). In principal the activation of MBP promoter could be obtained by the simple 
contact of SC with neurites, without induction of myelination. The quantitative analysis of 
luciferase allowed us to distinguish between the requirement of SC-neurites contact or the 
necessity of the myelination process, because they occur in two distinct phases of the 
culture. To test this possibility we measured luciferase activity in 9.0Kb co-cultures, after 
SC seeding on neurites, and precisely 3 days before the addition of ascorbic acid (-d3). We 
found that axons, per se, are not sufficient to upregulate luciferase expression in this 
situation (Table 2). As a control we checked luciferase activity of the same SC seeded 
without neurons and we found that it is not significantly different from the one measured at 
-d3 (data not shown). Based on this set of experiments we conclude that the simple axonal 
contact, per se, is not sufficient to induce the expression of the MBP gene.
For this reason we induced the myelination process through ascorbic acid addition, 
and we tested luciferase activity of pools of stably transfected SC by biochemical assay. In 
particular we checked these time points: day 0 (dO), the day in which we induced 
myelination, after four days (d4), after 8 days (d8), after 12 days (dl2) and after 15 days 
(dl5). We monitored luciferase expression during the myelination process in all three 
types of stably transfected SC. We checked, at each time point, the activity of SC bearing 
the 9.0Kb construct and the pXPl plasmid, as negative control. SC with the 8.4Kb 
construct were checked at dO and after 15days of ascorbic acid treatment, when the 
myelination process is well extended, as evidenced by the number of MBP positive fibers 
(Fig. 2.14a). All results, expressed as a ratio between luciferase activity and amount of 
protein used, are summarised in Table 2. The measurements represent 2-5 independent co­
culture experiments for most points. All values are expressed as the percentage of the peak 
value for 9.0MBP. We observed a small increase in luciferase activity in the 9.0Kb 
cultures, between dO and d4, but only after d8 we saw an increase of approximately 3 fold, 
that remained stable until dl5. Surprisingly the overall activation we observed in this 
system, measured with the biochemical assay, was not as strong as expected. On the
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contrary luciferase activity in the pXPl stable transfectants remained near background 
during all periods of myelination (Table 2).
TABLE 2
Luciferase specific activitv (9.0MBP max activitv=l001
-d3 do d4 d8 dl2 dl5 8 days post cut at
d6
SC9.0MBP 17+2 31+7.5 50 100 100 100 37
SC8.4MBP 24+1.5 15 27+0.5
SCpXPl 3±1 2±1.5 1±0.4 2±1.1
Table 2
Luciferase activity of SC-neuron co-cultures at various time points before and after 
ascorbic acid addition. Neurites were re-populated with SC stably transfected with 
9.0MBP, 8.4MBP, pXPl constructs. Fold activation is measured as a ratio between 
luciferase value and amount of protein used in the assay. The final activity is relative to the 
9.0MBP maximal activity detected as 100. Note the progressive increase in luciferase 
activity during myelinogenesis only in the 9.0MBP SC. In contrast luciferase activity 
measured on SC 9.0MBP 8 days after in vitro cut has an activity similar to dO.
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One possible explanation for limited overall upregulation of luciferase in the 9.0Kb 
SC is activation in only some SC. To determine which SC activated luciferase, we 
performed immunofluorescence analyses on co-eultures containing 9.0Kb SC. We made a 
double staining using a polyclonal antibody against luciferase and a mouse monoclonal 
antibody against MBP, as a marker of myelination. We also used DAPI to visualise SC 
nuclei (Fig. 2.14a). We repeated these analyses several times on different sets of 
preparations, at the same time points used in the biochemical assay. Interestingly we 
observed at d8 an upregulation in luciferase aetivity but only in a restricted number of 9.0 
SC (Fig. 2.14b). This is not due to a defect in the sensitivity of the antibody, since in the 
same field we could recognise a faint staining due to basal luciferase expression in almost 
all of the stably transfected SC. Interestingly we found strong luciferase upregulation only 
in SC that are in contact with axons, as judged by DAPI stained nuclear shape, which is 
cigar-shaped (Eldridge et a l, 1987). A proportion of the SC with strong upregulation have 
already formed myelin, as indicated by the positive MBP staining in these fibers (Fig. 
2.14b). Based on the immunofluorescence data it is possible to say that the major 
contribution to luciferase activity is coming only from a very reduced number of SC, some 
of which have formed myelin.
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Figure 2.14a
Double immunohistochemical analysis on 9.0MBP SC-neuron co-cultures. The 
culture was treated for 15 days with ascorbic acid. Cells were fixed and stained 
for MBP (red), luciferase (green) and DAPI to visualize Schwann cell nuclei.
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Figure 2.14b
Double immunohistochemical analysis on 9.0MBP SC-neuron co-cultures. The 
culture was treated for 8 days with ascorbic acid. Cells were fixed and stained for 
luciferase (A), DAPI (B) and MBP (C). (D) shows an overlapping of the other 
images. Note the perfect match between the only intemode evidenced by MBP 
staining and the SC upregulating luciferase. In panel (B) is easily recognisable a 
SC that upregulates luciferase but it is not expressing MBP.
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In order to estimate peak enhancer activation (dl2-dl5) we counted, by DAPI 
staining, the number of SC that are in contact with neurites. We also measured how many 
of these SC are myelinated, by counting the number of intemodes revealed by the MBP 
staining. First, we noted that more than 80% of SC are in contact with axons. We assumed 
that in this system, the total measured luciferase value, recovered with the biochemical 
assay, derives from two populations of SC. The first population is estimated by the 
percentage of SC in contact with axons but with no myelin (87.5%). Their activity is the 
basal one measured at dO. The other population is estimated by the percentage of SC in 
contact with axons and with myelin (12.5%). Their activity is unknown but significantly 
higher based on immunofluorescence staining (Fig. 2.14a). The weighted calculation to 
estimate the dilution of luciferase activity by low expressing SC is as follows:
lue value=(% cells w/o myelin) (lue activity dO)+(% cells with myelin) (X activity) 
e.g. 1107 = (0.875) (349.5) + (0.125) (X) or X=6410 or about 20-fold induced.
Based on this approximate calculation, we found that cells with luciferase 
upregulation increase the activity approximately 20-fold relative to dO. Because initially, in 
stable transfectants, the 9.0Kb construct has an activity 6-fold increased in respect to the 
8.4Kb construct, we can deduce that the real activation of the 9.0Kb construct in the co­
culture experiments, is approximately 6x20=120 or about two orders of magnitude relative 
to constructs without SCE without axons.
The approximation we made to estimate the increase in luciferase activity in this 
system, is under-estimating the real induction mediated by SCE. In fact we measured the 
activation as the ratio between the luciferase value and protein concentration. One major 
factor that can influence this calculation is the change in protein concentration due to 
neurons and SC. We estimated the contribution given by SC to luciferase specific activity 
by counting SC nuclei and the change in protein concentration during all the process of 
myelin induction. We also controlled for the contribution in protein concentration given by 
neurons. We maintained, in the same set of experiments, DRG neurons in the absence of 
SC and we checked protein concentration at dO and at dl5. We found that while the
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contribution of neurons remains almost the same between dO and dl5 (40% of total 
proteins), SC increased both in number and protein concentration (data not shown). Thus 
the specific activity we measured could be diluted.
To examine whether axons are necessary to maintain the induction of SCE activity, 
we cut projecting axons near their cell bodies, using a sterile scalpel (Fig. 2.15). We 
performed the cut 6 days after ascorbic acid treatment, when the process of myelination has 
already begun and luciferase is already induced, and we analysed luciferase activity 8 days 
after cut (Table 2), when we usually observe the maximal luciferase activity. We found 
that luciferase activity fell from the level of d6 to the level of dO, before myelination 
induction. This result strongly suggest that both induction and maintenance of SCE are 
axonally-dependent.
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Figure 2.15
Contrast phase images (A) and (C) of neurons SC9.0MBP co-cultures. (B) and (D) shows 
the same fields stained with DAPI to visualise nuclei of SC and neurons (*). In (A) and (B) 
cells were cut by scalpel, near the neuronal cell bodies as indicated by black arrows. Note 
the complete loss of neurites. (C) and (D) show control cultures in which neurites were not 
cut.
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To determine where the sequence targets of axonal signals reside, we performed co­
cultures experiments also with SC stably transfected with the 8.4Kb construct. It is in fact 
possible that not only SCE is the target for axonal signals, but also the proximal MBP 
promoter which is well known to be very important in directing MBP transcription 
(Wrabetz et a/. 1998). We measured luciferase activity and we found that the 8.4Kb SC in 
the co-culture system never activated luciferase after addition of ascorbic acid (Table 2). 
The fact that the 8.4Kb construct is never upregulated strongly suggests that SCE contains 
DNA sequences that are responsive to inductive signal coming from the axons. This 
observation was qualitatively confirmed also by immunofluorescence (Fig. 2.16). In fact 
luciferase staining on the 8.4MBP cultures do not reveal any SC with a bright staining.
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Figure 2.16
Double immunohistochemical analysis on 8.4MBP SC-neuron co-cultures. The 
culture was treated for 14 days with ascorbic acid. Cells were fixed and stained 
for, luciferase (A), DAPI (B) and MBP (C); In (D) the three images were 
overlapped. Note that there is no bright luciferase staining in any SC (A), 
whereas many fibers had already myelinated.
114
Results
From these culture experiments we can conclude that axons are fundamental to 
recapitulate the activation observed in transgenic mice. Moreover we found that SCE is a 
target of axonal signals that induce MBP expression. This activation, acting on these 
588nt, is in fact present only in the 9.0Kb stably transfected SC and not in SC 8.4MBP as 
revealed by biochemical assays and in vitro cut experiments.
Our analyses, both in transient and stable tranfectants, and even more with the co­
culture system, describe a valid model in which it is possible to investigate the mechanism 
of MBP transcriptional regulation, as well as the axonal signals responsible for this 
regulation.
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Chapter 3
DISCUSSION
MBP TRANSCRIPTION IN  VIVO
Many groups have investigated the transcriptional regulation of myelin genes 
and in particular of the MBP gene. The approaches used in these analyses involved 
both classical in vitro studies as well as in vivo analyses of transgenic mice. 
Unfortunately due to the difficulty of setting up an in vitro system that can recapitulate 
the complex and precise mechanisms of MBP regulation, not information has come 
from the analyses of transgenic mice (Forghani et al., 2001; Foran and Peterson, 1992; 
Goujet-Zalc et al., 1993; Goverman et a l, 1993; Gow et al., 1992; Hayes et a l, 1992; 
Jensen et al., 1993; Katsuki et al., 1988; Kimura et al., 1989; Miskimins et al., 1992; 
Readhead et al., 1987; Zingemakel et a l, 1990). One of the major advantages of 
performing these studies in transgenic mice is that the regulation of the transgene is 
influenced by the same environmental factors that normally control the expression of 
the endogenous gene. In particular we showed in transgenic mice that axons are 
fundamental in regulating MBP transcription (Wrabetz et a l, 1998). The same studies 
performed in transgenic mice also showed that SC and OL use different transcription 
mechanisms.
ADVANTAGES OF AN IN VITRO SYSTEM TO STUDY MBP REGULATION
Analyses in transgenic mice primarily allow the identification of cis-acting 
sequences and not of trans-acting factors. Moreover these studies can not be easily 
manipulated in order to obtain a dissection of transcription mechanisms. To completely 
understand the mechanisms of transcriptional regulation of a gene, more simplified 
systems are required, like cell culture systems. The choice of the correct cell system in 
which to analyse the expression of a gene is particularly relevant in the case of MBP. In
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fact previous in vitro studies were performed in cells that do not transcribe MBP and 
produced inconsistent results (reviewed in Wrabetz et a l, 1993 and in Taveggia et a l, 
199%^
To identify the elements that can account for the differential MBP regulation in 
the CNS and PNS, we took advantage of the in vivo analyses done in transgenic mice 
and we tested, both by functional and biochemical analyses, the same constructs 
previously used to generate transgenic mice. We showed not only that in primary OL 
and SC culture do they recapitulate the pattern of expression observed in transgenic 
mice, but we also identified binding sites that could account for the differential 
regulation in CNS and in PNS.
However our system does not fully recapitulate the expression of the MBP gene, 
in particular in SC. In fact in our transient transfection studies we observed an 
activation between 3.1Kb and the start site of transcription that is not present in 
transgenic mice (Forghani et a l, 2001). It is possible that between 6.0Kb and 3.1Kb of 
the MBP promoter there is a silencer whose activity is recognised only in much more 
physiological conditions, such as transgenic mice. In transgenic mice DNA sequences 
are in fact integrated into the genome and moreover they are influenced by the same 
axonal signals that normally control myelin gene expression. The fact that in stably 
transfected SC, the 3.1Kb construct maintains a strong activity even if  it is reduced, 
when compared to transient transfection analysis, strongly argue that chromatin is not 
sufficient and axons are important not only to modulate SCE amplitude (see below), but 
they also actively regulate MBP promoter (compare Fig. 2.3b and Fig. 2.11).
SCE CHARACTERISTICS
Our transient transfection studies showed that 9.0Kb of the MBP promoter are 
specifically active only in primary cultures of OL and SC, confirming the cell-specific 
activation of this promoter in our cell model. Moreover we found two regions relevant 
for luciferase expression: a distal sequence, between 9.0Kb and 8.4Kb both in SC and in 
OL, and the proximal MBP promoter in OL. The importance of the proximal MBP 
promoter in directing the expression of the gene is well known also from previous 
studies (Wrabetz et a l, 1993; Taveggia et a l, 1998; Haas et a l,  1993; Haas et a l, 
1995). In our functional studies we also showed that the region between 9.0Kb and
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8.4Kb is an enhancer only in SC, further confirming that the mechanisms of 
transcriptional regulation differ between SC and OL (see below).
In order to identify both cis-acting sequences and trans-acting factors 
responsible for this differential activation, we followed two parallel approaches. We 
used both biochemical and functional analysis of transversion mutations and random 
internal deletions. The results obtained with these two approaches are not concordant, 
strongly suggesting that there is a combinatorial effect mediated by many transcription
A
factors that can bind at different regions of SCE.
Since SCE behaves differently in SC and OL we made the assumption that 
specific differential binding could explain this. In fact, the biochemical analyses 
showed that there is a different set of interactions in SCE by SC as compared to OL 
nuclear extracts. In particular, we found 4 regions that are protected only in SC nuclear 
extracts, but not in brain or liver. However we could not rule out that other protected 
regions are important in regulating SCE. Particularly interesting are those regions 
protected both in SC and in brain. It is in fact possible that SC and OL contain the same 
set of transcription factors, but their different activity is mediated by the presence of a 
different subset of co-factors, in SC and OL, that differentially regulates the 
transcription of the MBP gene in these two glial cell types.
To explore the cellular origin of the differential bindings in SC as compared to 
OL, it would be useful to perform DNase I footprinting analyses using nuclear extracts 
prepared from OL and not from whole brain. In fact brains contain a mixture of cells 
and OL represent only a small part of them. One possibility would be to use nuclear 
extracts prepared from CG4 cells. These cells constitute a population of OL that can be 
differentiated in vitro by the addition of conditioned medium prepared from B104 
neuroblastoma cell line (Louis et a l, 1992). However DNase I footprinting experiments 
require a large amount of nuclear extract and the quantity we obtained from 
differentiated CG4 was insufficient. Due to these technical limitations, we used CG4 
nuclear extracts in EMSA analyses to verify the differential bindings, observed between 
SC and brain and we found that they are different in 3 out of 4 regions previously 
identified.
Specific mutations of these sites in the functional analyses were not able to 
assign a cell-specific role to any of these regions. In fact we found some effect in
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different regions and, moreover, those regions had a more pronounced effect in OL and 
not in SC as expected (see Fig. 2.9a and Fig. 2.9b). From these functional experiments 
we can conclude that multiple regions are necessary for SCE activity. This is not 
surprising in fact; many enhancers require combinatorial interactions among distinct 
regulatory elements. The activity of the intact enhancer is distinct from that of 
individual elements. This was shown for the virus inducible enhancer of the human 
interferon P gene, in which none of the overlapping regulatory elements found can 
function on its own, but only a combinatorial effect of them can give a complete 
functionality (Du et a l, 1993).
The discrepancy between these functional studies and our biochemical analyses 
is emphasized also by transversion of PPAR binding site which has no effect in either 
primary SC or OL. From previous studies we expected that not only PPAR, but also 
Krox-20, whose consensus binding site is present in region 4, would play a role in OL 
and SC respectively (Grannemann et a l, 1998; Topilko et a l, 1994). Our results argue 
against a possible role for PPAR on SCE in inducing MBP transcription. It is still 
possible that the low amplitude we observe is not sufficient to assign an effective role to 
this mutation. Also in vivo, in transgenic mice, A. Peterson and colleagues (2001) 
mutated the consensus-binding site for the Krox-20 transcription factor, but this did not 
abolish the activity of the reporter gene (see below).
Since binding by nuclear extracts did not predict regions that mediate cell- 
specific effects, we also tried to dissect SCE by random internal deletions. But even in 
this case we were not able to assign to a specific region inside SCE a fundamental role 
in directing the expression of MBP. In fact the results we obtained were not in 
agreement with those of the biochemical assays. The maximum reduction we observed 
lies in a region that does not contain any protected element identified by previous 
biochemical assays. Moreover this effect is stronger in primary OL and not in SC. A ll. 
these results strongly suggest that the enhancer activity of SCE represents a 
combinatorial mechanism mediated by several transcription factors.
One of the major problems we had in our cell culture system, was the defect in 
the overall amplitude. In general the activation observed in our in vitro system is not as 
high as the one observed in transgenic mice and this could obscure our ability to 
recognise cell-specific activation by sub-regions. An explanation for this difference
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could lie in the fact that SC we currently used in our cell culture have the characteristics 
of pre-myelinating SC, and the addition of forskolin, an analogue of cAMP that is 
thought to partially mimic axonal signals (Lemke and Chao, 1988), can upregulate the 
expression of MBP only 2-3 fold above background. This strongly implies that some 
elements, that are fundamental to enhance transcription of not only MBP but also other 
myelin genes, may not be activated.
A
REGULATION IN  TRANS OF SCE
To overcome this lack in amplitude we studied the effect of two external cues 
that are present in transgenic mice but not in transiently transfected plasmids in SC: the 
chromatin context and more importantly, the absence of axons. The analyses of our 
primary SC stable transfectants revealed that even for MBP, chromatin plays an 
important role on SCE induction. In fact, when integrated in the genome, SCE 
increases activation up to 6-fold. A comparison of the activation of deletion constructs, 
8.4Kb and 3.1Kb, relative to the promoterless pXPl control, in stable versus transient 
transfection, shows that this 6-fold activation depends on SCE, not effective repression 
of cis-acting elements proximal to SCE. The importance of chromatin in controlling 
transcription of genes is underlined by many studies. It is in fact becoming clear that 
chromatin is a dynamic and active structure in regulating transcription (Lemon and 
Tjian, 2000). Distinct mechanisms are involved in modulating chromatin: some of them 
function as motors to disrupt nucleosomes or as enzymatic machinery to chemically 
modify histones thereby facilitating promoter accessibility (Kwok et al., 1994; Yang W- 
M et al., 1996; Utley et a l, 1998).
AXONAL REGULATION OF SCE AS DETERMINED IN  MYELINATING CO­
CULTURES
More interestingly we found that axons are fundamental for induction of the 
expression of the MBP promoter. In fact when co-cultured with DRG neurites, our 
stably transfected SC can increase the activity 2 order of magnitudes above that induced 
by the presence of forskolin. Axons are well known to be necessary to produce robust 
transcription of myelin genes, including MBP, in both the CNS and PNS. MBP 
expression is regulated by axons during development and after axonal injury (Kidd et
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a l, 1990; McPhylemy et a l, 1990; Scherer et a l, 1992). This is particularly relevant in 
the case of the proximal MBP promoter (Wrabetz et a l, 1998). In the CNS, OPC 
prepared from transgenic mice bearing 256nt of the proximal MBP promoter fused to 
lacZ and cultured in vitro do not express P-galactosidase while they can normally 
differentiate. On the contrary, if co-cultured with neurons, they can activate the lacZ 
expression (Lubetzki et a l, 1993).
The DRG neuron-SC co-culture is a well established system in which 
myelination can be induced by the addition of ascorbic acid in the presence of serum 
(Wood et a l, 1990). This system has many advantages if  compared to studies 
performed in vivo in transgenic mice. In fact a precise analysis of how myelin genes 
are induced during myelination in the early phases of post-natal nerve development is 
particularly difficult because SC are not synchronized. Thus, some SC are still sorting 
axons and achieving proper relationships with axons, while others have already 
produced compact myelin. In contrast, in these co-cultures, we can induce myelination 
relatively synchronously and therefore precisely monitor how luciferase activation 
occurs both before and during myelination. Moreover, by using this method we were 
also able to discriminate between the necessity of simple axonal contact or the 
requirement of induction of myelination to achieve luciferase activation.
A second advantage of co-cultures using permanently transfected SC with 
luciferase constructs is axotomy. Until now in fact all the studies performed to 
understand the influence of axons on myelin genes were performed in vivo, in mice. 
However the stability of the lacZ reporter gene normally used in transgenic mice is too 
elevated in order to precisely correlate the decay after axonal injury with the decay in 
the activity of promoters. On the contrary luciferase is characterised by a rapid 
degradation of the protein, in fact it has a very rapid half-life that in mammalian cells is 
approximately of 3 hours (Thompson et a l, 1991), allowing us to analyse the effect on 
its activity after axotomy.
Thus, we were able to perform in vitro axotomy on 9.0Kb co-cultures, as in 
transgenic mice, showing that luciferase induction in this system is strictly controlled by 
the presence of the axon and confirming that 9.0Kb of the MBP promoter are axonally 
modulated. Axonal regulation of this region of the promoter is particularly important 
because many transcription factors involved in the myelination process were shown to
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be axonally regulated. In particular Krox-20, after in vivo transection in adult mice, is 
downregulated strongly suggesting that it is positively regulated by signals coming from 
the axons (Topilko et ah, 1994). Even Oct-6 nerve crush and transection experiments 
showed that it is axonally regulated (Scherer et al. 1994b). To confirm in vivo the 
axonal regulation of SCE it will be interesting to perform crush and cut experiments on 
transgenic mice bearing the hsp68 promoter driven by SCE. Preliminary cut 
experiments performed in adult transgenic mice containing the 9.0Kb construct showed 
that lacZ is downregulated, but it is not reactivated during re-myelination (A. Peterson, 
unpublished result). This loss of reactivation can be due to a mosaicism effect of the 
transgene. Further experiments need to be done in order to investigate whether only 
SCE and not the proximal MBP promoter is axonally regulated also in vivo, as 
suggested by our in vitro results.
Finally, we found that SCE is the target of luciferase activation. In fact stably 
transfected SC containing the 8.4Kb construct do not activate the reporter gene in this 
co-culture system as revealed by both the biochemical assay and immunofluorescence 
analyses. This is not the only enhancer specific for SC and dependent on axons. 
Recently Mandemakers and colleagues localised a SC enhancer 12Kb downstream of 
the Oct-6 transcription initiation site (Mandemakers et a l, 2000). This enhancer, which 
is axonally regulated, can drive Oct-6 expression that rescues the peripheral nerve 
phenotype observed in Oct-6 null mice, and specifically directs the heterologous hsp68 
promoter in peripheral nerve. To see whether these two DNA sequences have common 
cis-acting elements, we compared their sequences, but we were not able to find any 
similarities at the level of sequence.
Re-evaluation of the cis-acting sequences identified by footprinting and EMSA 
analyses is particularly interesting, because we expect that some are axonally controlled 
and the co-culture system constitutes a good model in which evaluate their function. 
We can not exclude that some of the transcription factors identified in this region, but 
previously discarded by transient transfection analysis, could be important to mediate 
SCE activity. In particular the signal scan analysis on the MBP enhancer revealed a 
consensus-binding site for Krox-20 in region 4. We confirmed by supershift analysis 
the binding of Krox-20 in this region (data not shown). The role played by this 
transcription factor was explored in vivo in transgenic mice. Peterson and colleagues
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showed that it is neither necessary nor sufficient for qualitative activation (Forghani et 
a l, 2001). However they never performed a quantitative analyses of lacZ activity on 
these mice, and we can not exclude the possibility that this transcription factor can 
partially induce SCE. To more fully explore the role of Krox-20, it will be interesting 
to perform a quantitative analyses on these transgenic mice, as we did for the proximal 
MBP promoter (Wrabetz et a l, 1998) or to analyse the effect of mutation in this specific 
site on luciferase expression in our co-culture system; in both cases axonal signals 
activate SCE.
SCE ACTIVATION MOST CLOSELY PARALLELS MYELINOGENESIS
In our analyses we found that to obtain an upregulation in luciferase activity we 
have to induce myelination. Simple contact with axons before addition of ascorbic acid 
was insufficient to increase luciferase activity. Another confirmation of the correlation 
between luciferase expression and myelination process came from the parallel increase 
in luciferase protein, detected with the biochemical assay, and the increasing in number 
of MBP fibers positive by immunofluorescence analyses. These results parallel 
previous analyses performed in this culture system on myelin gene expression. The first 
myelin segments observed in this system by immunofluorescence and positive for 
MAG, appear 3-4 days after ascorbic acid addition (Owens and Bunge 1989), but after 8 
days myelin sheaths are considerably longer and complete, and they stain positive for 
MBP used as a marker of compact myelin (Zanazzi et a l, 2001). MAG is the first 
myelin protein accumulated also in vivo, while MBP is revealed only after the myelin 
sheath contains several turns (Hahn et a l, 1987).
QUANTIFICATION OF SCE INDUCTION BY AXONS
From our analyses we found that the biological stimulus to obtain sustantial 
luciferase activation is the induction of myelination. However even if  the number of 
fibers strongly positive for luciferase parallel those positive for MBP as detected by 
immunofluorescence, the biochemical analyses revealed that the absolute values 
measured after dl5 of ascorbic acid treatment are only 2-3 fold induced above that of 
stable integration in chromatin.
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The most likely explanation for this discrepancy is suggested by 
immunofluorescence analysis for luciferase. The majority of cells contact axons, but do 
not upregulate luciferase, nor form myelin. A minority of cells do upregulate luciferase 
and form myelin. This is sensible, because up-regulation of MBP transcription 
(reported by luciferase) just precedes myelin formation. Our weighting calculation 
aimed to adjust for the diluting effect of the majority (70%) of uninduced cells (20% of 
cells do not contact axons) and it shows that the robustly induced cells (10%) activate 
luciferase expression 150-fold over the basal level in constructs without SCE and 
without axons.
This is a rough approximation, and may be an understimate for several reasons. 
First, when comparing the specific activity of luciferase from 9.0Kb with axons to the 
8.4Kb without axons, the proteins are assumed to be similarly from SC, but in co­
cultures, neurons contribute 40% of protein, reducing the luciferase specific activity 
proportionately. Second, the weighting calculation assumes that the proportion of SC in 
the two categories is stable after dl2-dl5. But we counted SC directly and we found 
that they increase 2.5-fold between dO and dl5. We measured proteins in parallel and 
they increase proportionately. Since most of these cells are dividing, they are not 
myelinating, and will tend to dilute luciferase activity, while contributing protein. Thus 
the luciferase peak at dl2-dl5 is an underestimate.
Other explanations for reduced induction in the population of SC in co-culture 
include a specific effect of plasmid integration sites on myelin gene expression. But 
this is much less likely; in fact our stably transfected SC can myelinate and the myelin 
sheaths are normally compacted, as shown both by electron microscopy and 
immunofluorescence. Moreover we did not find a significant difference in the number 
of fibers that are myelinated between our stably SC and wild type SC used as a control 
(data not shown).
It should not be surprising that a majority of cells are non-induced, in fact it is 
possible that not all SC are competent for immediate luciferase induction. The process 
of myelination, even in this culture system, requires that SC exit the cell cycle, take a 
1:1 relationship with neurites, allow basal lamina formation and induce the generation 
of myelin. The signals involved in this process are not completely understood, but this 
is not an all or none mechanism. This is underlined by the fact that even in mature
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cultures the majority of nerve fibers are ensheathed but not myelinated (Salzer and 
Bunge, 1980).
To indirectly control for these changes and to monitor changes in protein 
concentration that can affect the calculation of luciferase specific activity, we estimated 
the SC number in our co-culture and we found that they still increase even during 
myelination induction. This is in partial agreement with previous studies performed on 
SC proliferation in this system (Salzer and Bunge, 1980). Even if  the system used in 
this study was a little different, the authors described an initial burst in SC proliferation, 
due to the presence of neurons, and a subsequent decrease in its rate. Differences 
include that we made nuclei counting as well as protein determination on cultures 
performed on 35mm collagen-coated plastic dishes, while all previous studies that 
checked for SC proliferation rate in this system, were performed in collagen coated 
coverslips. The amount of SC added back to re-populate the culture is different and it is 
possible that the rate of proliferation is influenced by the initial numbers of plated SC. 
In addition they found that even after myelination, proliferation continues at lower rate 
in the peripheral region of the culture. It is not surprising that we found an increase in 
SC number, in fact the difference can be due to the geometry of our culture system.
We also showed that the activation is present only after the myelination process 
is induced, strongly supporting the idea that this is the correct system in which it is 
possible to investigate mechanisms of transcriptional regulation of myelin genes.
DIFFERENTIAL TRANSCRIPTIONAL REGULATION IN  SC AS COMPARED TO OL
These studies, beside the identification of promoter sequences, confirmed that 
although MBP is expressed in both central and peripheral myelin, the mechanisms that 
govern its transcription are completely different in OL as compared to SC. Supporting 
the idea of the existence of different mechanisms came from in vivo analyses of the 
entire 9.0Kb of the MBP promoter (Forghani et a l,  2001). Another confirmation that 
the mechanisms of transcriptional regulation of the MBP gene are different between SC 
and OL came also from the analysis of Nkx2.2 transcription factor null mutants, in 
which the MBP expression is affected only in OL but not in DRG satellite cells (which 
usually behave like SC) (Qi et a l, 2001). Even the different developmental origins of 
SC and OL support the idea that even if they have similar function and they are
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expressing a similar set of myelin proteins, they could have a different subset of 
transcription factors that are responsible for their specific function. The analysis of the 
MBP promoter is particularly interesting, because it is present in both CNS and PNS but 
it is clearly differentially regulated at the transcriptional level.
Interestingly, the only region in which we found the same binding in SC as well 
as OL, is region 3 in which there is a consensus-binding site for a member of the PPAR 
family of transcription factors. These are ligand-activated transcription factors 
composed of at least three isoforms (a,p/ô,Y) belonging to the family of orphan 
receptors (Kliewer et a l ,  1999). They are involved in the regulation of lipid 
metabolism, production and homeostasis. The |3/5 isoform is expressed in immature OL 
(Granneman et a l, 1998) and treatment of cultured OPC with specific PPARô agonists 
induces an enrichment in membrane formation (Saluja et a l, 2001). The fact that we 
found a common binding site for this family of transcription factor in SC as well as in 
OL is not arguing against a possible role of PPAR in SC. The mechanism of MBP 
activation, as for other genes, is composed by many transcription factors and it is 
possible that PPAR is a common one present both in SC and in OL, but the specificity 
of SCE behaviour is given by unidentified co-factors in SC as compared to OL.
Nevertheless it is also possible that PPAR plays a different role in SC and in OL. 
Many transcription factors in fact mediate different functionality, like activation or 
repression, depending on different conditions such as cellular amount, the presence of 
various domains as well as interactions with other transcription factors. Examples of 
these transcription factors are W Tl, p53, Pax-5. W Tl, the Wilms tumor suppressor 
protein, possesses independent activation and repression domains that may interact with 
different cellular proteins (Rauscher et a l,  1990). On the contrary in p53 different 
functions are mediated by different cellular concentrations, in fact it can activate at high 
concentrations and repress at lower levels (Kristjuhan et a l ,  1995). The same 
mechanism has been described for another transcription factor Pax-5, which at low level 
activates transcription from high affinity binding sites but at higher concentrations 
represses transcription from low affinity binding sites (Wallin et a l, 1998).
The existence of these different mechanisms is particularly relevant not only for 
myelination, but also for re-myelination. In fact SC re-myelinate better than OL after 
nerve damage and the mechanisms that account for these differences in myelination are
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likely to be the same also in re-myelination. During re-myelination, SC dedifferentiate 
to a pro-myelinating stage and they turn on the same transcriptional factors that are 
involved in their development. (Ghislain et a l, 2002). Comparing the transcriptional 
mechanisms that govern the behaviour of this enhancer can be indirectly important to 
clarify the mechanisms that control re-myelination events. However our analysis 
strongly suggests that only with co-cultures is it possible to correctly estimate the 
mechanisnis involved in MBP transcription, which are relevant not only in myelination 
but also in re-myelination mechanisms at least in PNS.
CONCLUSIONS AND FUTURE DIRECTIONS
In our studies we described a system in which it is possible to analyse MBP 
regulation in detail. We were in fact able to functionally dissect 9.0Kb of the MBP 
promoter. More interestingly we showed that a distal region located at the 5’-end of the 
promoter is a specific SC enhancer (SCE), whose function is mediated by a series of 
combinatorial components. We also showed that MBP transcriptional mechanisms 
differ between SC and OL not only at the level of the proximal promoter, but also in 
SCE. The setting up of a co-culture system between our stably transfected SC and DRG 
neurites, allowed us to recapitulate the full activation observed in vivo in transgenic 
mice. We also showed that not only 9.0Kb of the MBP promoter are axonally 
regulated, but that SCE is a target sequence for a signal coming from the axons that are 
responsible for a strong induction of the MBP gene during myelination.
Our ability to completely restore the activation observed in transgenic mice with 
the co-culture system can be used to further investigate SCE. We can in fact create 
stably transfected SC bearing both random SCE deletions and transversion mutations, 
and use these SC to re-populate DRG neurites in the co-culture model. Since the co­
culture model is a more physiological system, and since we can exactly control the 
myelination process, we can use this system to further dissect SCE and identify regions 
inside it responsible for the activation of the MBP gene.
Our analyses also showed that luciferase induction occurs only in those SC that 
are strictly in contact with axons. Based on this observation we can hypothesise that the 
axonal signal/s responsible for reporter gene induction is present on the axonal 
membrane. In principle, we can prepare axonal membranes and add them to our 9.0Kb
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stably transfected SC. If our hypothesis is correct we should be able to restore the same 
activation observed in our co-culture experiments. We can also consider the possibility 
to fractionate this membrane preparation in order to characterise the molecule/s that are 
responsible for MBP induction.
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Chapter 4
MATERIALS AND METHODS
4.1 PLASMID CONSTRUCTS
All plasmids containing the firefly luciferase gene were generated by cloning the 
elements in the promoterless pXPl construct, derived from a pSV vector, containing the 
(3-lactamase gene, an E. coli origin of replication and a sequence derived from SV40 with 
multiple cloning sites (Nordeen SK, 1988). All MBP promoter fragments were derived
from a pBluescript SK' plasmid containing 9.0Kb of the mouse MBP promoter (a 
generous gift from A. Peterson).
Restriction and modification enzymes were provided by Promega Corp., or New 
England Biolabs Inc. and used according to manufacturer’s instructions.
- pX9.0MBP plasmid was generated by removing 9.0Kb of the MBP promoter from 
the original plasmid using SacII/Sall restriction enzymes. The SacII extremity was 
filled-in using T4 DNA polymerase and the fragment, after gel purification, was 
cloned into the pXPl vector previously cut with Smal/Sall restriction enzymes.
- pXSAKbMBP plasmid was generated from the pX9.0MBP plasmid. The plasmid 
was cut using Nael restriction enzyme. The Nael fragment (511 bp) was removed, 
gel purified and the plasmid was re-ligated.
- pXô.OMBP plasmid was generated from the pX9.0MBP plasmid. It was cut using 
Kpnl restriction enzyme. The Kpnl fragment, containing the region from 9.0Kb to 
6.0Kb of the MBP promoter and part of the polylinker of pXPl, was gel extracted 
and the plasmid re-ligated.
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pXS.lMBP  was generated by cutting the original plasmid from Peterson using 
EcoRV/Xbal restriction enzymes. The Xbal extremity was filled-in using the DNA 
Polymerase I Large (Klenow) fragment enzyme. The fragment was gel purified and 
cloned into the pXPl vector cut at the Smal restriction site and dephosphorylated.
plasmid was generated from the pX3.1 MBP plasmid. A 1.9Kb fragment 
was created by cutting it at Sacl/Sall sites and, after gel purification, it was cloned 
into the pXPl vector cut at Sacl/Sall restriction enzymes.
pX256MBP was generated from pX9.0MBP. The 256nt fragment was created by 
cutting the original plasmid with Stul/Hindlll and, after gel purification, it was 
cloned into the recipient vector pXPl previously cut at Smal/Hindlll sites.
pXPO plasmid, containing 1.1Kb of the PO promoter, was generated by cutting the 
P0CAT3 plasmid using Hindlll restriction enzyme. The fragment was gel purified 
and cloned into the recipient vector pXPl cut at Hindlll site and dephosphorylated.
pXPOE and pXPOEr were generated by cloning SCE, in both orientations, upstream 
of pXPO plasmid. SCE fragment was prepared from the original Peterson plasmid 
by cutting it with Sad restriction enzyme. The fragment was gel purified and cloned 
into the Sad site upstream of the 1.1Kb region of the PO promoter. Restriction 
enzyme digestions determined the correct orientations.
pT109EMBP and pT109ErMBP were created by cloning SCE, in both orientations, 
in the Sad site upstream of pT1091uc. This plasmid contains 109bp of the 
promoter of the Thymidine Kinase gene upstream of transcription start site of 
pXPl plasmid. Restriction enzyme digestions determined the correct orientations.
pX256EMBP andpX256ErMBP were created by cloning the Sad fragment containing 
SCE, in both orientations, into the Sad site upstream of pX256MBP plasmid. 
Restriction enzyme digestions determined the correct orientations.
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- pLOXluc was created to generate a probe for the Southern blot analyses on genomic 
DNA prepared from stably transfected SC. The luciferase fragment Xbal/BsrGI 
(+128 to +571) was cut, gel purified and cloned in the Xbal/BsrGI site of the 
pLOX(BsrGI) plasmid available in laboratory.
SCE INTERNAL DELETIONS
We.created a series of internal deletions of approximately lOObp inside SCE (see 
Fig2.10a). All deletions were initially produced in pBluescript SK(+) containing SCE, 
and then cloned in the original context of pX9.0MBP. Four out of six deletions were 
generated using unique restriction sites in SCE, while two of them (Ad and Ae) were 
generated by PCR and then checked by sequence analysis.
In particular:
Aa: comprises the deletion from +1 (SacII) to +103bp(BstEII)
Ab: comprises the deletion from +103(BstEII) to +204bp(StuI)
Ac: comprises the deletion from +204(StuI) to +290bp(BglII)
Ad: comprises the deletion from +290(BglII) to +400bp 
Ae: comprises the deletion from +400 to +519bp(NaeI)
Af: comprises the deletion from +519(NaeI) to +588bp(SacI)
- Aa: the deletion was created by cutting the pBluescript containing SCE with SacII
and BstEII restiction enzymes. Both ends were filled-in by T4 DNA polymerase 
and, after gel purification, ligated.
- Ab: the deletion was created by cutting the pBluescript containing SCE, with
BstEII/StuI restriction enzymes. The BstEII site was the filled-in by DNA 
Polymerase I Large (Klenow) fragment. The plasmid was gel purified and then 
ligated.
- Ac: the deletion was created by cutting the pBluescript containing SCE, with
Bglll/StuI restriction enzymes. The Bglll extremity was blunted by DNA
Polymerase I Large (Klenow) fragment. The plasmid was gel purified and then 
ligated.
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- Ad: the deletion was generated by PCR using as template pBluescript SK (+)
plasmid containing SCE cloned in the antisense orientation. Primers used in the
reaction were designed in order to have a deletion from 290nt to 400nt (see PCR 
section). Deleted SCE was confirmed by sequence analysis.
- Ae: the deletion was generated by PCR using as template a pBluescript SK (+)
plasmid containing SCE cloned in the antisense orientation. Primers used in the
reaction were designed in order to have a deletion from 400nt to 519nt (see PCR 
section). Deletion was confirmed by sequence analysis.
- Af: the deletion was generated in three steps. We first subcloned the region from - 
9.1Kb to -7.2Kb of the MBP promoter in pXPl promoterless plasmid containing 
SCE cloned in the antisense orientation. In the second step we cut this plasmid 
using Ecll36II/NaeI restriction enzymes and after gel purification, it was ligated. In 
this second plasmid we created the final deletion. In the third step we recovered the 
deletion and, by cutting the recipient plasmid Ecll36II/XhoI, we cloned it in 
pX9.0MBP previously cut with XhoI/BamHI and filled-in.
Deletions from Aa to Ae were removed from pBluescript recipients using 
BamHI/MluI and cloned in the pX9.0MBP previously cut with the same restriction 
enzymes.
SCE MUTATIONS
Mutations were generated by PCR in a pBluescript SK(+) plasmid and 
sequenced (see PCR section). SCE was divided in two parts and subcloned in 
pBluescript SK(+) plasmid. After mutagenesis, each fragment, containing the mutated 
site, was removed from pBluescript SK(+) using BamHI/MluI restriction enzymes and 
cloned in the pX9.0MBP previously cut with the same restriction enzymes.
PROXIMAL AND DISTAL DNASE I  HYPERSENSITIVE PROBE
The proximal probe was generated by PCR using primers based on the sequence 
of the mouse Golli MBP exon 5C (Campagnoni et a l, 1993). After amplification, the
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DNA was inserted in a pBluescript SK(+) plasmid. The distal probe contains 0.2Kb of 
the MBP promoter located at -12.6Kb of the MBP mouse promoter. This region was 
obtained from a plasmid kindly provided by A. Peterson. The fragment was prepared 
by digestion with BamHI/PstI restriction enzymes, gel purified and cloned in the 
pBluescript SK(+) plasmid previously cut with BamHI/Pstl.
All plasmids were prepared for transfection experiments, with a Quiagen Maxi 
kit plasmid (Quiagen, Italy) according to manufacturer’s instructions. Usually XI1 Blue 
host bacteria were grown overnight in 500ml of LB medium, and the day after plasmid 
DNA was extracted. DNA preparation and concentration were determined both by 
restriction enzyme digestion, and spectrophotometer measurement at a wavelength of 
260nm (Ultrospec 2000, Pharmacia Biotech).
LB medium (IL): - lOg Bacto Tryptone
- 5g Yeast Extract 
-lOgNaCl
The pH was adjusted to 7.0 with NaOH, and the medium was sterilised by autoclaving.
4.2 POLYMERASE CHAIN REACTION (PCR)
DNase I  HYPERSENSITIVE PROBE
Primers used in the amplification of mouse genomic DNA to generate the 
proximal probe for the DNA hypersensitive assay are: 
sense primer: 5’-TTGGATCCTCCACGGCTCTAG-3' 
antisense primer: 5'-GGAAGCTTTGTTAGCAAGTGAGA-3'
Reaction is produced in a final volume of 25pl, and it contains:
- 2.5ul of lOx PCR buffer lOmM MgCh
- Ipl of dNTP lOmM
- Ipl of primer 1 50pmol/p,l
133
Materials and Methods
- 1 jil of primer 2 50pmol/pl
- 0.25pl of Taq DNA polymerase 5p/pl (Applied Biosystems)
-1 pi of mouse genomic DNA
PCR conditions are: 
dénaturation: 94°C x 30" 
renaturation: 55°C x 1' 
polymerisation: 72°C x 1'
All steps were repeated for 25 cycles, and at the end the reaction was left 10' at 
72°C to complete the polymerisation step. At the end templates were cut at 
Hindlll/BamHI sites and cloned in pBluescript SK(+) previously cut with the same 
restriction enzymes.
MUTAGENESIS
Mutagenesis was generated by nucleotide transversions using PCR techniques. 
We first amplify the template with an external primer designed to it, and an internal one, 
which contains the mutation. In the second round of PCR the template produced in the 
first PCR was amplified using only external primers, in order to generate the mutation. 
All mutations were confirmed by sequence analysis.
Internal primers used in the amplification are:
- region 1 : (nt 33 - nt 42)
sense: 5'-CTTTCATCTCGTACTCCTTTCTGTCATAGCAAGTCCAC-3' 
antisense: 5'-ACAGAAAGGAGTACGAGATGAAAGGCATGTGGCTGCCG-3'
- region 2: (nt 112 - nt 127)
sense: 5'-GGTGACCCACCTAAACTTAGTAACGCGGCAGAAGTATTCCATCA-3' 
antisense: 5'-TCTGCCGCGTTACTAAGTTTAGGTGGGTCACCTGGGAGGGCACA-3'
- region 3: (nt 372 - nt 380)
sense: 5'-CTTAACAAGTCAAGTGCCCCAGACCTCCTCCTTCA-3' 
antisense: 5'-TGGGGCACTTGACTTGTTAAGTGGCACCCAGCCAT-3'
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The external primers used are:
sense: 5’-ACCCTCACTAAAGGGAACAAAAGC-3'
antisense primer: 5'-GAGGTCGACGGTATCGATAAGCTT-3'
Both reactions were produced in a final volume of lOOpl, and the reaction mixture 
contains:
- lOpl of lOx PCR buffer 15mM MgCh
- 2pl of dNTP lOmM
-1 pi of primer 1 200pmol/pl
- 1 pi of primer 2 200pmol/pl
- 0.5pl of Taq DNA polymerase 5p/pl (Applied Biosystems)
- Ipl of DNA template Ipg/pl
Conditions of the cycle used in the first PCR are: 
dénaturation: 94°C x T 
renaturation: 50°C x 2' 
polymerisation: 72°C x 3'
All steps were repeated for 25 cycles, and at the end the reaction was left 10' at 
72°C to complete the polymerisation step.
Conditions of the cycle used in the second PCR are: 
dénaturation: 94°C x 1' 
renaturation: 50 °C x 2' 
polymerisation: 72°C x 3'
All steps were repeated for 25 cycles, and at the end the reaction was left 10' at 
72°C to complete the polymerisation step.
DELETIONS
Deletions inside SCE are generated with two different PCRs on a pBluescript 
SK (+) plasmid containing SCE. In the first PCR we amplified the template using an 
external primer designed to it, and an internal one in which half of the primer can exactly
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match the template, whereas the other half is complementary to the region downstream 
of the one we deleted. In the second round of PCR the template produced in the first 
was amplified using only external primers, in order to generate the deletion. All 
deletions were confirmed by sequence analysis.
Internal primers are:
Ad: 4
sense primer: 5'-CCAGGTAGGAGCCAGGTTCTGGTGACAGTATCCGGG-3' 
antisense primer: 5'-CCCGGATACTGTCACCAGAACCTGGCTCCACCTGG-3'
Ae:
sense primer: 5'-CCCAGACCTCCTCCTTCAGGCACCCTCGCACCCACC-3'
antisense primer: 5'-GGTGGGTGCGAGGGTGCCTGAAGGAGGAGGTCTGGG-3'
External primers are:
sense: 5'-ACCCTCACTAAAGGGAACAAAAGC-3' 
antisense primer: 5'-GAGGTCGACGGTATCGATAAGCTT-3'
Both reactions are produced in a final volume of lOOpl, and the reaction mixture 
contains:
- lOpl of lOx PCR buffer 15mM MgCh
- 2pl of dNTP lOmM
- Ipl of primer 1 200pmol/pl
- Ipl of primer 2 200pmol/pl
- 0.5pl of Taq DNA polymerase 5U/pl (Applied Biosystems)
- Ipl of DNA template Ipg/pl
Conditions of the cycle used in the first PCR are: 
dénaturation: 94°C x V 
renaturation: 55°C x 2' 
polymerisation: 72°C x 3'
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All steps were repeated for 25 cycles, and at the end the reaction was left 10' at 
72°C to complete the polymerisation step.
Conditions of the cycle used in the second PCR are: 
dénaturation: 94°C x 1' 
renaturation: 58°C x 2' 
polymerisation: 72°C x 3'
All steps were repeated 25 cycles, and at the end the reaction was left 10' at 
72°C to complete the polymerisation step.
4.3 NUCLEAR EXTRACT PREPARATION
TISSUES
Nuclei used in the EMSA analysis and in the DNasel footprinting assay were 
dissected from 30 day rats, whereas nuclei used in DNase I hypersensitivity assay were 
obtained from 30 day CDl mice. After dissection tissues were washed with PBS IX to 
remove all remaining blood, resuspended in homogenisation buffer (Im l/lg of tissue) and 
minced with scissors. Tissues were put in a potter homogeniser containing 12.5ml of 
homogenisation buffer + 2.5ml of tissue and they were homogenised with 2-3 strokes at 
800rpm. Nuclear integrity was checked with trypan blue staining. The homogenate is 
centrifuged for 1 hour at 4°C at 24000rpm using an SW28 Beckman rotor in a Beckman 
ultracentrifuge. The pellet containing nuclei was recovered and washed twice in 5ml of 
swelling buffer plus protease inhibitors and 1/10 of PAL-P. Nuclei were centrifuged 10’ 
at 4°C at 2000rpm. At this point nuclei used in the DNase I hypersensitivity assay, 
were resuspended in W solution plus 50% glycerol and stored at -20°C to perform the 
assay; whereas nuclei derived from rats were processed to obtain nuclear extracts. To 
prepare nuclear extracts, they were resuspended in 2-3 vol of extraction buffer plus 
protease inhibitors and left on ice 30'. After centrifugation 30' at 14000rpm at 4°C the 
supernatant was recovered and dialysed against dialysis buffer for 5 hours at 4°C. At 
the end it was aliquoted and stored in liquid nitrogen. Protein concentration was 
checked with the Biorad Assay according to manufacturer’s instructions.
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CELLS
Approximately 400 million Schwann cells were grown to confluence in standard 
growing conditions and left in the presence of 20pM forskolin three days before 
collecting them. Cells were trypsinized and washed three times in PBS Ix to remove all 
remaining media and then processed to obtain nuclei. Cells were passed through a 
dounce (pestle A) homogeniser approximately 80-times to obtain free nuclei, whose 
integrity was checked with trypan blue. Nuclei were then processed, as described 
before, to prepare nuclear extracts.
Homogenisation buffer: - 2.0M Sucrose
- lOmM Hepes pH7.6
- 15mM KCl
- ImM EDTA
- 0.15mM Spermine
- 0.5mM Spermidine
-1:100 v:vTPL lOOxmix
- 0.5mM DTT
- 0.5mM PMSF
TPL lOOxmix: 2.1 mg/ml Aprotinin 
70pg/ml Pepstatin 
70pg/ml Leupeptin 
lOmM Hepes pH7.8
Swelling buffer: 20mM Hepes pH7.8 
ImM MgCl2 
0.5mM CaCl2 
ImM DTT 
ImM PMSF
PAL-P: 40mM Tris pH8.0 
ImM MgCl]
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Extraction buffer: lOOmM Tris pH 7.9 
420mM NaCl 
5% Glycerol 
5mM MgCl2 
ImM BDTA 
ImM DTT 
0.5mM PMSF
Dialysis buffer: 20mM Hepes pH7.8 
20% Glycerol 
lOOmM KCl 
0.2mM EDTA 
ImM DTT 
0.5mM PMSF
4.4 DNase I HYPERSENSITIVITY
Nuclei were washed in RSB buffer three times to remove all remaining glycerol, 
and then processed with DNase I. Usually 2x10? nuclei were digested with 0.05 to 2OU 
of DNase I (Boehringer-Mannheim) 10’ at 37°C in a total volume of 2 ml. Reactions 
were stopped by the addition of Ix DRO-Stop solution and left 1 hour at 37°C, after 
the addition of RNase I at a concentration of 100|ig/ml. DNA was extracted with 
Proteinase K leaving the samples at 50°C overnight. Samples were then processed three 
times with phenol/chloroform, precipitated and resuspended in lOOpl of TEpHS.O. The 
extent of digestion was determined by electrophoresis of an aliquot of DNA on a 1% 
(w/v) agarose gel in Ix TBE buffer.
RSB buffer: - lOmM Tris pH7.5
- lOmM NaCl
- 3mM MgCl2
- 300mM Sucrose
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Solution W: 60mMKCl 
15mM NaCl 
12.5mM Tris pH7 
2.5mM Tris pH8 
320mM Sucrose 
0.15mM Spermine 
0.5mM Spermidine 
0.05mg/ml DTT
5x Dro-Stop solution: 40mM EDTA pH8.0 
0.5% Lauril Sarcosyne 
200pg/ml Proteinase K
4.5 SOUTHERN ANALYSIS
Genomic DNA was completely cut using the appropriate restriction enzymes, 
and run on a 1% (w/v) agarose gel in Ix TAE buffer. For Southern blot analysis in 
DNase I hypersensitivity assays, DNA was digested with BamHI restriction enzyme; 
whereas to characterise pools of stably transfected SC, DNA was digested with Xbal 
restriction enzyme. The gel was denatured 45' in 0.5M NaOH/1.5M NaCl, and 
renatured 45' in l.OM Tris pH8.0/1.5M NaCl. DNA was transferred overnight onto a 
cellulose membrane (Duralon, Stratagene) through capillarity in SSC 20x. The day after 
DNA was fixed on the membrane by UV-cross linking (Stratagene). The filter was 
incubated with probe overnight at 42°C, in 50% Formamide (Fluka), 5x SSPE, 1%SDS, 
5x Denhardt's, lOOpg/ml ssDNA. The day after the filter was washed three times by 
increasing the stringency to remove non-specific signals. The last wash was performed 
at 65°C in 0.2xSSC, 0.1%SDS. The membrane was exposed to Kodak XAR film 
overnight at -80°C, with an intensifying screen.
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4.6 DNase IFOOTPRINTING
Fragments used in the DNasel footprinting experiments were generated by 
subdividing SCE in 5 overlapping regions using unique restriction enzyme sites. All the 
fragments were blunted and cloned into the Smal site of pBluescript SK+. The 
orientation was then determined by sequencing. In particular:
- fragment 1 : from Ncol site (+72bp) to Bglll site (+290bp)
- fragment 2: from Bglll site (+290bp) to Mlul site (+570bp)
- fragment 3: from SacII site (+lbp) to BseRI site (+195bp)
- fragment 4: from BseRI site (+195bp) to BseRI site (+390bp)
- fragment 5: from BseRI site (+390bp) to Sad site (+588bp)
40-80pg of nuclear extract were incubated with the Klenow end-labelled probe 
and digested with 500ng of DNasel (Boehringer Mannheim, dissolved in LSBD buffer). 
The binding reaction was carried out in a final volume of 50pl containing 1/10 vol. of 
KM buffer, 2pg of poly-[d(I-C)], nuclear extract (eventually diluted in LSDB buffer) 
and the probe (30,000cpm). All reactions were maintained for 45' on ice. DNase I 
digestion was performed at room temperature by adding the DNase for 2'. The reaction 
was then immediately stopped with lOOpl of Stop solution and extracted with 1:1 
(vol/vol) phenohchloroform. DNA was precipitated with the addition of Ipg of tRNA 
as a carrier. All reactions were resolved on a 6% poliacrylamide denaturing gel. The gel 
is dried and exposed to Kodak XAR film overnight at -80°C, with an intensifying 
screen. As a ladder we used a G+A reaction of the same fragment treated using the 
Maxam-Gilbert method.
G+yf LADDER PREPARATION
Approximately 200,000cpm of the same probe are put in a final vol. of lOpl of 
dH20 plus Ipg/pl of ssDNA (Sigma) as carrier. 25pl of pure Formic Acid (Fluka) was 
added to DNA 5’ at room temperature, to get chemical modifications. The reaction was 
stopped with 200pl of HZ solution. The chemically modified probe is precipitated 
twice and nucleotides were modified with IM Piperidine (Fluka) 30' at 90°C.
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Piperidine is removed by lyophilisation in a speedvac overnight, and washed many 
times to remove it completely the day after.
LSDB buffer: - 50mM KCl
- ImM MgCl2
- 25% Glycerol
- 20mM Tris pH8.0
- ImM DTT
KM buffer: 300mM KCl 
20mM MgCl2
HZ solution: 30mM EDTA pH 8.0 
200mMNaCl ,
1% SDS
lOOug/ml yeast tRNA
HZ Stop solution: 300mM Sodium acetate pH7.5 
O.lmM EDTA pH 8.0 
25ug/ml yeast tRNA
4.7 EMSA AND PPAR SUPERSHIFT
Synthetic double strand oligonucleotides containing potential binding sites were 
commercially produced. Complementary pairs of oligonucleotides were annealed in 
150mM NaCl in TE by heating 2' at 85°C, followed by slow cooling to room 
temperature. Oligonucleotides were end-labelled by filling or replacing 5' protruding 
ends with DNA Klenow polymerase enzyme. Unincorporated radiolabelled 
oligonucleotides were removed by column purification. The binding reaction was carried 
out in a final volume of 20pl containing lOOmM or 50mM KCl, 2pg of poly-[d(I-C)], 
nuclear extracts (eventually diluted in dialysis buffer) and the probe (60,000cpm). All
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reactions were maintained 45' on ice with a pre-incubation of 30' when a cold competitor 
was added. Binding was resolved on a 2xTAE, 8% or 5% acrylamide non-denaturing 
gel. The dried gel is exposed to Kodak XAR film overnight at -80°C, with an 
intensifying screen. EMSA supershift is made in the same way as standard EMSA 
except that the binding reaction, and antibody incubation, were performed 20' at room 
temperature. The antibody is a commercially available antiserum directed against mouse 
PPAR (Alexis Biochemical Corp).
Oligonucleotides used in EMSA analysis are:
- region 1 (nt 24-nt 55):
sense: 5'-GCCTTTCATAGATGCAGAATTTCTGTCATAGC-3' 
antisense: 5'-GCTATGACAGAAATTCTGCATCTATGAAAGGC-3'
- - region 2 (nt 103-nt 143):
sense: 5'-GGTGACCCCAAGCCCAGGCTGCCAGCGGCAGAAGTATTCC-3' 
antisense: 5'-GGAATACTTCTGCCGCTGGCAGCCTGGGCTTGGGGTCACC-3'
- - region 3 (nt 362-nt 396):
sense: 5'-GCCACTTAACCCTGACCTGGCCCCAGACCTCCTCC-3' 
antisense: 5'-GGAGGAGGTCTGGGGCCAGGTCAGGGTTAAGTGGC-3'
- - region 4 (nt 530-nt 569):
sense: 5'-CGCACCCACCCACGCTTAATGGATATGGAGACATTGAGCC-3' 
antisense: 5'-GGCTCAATGTCTCCATATCCATTAAGCGTGGGTGGGTGCG-3'
As unrelated competitor we used oligonucleotides encompassing region (nt-149- 
nt-116) of human MBP proximal promoter.
sense: 5'-GCGCACAGCGGACCCGAAGAATGCCTGGCAGGAT-3' 
antisense: 5'-ATCCTGCCAGGCATTCTTCGGGTCCGCTGTGCGC-3'
As a positive control in EMSA supershift we used synthetic oligonucleotides 
designed fi'om the acyl-CoA oxidase promoter previously shown to contain a PPAR 
responsive element (Schulman et a l, 1998):
sense: 5'-GACAGGGGACCAGGACAAAGGTCACGTTCGGGAGT-3' 
antisense: 5'-ACTCCCGAACGTGACCTTAGTCCTGGTCCCCTGTC-3'
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4.8 CELL CULTURE AND TRANSIENT TRANSFECTION
SCHWANN CELLS
Schwann cells were prepared from sciatic nerve of P3 Sprague-Dawley rats 
(Charles River). Sciatic nerves were minced and incubated at 37°C, 30’ in 0.1% (wt/vol) 
Collagenase type IV (Boehringer Mannheim, Germany) and in 0.2% trypsin (GIBCO) 
prepared ip Hank's balance salt solution. Reactions were stopped by the addition of 
1/10 of heat inactivated Foetal Calf Serum (FCS). After mild triturating with a Pasteur 
pipette, cells were cultured in 100-mm plastic dishes covered by poly-L-Lysine 
(Sigma). Schwann cells were plated in Dulbecco's minimal essential medium (DMEM) 
supplemented with 10% FCS. Contaminating fibroblasts were eliminated by treatments 
with the antimitotic agent cytosine arabinoside (10-^ M, Sigma) and antibody- 
complement-mediated cell lysis, using the monoclonal anti-Thy 1.1 antibody (undiluted 
hybridoma culture supernatant, American Tissue Culture Collection), and rabbit 
complement (Sigma). Cells are then passaged three times to expand in DMEM + 10% 
FCS + 2pM Forskolin (Calbiochem) and crude GGF prepared from bovine pituitaries 
(Brockes et a l, 1980; Porter et al, 1986). The day before transfection 2.5x10^ cells 
were plated in a 60mm plastic dish covered by poly-L-Lysine (Sigma).
OLIGODENDROCYTES
Oligodendrocyte precursors were prepared from brains of P6 Sprague-Dawley 
rats (Charles River). After mechanical dissociation, brains were incubated 30' at 37°C in 
lOOpg/ml of DNase I (Sigma) and 0.1% trypsin (Sigma) prepared in PBS Ix. The 
reaction is inhibited by the addition of Calf Serum. Cells were then filtered through 
filters of 140pm and 25pm in diameter. Approximately 3x10^ cells were cultured in 
60mm plates (Nalgene) in MEM and supplemented medium. The day after medium 
was switched to a defined medium (FI2 and supplements), and left in this medium for 4 
days. Precursors were differentiated to mature oligodendrocytes by the addition of 1% 
human PPP (Poor Platelet Plasma) and 8% PDGF (R&D Systems).
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MEM supplement medium: Eagle's Minimal Essential medium (GIBCO) 
Ix Non essential Aminoacids (GIBCO)
5x Calf serum 
5x Foetal Calf serum
Ix Penicillin/Streptomycin solution (GIBCO)
F 12 supplement medium: F12 medium (GIBCO)
2x MEM aminoacid (GIBCO)
Ix MEM vitamins (GIBCO) 
lOOu/ml Insulin (Sigma) 
lOmg/ml Human Transferrin (Sigma)
0.5mg/ml Hydrocortisone (Sigma) 
lOnM T3 (Sigma)
3nM Sodium Selenite (Collaborative Research) 
Ix Penicillin/Streptomycin solution (GIBCO)
HeLa CELLS, L CELLS, Cos? CELLS
All cell lines were maintained in a medium containing DMEM supplemented 
with 10%FCS, 2mM glutamine and lOOpg/ml Penicillin/Streptomycin solution. The 
day before transfection, 2.5x10^ cells were plated on 60mm plastic dishes.
TRANSFECTION
All cells were transfected using CaPO^ precipitation as previously described 
(Graham and VanDerErb, 1973). An hour before transfection, cells were put in 
DMEM, 10%FCS, 2mM glutamine and lOOpg/ml Penicillin/Streptomycin solution. 
Usually lOpg of DNA were transfected per dish (5pg of supercoiled pBluescript SK (+) 
DNA as a carrier, 2.5pg of supercoiled plasmid containing the luciferase gene as a 
reporter, and 2.5jig of a pRSVgal plasmid whose activity is a measure of transfection 
efficiency). The amount of supercoiled reporter plasmid transfected was usually 
normalised to molar ratio. Cells were left in the presence of the precipitate for 4 hours 
except SC, which were left 16 hours. Cells were washed twice with HBSS and re-fed in
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the same medium used for culture for 72 hours, before testing luciferase and p-gal 
activity.
4.9 LUCIFERASE ASSAY AND P-GAL ASSAY
Cells were washed twice with PBS Ix to remove medium. Cells were detached 
with a cell scraper and the addition of 200pl of lysis buffer per 60-mm plastic dish. 
After recovery all cellular debris was removed by centrifugation and the supernatant 
was tested for the luciferase and P-gal activity.
LUCIFERASE ASSAY
20pl of cell extract were added to 350pl of reaction buffer and tested in a 
Luminometer (Lumat LB 9501, Berthold). Approximately lOOpl of d-Luciferin (Sigma) 
were injected into each sample. The activity was recovered after 10". Each sample was 
tested in duplicate.
Lysis buffer: - 1% Triton X-100 (Fluka)
- 25mM Gly-Gly solution pH7.8 (Sigma) 
-15mM M gS04
- 4mM EGTA
- ImM DTT
Reaction buffer: - 2.5mM Gly-Gly solution pH7.8
- 2mM ATP (Sigma)
- lOmM MgS0 4  
Injection mix: - 20mM Gly-Gly pH7.8
- 0.2mM d-Luciferin (Sigma)
lOOpl of each extract were added to 1ml of Z-buffer Ix and 200pl of 4mg/ml of 
o-Nitrophenyl-P-D-Galactopyranoside (ONPG, Sigma). The reaction was then
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incubated at 37°C until the sample become yellow. The reaction was stopped by the 
addition of 500jil of IM NaCOg and the extent of substrate hydrolysation was 
measured in a spectrophotometer with a wavelength of 420nm (Ultrospec 2000, 
Pharmacia Biotech).
Buffer Z1 Ox: - 600mM Na2HP0 4
- 400mM NaH2P0 4  
-lOOmMKCl
- lOmM MgCl2
PROTEINASSAY
Protein concentration was measured using a Biorad Assay (Biorad) according to 
manufacturer’s instructions. The substrate was diluted 1:5 in dH20 and protein 
concentration determined relative to a standard curve made with a known amount of 
BSA. Protein concentration was determined in a spectrophotometer with a wavelength 
of 595nm (Ultrospec 2000, Pharmacia Biotech).
4.10 SC STABLE TRANSFECTION
Schwann cells were transfected using CaP0 4  precipitation as previously 
described. An hour before transfection, cells were put in a medium containing DMEM, 
20%FCS, 2mM glutamine, lOOpg/ml penicillin/streptomycin solution, 4pM forskolin 
and crude GGF prepared from bovine pituitaries. Usually 40pg, 30pg or lOpg of 
supercoiled DNA were transfected in 100mm plastic dishes coated with PEL in which, 
the day before, we plated 5x10^ SC. We co-transfected pXPl promoterless plasmid, 
pX3.1MBP, pX8.4MBP, pX9.0MBP with pMAMneo plasmid containing the neo 
gene for positive selection. Plasmids were transfected both at a 5:1 and at a 10:1 ratio. 
Selection of positive clones was made by adding to standard medium 400ug/ml of G418 
(GIBCO). Selected clones, obtained in each plate, were then pooled together by passage 
and tested for luciferase activity, protein concentration and copy number insertions by 
Southern Blot. The final activity of each pool, was measured as a ratio between 
luciferase activity and copy number insertions.
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4.11 DRG-SC CO-CULTURES
Purified DRG neurons were dissociated firom E l5.5 Sprague-Dawley rats 
(Charles River) and placed in culture as previously reported (Kleitman et a l, 1998). 
After excision, DRG were treated with trypsin (0.25% in HBSS, GIBCO) and left at 
37°C 45'. DRG were also mechanically dissociated trough a sterile pasteur pipettes. 
The cell suspension (approximately 3-5 DRG per drop) was plated as a drop onto 
ammoniated rat collagen (0.2 mg/ml. Biomedical Tech. Inc, Stoughton, MA) -  coated 35- 
mm plates (Nalgene) or 12 mm glass coverslips in Cbio media and left overnight. The 
day after medium was changed to E2F medium and cycled on Cbio every other feeding 
for 2 weeks to remove non-neuronal cells. 2.5 weeks after neuronal seeding, Schwann 
cells were added to plates and coverslips (75,000 each one). Co-cultures were kept in 
DM medium for 1 week to allow re-population of neurites. To initiate myelination, co­
cultures were treated with MF medium.
Cbio medium: Eagle's Minimal Essential medium (GIBCO) 
10% FCS
5mg/ml D-glucose (Sigma)
50ng/ml 2.5S NGF (Harlan, Indianapolis, IN)
E2F medium: EMEM
5mg/ml D-glucose (Sigma)
50ng/ml 2.5SNGF 
5pg/ml Insulin (Sigma)
lOpg/ml rat Trasferrin (Jackson Immunoresearch) 
lOOpM Putrescine (Sigma)
20nM Progesteron (Sigma)
30nM Sodium Selenite (Becton Dickinson) 
lOjiM Uridine (Sigma) 
lOpM FdU (Sigma)
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DM medium: 1:1 DMEM/F12 
50ng/ml2.5SNGF 
Spg/ml Insulin (Sigma)
lOpg/ml rat Trasferrin (Jackson Immunoresearch) 
lOOpM Putrescine (Sigma)
20nM Progesteron (Sigma)
30nM Sodium Selenite (Becton Dickinson)
MF medium: Eagle's Minimal Essential medium (GIBCO) 
15% FCS
5mg/ml D-glucose (Sigma)
50ng/ml 2.5S NGF (Harlan, Indianapolis, IN) 
50ug/ml Ascorbic acid (Sigma)
4.12 IMMUNOFLUORESCE
Cells were fixed 10’ in paraformaldehyde and for 15’ in cold methanol. Double 
staining was performed with mouse anti-myelin basic protein mAb (Roche) diluted 
1:300, and goat polyclonal anti luciferase (Promega) diluted 1:100, applied 60’ at room 
temperature. Positivity was revealed with FITC- or TRITC-conjugated secondary 
antibodies, and examined with fluorescence microscope (Olympus AX).
NUCLEAR STAINING
DRG co-cultures were incubated for 1’ with DAPI diluted 1:2500 (Sigma) or 20’ 
at 37°C in PBSlx with Ipg/ml of vital Hoechst (Sigma). After this period of time, cells 
were washed twice with sterile PBSlx and re-fed with their original medium. DAPI 
staining was examined with fluorescence microscope (Olympus AX), while a count of 
nuclei was made at a fluorescence inverted microscope (Zeiss).
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4.13 ELECTRON MICROSCOPY
SC-DRG neuronal co-cultures were fixed for 20’ in 2% buffered glutaraldehyde 
and post-fixed for two hours in 1% osmium tetroxide at room temperature. After 
alcohol dehydration (50-70-95-100%, 10’ each), the samples were embedded in a 
mixture containing Epon hydrophobic resin and ethanol 100% 2:1, 16 hours at 37°C. 
Fixed co-Qultures were then transferred for 48 hours at 60°C to facilitate the removal of 
plastic dishes from cells. After plastic removal, semi-thin sections (0.5 pm) were stained 
with toluidine blue and examined by light microscopy (Olympus AX-70). Ultra-thin 
sections (60nm thick) were stained with uranyl acetate and lead citrate and examined by 
electron microscopy (Zeiss).
4.14 IN VITRO AXOTOMY
SC DRG co-cultures were cut with a disposable sterile scalpel 6 days after 
ascorbic acid addition. The cut was made proximal to neuronal cell bodies. Cultures 
were maintained in the same myelinating medium until dl4, when they were processed 
for nuclear counting, luciferase assay and protein determination as for standard co­
culture.
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